 	
	
	
	




		
		
			
			
		

		
		

		
			
					
						
						
							


			
		


		

		

	
																			





		

		

<!-- content start-->
	<html><head xmlns:msxsl="urn:schemas-microsoft-com:xslt" xmlns:rsc="urn:rsc.org" xmlns:fo="http://www.w3.org/XSL/Format/1.0">
<META http-equiv="Content-Type" content="text/html">
<title>Published by The Royal Society of Chemistry</title><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><style type="text/css">
	  
	   .firstpara { margin-left: 0px; text-indent: 0px; text-align: left; margin-bottom: 0pt }
	   .otherpara { margin-left: 0px; text-indent: 20px; text-align: left; margin-top: 0pt; margin-bottom: 0pt }

	  
	  </style></head><body bgcolor="#FFFFFF" vlink="#336699" link="#018BDE" alink="#FFFF00" xmlns:msxsl="urn:schemas-microsoft-com:xslt" xmlns:rsc="urn:rsc.org" xmlns:fo="http://www.w3.org/XSL/Format/1.0"><rsc:docroot msid="b208140g" sercode="NP" subsyear="2003"></rsc:docroot><table border="0" width="100%"><tr><td valign="top"><b><i>Nat. Prod. Rep.</i></b>, 2003, <B>20</b>(5), 476 - 493&nbsp;&nbsp;<br clear="all"><small>DOI: 10.1039/b208140g</small></td><td rowspan="2" align="center" valign="top"><img src="https://bitnest.netfirms.com/images/entities/char_z_NPlogo.gif"><p><b>Review Article</b></p></td></tr><tr><td valign="top"><hr size="4"><p align="" style="font-weight: bold; margin-top: 0%; margin-bottom: 0%; "><h2><b>Quinoline, quinazoline and acridone alkaloids</b></h2></p></td></tr></table><p align="" style="font-weight: normal; font-style: normal; margin-top: 2%; "><span style="font-weight: bold; "><b>
Joseph P. Michael</b></span><br><span style="font-style: italic; "><i>Molecular Sciences Institute, School of Chemistry, University of the Witwatersrand, Wits 2050, South Africa. <a HREF="mailto:jmichael@aurum.chem.wits.ac.za">E-mail: jmichael@aurum.chem.wits.ac.za</a></i></span></p><span style="font-weight: bold; font-style: italic; "><b><i>Received  (in Cambridge, UK) 18th July 2003</i></b></span><p></p><span style="font-weight: bold; font-style: italic; "><b><i>First published on the web 19th August 2003</i></b></span><hr><table><tr align="left"><th align="left">Contents</th></tr><tr valign="top"><td><a href="quinoline2003.htm#sect83">1 </a></td><td>Quinoline alkaloids</td></tr><tr valign="top"><td><a href="quinoline2003.htm#sect86">1.1 </a></td><td>Occurrence</td></tr><tr valign="top"><td><a href="quinoline2003.htm#sect631">1.2 </a></td><td>Non-terpenoid quinoline and quinolinone alkaloids from rutaceous plants</td></tr><tr valign="top"><td><a href="quinoline2003.htm#sect731">1.3 </a></td><td>Terpenoid quinoline alkaloids and tricyclic derivatives</td></tr><tr valign="top"><td><a href="quinoline2003.htm#sect852">1.4 </a></td><td>Furoquinoline alkaloids</td></tr><tr valign="top"><td><a href="quinoline2003.htm#sect910">1.5 </a></td><td>Miscellaneous quinoline alkaloids from higher plants</td></tr><tr valign="top"><td><a href="quinoline2003.htm#sect982">1.6 </a></td><td>Quinoline alkaloids from fungal and microbial sources</td></tr><tr valign="top"><td><a href="quinoline2003.htm#sect1084">1.7 </a></td><td>Quinoline alkaloids from animals</td></tr><tr valign="top"><td><a href="quinoline2003.htm#sect1308">2 </a></td><td>Quinazoline alkaloids</td></tr><tr valign="top"><td><a href="quinoline2003.htm#sect1311">2.1 </a></td><td>Occurrence, characterisation and biological activity</td></tr><tr valign="top"><td><a href="quinoline2003.htm#sect1407">2.2 </a></td><td>Synthesis and other chemical studies</td></tr><tr valign="top"><td><a href="quinoline2003.htm#sect1751">3 </a></td><td>Acridone alkaloids</td></tr><tr valign="top"><td><a href="quinoline2003.htm#sect1821"></a></td><td></td></tr><tr valign="top"><td><a href="quinoline2003.htm#sect1823"></a></td><td></td></tr></table><p></p><hr><p></p><p align="left" style="text-align: left; ">Covering: July 2001 to June 2002. Previous review: <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2002, <span style="font-weight: bold; "><b>19</b></span>, 742</p><p></p><hr><p></p><p></p><hr><p></p><p align="left" style="text-align: left; ">This review covers the isolation, structure determination, synthesis and biological activity of quinoline, quinazoline and acridone alkaloids from plant, microbial and animal sources. The literature from July 2001 to June 2002 is reviewed, and 125 references are cited.</p><p></p><hr><p></p><a name="sect83"><p align="" style="font-weight: bold; margin-top: 0%; margin-bottom: 0%; "><h3><b>1 Quinoline alkaloids</b></h3></p></a><a name="sect86"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>1.1 Occurrence</b></p></a><p class="firstpara">The past year has brought to light an astonishing number of new quinoline alkaloids, some from unusual sources. By contrast, the number of known quinoline alkaloids isolated from previously unexplored sources was relatively small. The compounds of interest and their sources are listed in <a title=" Isolation and detection of quinoline alkaloids from plant, microbial and animal sources" href="quinoline2003.htm#tab1">Table 1</a>.<small><sup style="color: ;"><a title="A. Buske, J. Schmidt, A. Porzel, G. Adam,  Eur. J. Org. Chem. 2001 3537; R. A. Davis, A. R. Carroll, R. J. Quinn,  J. Nat. Prod. 2002 65 454; S.-B. Chen, G.-Y. Gao, Y.-S. Li, S.-C. Yu, P.-G. Xiao,  Planta Med. 2002 68 554; A. E. M. Khaleel,  Monatsh. Chem. 2002 133 183; A. D. Wright, E. Goclik, G. M. Konig, R. Kaminsky,  J. Med. Chem. 2002 45 3067; M. Y. Rios, E. Rosas-Alonso, A. B. Aguilar-Guadarrama,  Biochem. Syst. Ecol. 2002 30 367; I. Jacquemond-Collet, J.-M. Bessiere, S. Hannedouche, C. Bertrand, I. Fouraste, C. Moulis,  Phytochem. Anal. 2001 12 312; B. P. Smith, M. J. Tyler, T. Kaneko, H. M. Garraffo, T. F. Spande, J. W. Daly,  J. Nat. Prod. 2002 65 439; T. Pacher, M. Bacher, O. Hofer, H. Greger,  Phytochemistry 2001 58 129; N. Sultana, P. G. Waterman,  Phytochemistry 2001 58 329; M. S. Ali, M. K. Pervez, M. Saleem, R. B. Tareen,  Phytochemistry 2001 57 1277; L. Puricelli, G. Innocenti, L. Delle Monache, R. Caniato, R. Filippini, E. M. Cappelletti,  Nat. Prod. Lett. 2002 16 95; S. Aoki, Y. Ye, K. Higuchi, A. Takashima, Y. Tanaka, I. Kitagawa, M. Kobayashi,  Chem. Pharm. Bull. 2001 49 1372; A. L. Okunade, W. H. Lewis, M. P. Elvin-Lewis, S. J. Casper, D. E. Goldberg,  Fitoterapia 2001 72 717; X.-M. Niu, S.-H. Li, L.-Y. Peng, Z.-W. Lin, G.-X. Rao, H.-D. Sun,  J. Asian Nat. Prod. Res. 2001 3 299( Chem. Abstr., 2002,136, 259980); I.-S. Chen, H.-F. Chen, M.-J. Cheng, Y.-L. Chang, C.-M. Teng, I. Tsutomu, J.-J. Chen, I.-L. Tsai,  J. Nat. Prod. 2001 64 1143; H. Wang, S. L. Yeo, J. Xu, X. Xu, H. He, F. Ronca, A. E. Ting, Y. Wang, V. C. Yu, M. M. Sim,  J. Nat. Prod. 2002 65 721; T. S. Tulyaganov, F. K. Allaberdiev,  Chem. Nat. Compd. 2001 37 556( Engl. transl. of Khim. Prir. Soedin., 2001, 476); H. S. Chung, W. S. Woo,  J. Nat. Prod. 2001 64 1579; H. S. Chung,  Nutraceuticals Food 2002 7 119( Chem. Abstr., 2003,138, 163102); W.-G. Kim, N.-K. Song, I.-D. Yoo,  J. Antibiot. 2001 54 831; W. Fakhouri, F. Walker, B. Vogler, W. Armbruster, H. Buchenauer,  Phytochemistry 2001 58 1297; M. W. Biavatti, P. C. Vieira, M. F. das G. F. da Silva, J. B. Fernandes, S. R. Victor, F. C. Pagnocca, S. Albuquerque, I. Caracelli, J. Zukerman-Schpector,  J. Braz. Chem. Soc. 2002 13 66( Chem. Abstr., 2002,136, 263287); N. Fokialakis, P. Magiatis, A. Terzis, F. Tillequin, A.-L. Skaltsounis,  Tetrahedron Lett. 2001 42 5323; N. Fokialakis, P. Magiatis, I. Chinou, S. Mitaku, F. Tillequin,  Chem. Pharm. Bull. 2002 50 413; N. Noda, Y. Yashiki, T. Nakatani, K. Miyahara, X.-M. Du,  Chem. Pharm. Bull. 2001 49 930; C.-M. Chen, F.-W. Lin, P.-C. Kuo, L.-S. Shi, J.-J. Wang, T.-S. Wu,  J. Chin. Chem. Soc. 2001 48 933; T.-S. Wu, C.-M. Chen, F.-W. Lin,  J. Nat. Prod. 2001 64 1040; K. Kurosawa, K. Takahashi, E. Tsuda,  J. Antibiot. 2001 54 615; K. Takahashi, H. Koshino, Y. Esumi, E. Tsuda, K. Kurosawa,  J. Antibiot. 2001 54 622; H. D. T. Mai, H. T. Van-Dufat, S. Michel, F. Tillequin, D. Bastien, T. Sevenet,  Z. Naturforsch., Teil C 2001 56 492; N. F. de Moura, A. F. Morel, E. C. Dessoy, N. Zanatta, M. M. Burger, N. Ahlert, G. P. Porto, B. Baldisserotto,  Planta Med. 2002 68 534" href="quinoline2003.htm#cit1">1ï¿½32</a></sup></small></p><br><a name="tab1"><a></a><b>Table 
	1</b>
	Isolation and detection of quinoline alkaloids from plant, microbial and animal sources
	
	<hr></a><table align="center" width="100%" border="0"><table border="0" width="100%"><colgroup><col align="left" char="" charoff="" width=""><col align="left" char="" charoff="" width=""><col align="left" char="" charoff="" width=""></colgroup><thead align="left"><tr valign="bottom"><td align="left">Species<hr></td><td align="left">Alkaloid<i><small><sup style="color: red;"><a title="Only new alkaloids and new records for a given species are listed in the Table. Structures of known alkaloids, if not specifically numbered, may be found in previous reviews in this series." href="quinoline2003.htm#tab1fna">a</a></sup></small></i><hr></td><td align="left">Ref.<hr></td></tr></thead><tbody><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Antidesma membranaceum</i></span></td><td valign="top">(+)-(17<span style="font-style: italic; "><i>RS</i></span>)-17-(<img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">-<span style="font-variant: 80; "><small>D</small></span>-Glucopyranosyloxy)antidesmone<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>66</b></span></td><td valign="top"><a title="A. Buske, J. Schmidt, A. Porzel, G. Adam,  Eur. J. Org. Chem. 2001 3537" href="quinoline2003.htm#cit1">1</a></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-(17<span style="font-style: italic; "><i>RS</i></span>)-8-Deoxo-17-(<img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">-<span style="font-variant: 80; "><small>D</small></span>-glucopyranosyloxy)antidesmone<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>67</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Aplidium tabascum</i></span> (tunicate)</td><td valign="top">(+)-Lepadin F<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-style: italic; "><i>rel</i></span>-<span style="font-weight: bold; "><b>96</b></span></td><td valign="top"><a title="R. A. Davis, A. R. Carroll, R. J. Quinn,  J. Nat. Prod. 2002 65 454" href="quinoline2003.htm#cit2">2</a></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-Lepadin G<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-style: italic; "><i>rel</i></span>-<span style="font-weight: bold; "><b>98</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-Lepadin H<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-style: italic; "><i>rel</i></span>-<span style="font-weight: bold; "><b>99</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Aquilegia ecalcarata</i></span></td><td valign="top">7-Hydroxy-4-[5-(hydroxymethyl)-2-furyl]quinolin-2(1<span style="font-style: italic; "><i>H</i></span>)-one<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>68</b></span></td><td valign="top"><a title="S.-B. Chen, G.-Y. Gao, Y.-S. Li, S.-C. Yu, P.-G. Xiao,  Planta Med. 2002 68 554" href="quinoline2003.htm#cit3">3</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Casimiroa edulis</i></span></td><td valign="top">5,6-Dimethoxy-2-(3-methoxyphenyl)quinolin-4(1<span style="font-style: italic; "><i>H</i></span>)-one<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>1</b></span></td><td valign="top"><a title="A. E. M. Khaleel,  Monatsh. Chem. 2002 133 183" href="quinoline2003.htm#cit4">4</a></td></tr><tr valign="bottom"><td></td><td valign="top">5,6-Dimethoxy-2-(3,4-dimethoxyphenyl)quinolin-4(1<span style="font-style: italic; "><i>H</i></span>)-one<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>2</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">5,6-Dimethoxy-2-(2,5,6-trimethoxyphenyl)quinolin-4(1<span style="font-style: italic; "><i>H</i></span>)-one<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>3</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Didemnum</i></span> sp. (tunicate)</td><td valign="top">(+)-Lepadin D<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-style: italic; "><i>rel</i></span>-<span style="font-weight: bold; "><b>94</b></span></td><td valign="top"><a title="A. D. Wright, E. Goclik, G. M. Konig, R. Kaminsky,  J. Med. Chem. 2002 45 3067" href="quinoline2003.htm#cit5">5</a></td></tr><tr valign="bottom"><td></td><td valign="top">(ï¿½)-Lepadin D, quaternary derivative<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(ï¿½)-Lepadin E<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-style: italic; "><i>rel</i></span>-<span style="font-weight: bold; "><b>95</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(ï¿½)-Lepadin F<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-style: italic; "><i>rel</i></span>-<span style="font-weight: bold; "><b>96</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Esenbeckia conspecta</i></span></td><td valign="top">Flindersiamine <span style="font-weight: bold; "><b>58</b></span></td><td valign="top"><a title="M. Y. Rios, E. Rosas-Alonso, A. B. Aguilar-Guadarrama,  Biochem. Syst. Ecol. 2002 30 367" href="quinoline2003.htm#cit6">6</a></td></tr><tr valign="bottom"><td></td><td valign="top">Maculosidine</td><td></td></tr><tr valign="bottom"><td></td><td valign="top">8-Methoxy-<span style="font-style: italic; "><i>N</i></span>-methylflindersine (zanthobungeanine)</td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Galipea officinalis</i></span></td><td valign="top">2-[2-(3,4-Dimethoxyphenyl)ethyl]quinoline</td><td valign="top"><a title="I. Jacquemond-Collet, J.-M. Bessiere, S. Hannedouche, C. Bertrand, I. Fouraste, C. Moulis,  Phytochem. Anal. 2001 12 312" href="quinoline2003.htm#cit7">7</a></td></tr><tr valign="bottom"><td></td><td valign="top">2-[2-(3,4-Dimethoxyphenyl)ethyl]-1,2,3,4-tetrahydroquinoline<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>4</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">2-[2-(3-Hydroxy-4-methoxyphenyl)ethyl]-4-methoxyquinoline (or 3-methoxy-4-hydroxyphenyl isomer)<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>5</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">Maculosidine</td><td></td></tr><tr valign="bottom"><td></td><td valign="top">2-[2-(3,4-Methylenedioxyphenyl)ethyl]-1,2,3,4-tetrahydroquinoline<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>6</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">1-Methyl-2-propyl-1,2,3,4-tetrahydroquinoline<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>7</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">2-Pentyl-1,2,3,4-tetrahydroquinoline<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>8</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Geocrinia laevis</i></span> (frog)</td><td valign="top">Decahydroquinoline 195A <span style="font-weight: bold; "><b>115</b></span></td><td valign="top"><a title="B. P. Smith, M. J. Tyler, T. Kaneko, H. M. Garraffo, T. F. Spande, J. W. Daly,  J. Nat. Prod. 2002 65 439" href="quinoline2003.htm#cit8">8</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Glycosmis parviflora</i></span> (= <span style="font-style: italic; "><i>G. citrifolia</i></span>)</td><td valign="top">Flindersine <span style="font-weight: bold; "><b>34</b></span></td><td valign="top"><a title="T. Pacher, M. Bacher, O. Hofer, H. Greger,  Phytochemistry 2001 58 129" href="quinoline2003.htm#cit9">9</a></td></tr><tr valign="bottom"><td></td><td valign="top"><span style="font-style: italic; "><i>N</i></span>-Methylflindersine <span style="font-weight: bold; "><b>45</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Halfordia kendack</i></span></td><td valign="top">(+)-<span style="font-style: italic; "><i>trans</i></span>-Deacetoxyerioaustralasine<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>29</b></span></td><td valign="top"><a title="N. Sultana, P. G. Waterman,  Phytochemistry 2001 58 329" href="quinoline2003.htm#cit10">10</a></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-<span style="font-style: italic; "><i>trans</i></span>-Deacetoxyerioaustralasine hydrate<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>30</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-<span style="font-style: italic; "><i>trans</i></span>-1<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">-Epideacetoxyerioaustralasine hydrate<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>32</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-<span style="font-style: italic; "><i>trans</i></span>-Erioaustralasine <span style="font-weight: bold; "><b>28</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-<span style="font-style: italic; "><i>trans</i></span>-Erioaustralasine hydrate<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>31</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Haplophyllum acutifolium</i></span></td><td valign="top">Flindersine <span style="font-weight: bold; "><b>34</b></span></td><td valign="top"><a title="M. S. Ali, M. K. Pervez, M. Saleem, R. B. Tareen,  Phytochemistry 2001 57 1277" href="quinoline2003.htm#cit11">11</a></td></tr><tr valign="bottom"><td></td><td valign="top">Haplophytin-A<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>33</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-Haplophytin-B (= evoxine) <span style="font-weight: bold; "><b>35</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Haplophyllum patavinum</i></span></td><td valign="top">(ï¿½)-Edulinine</td><td valign="top"><a title="L. Puricelli, G. Innocenti, L. Delle Monache, R. Caniato, R. Filippini, E. M. Cappelletti,  Nat. Prod. Lett. 2002 16 95" href="quinoline2003.htm#cit12">12</a></td></tr><tr valign="bottom"><td></td><td valign="top">Haplopine <span style="font-weight: bold; "><b>55</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(+)-Isoplatydesmine</td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(ï¿½)-Ribalinine</td><td></td></tr><tr valign="bottom"><td></td><td valign="top">Skimmianine <span style="font-weight: bold; "><b>57</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Hyrtios erecta</i></span> (sponge)</td><td valign="top">6-Bromo-4-hydroxyquinolin-2(1<span style="font-style: italic; "><i>H</i></span>)-one<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>102</b></span></td><td valign="top"><a title="S. Aoki, Y. Ye, K. Higuchi, A. Takashima, Y. Tanaka, I. Kitagawa, M. Kobayashi,  Chem. Pharm. Bull. 2001 49 1372" href="quinoline2003.htm#cit13">13</a></td></tr><tr valign="bottom"><td></td><td valign="top">6,7-Dibromo-4-hydroxyquinolin-2(1<span style="font-style: italic; "><i>H</i></span>)-one<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>103</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Ladenbergia oblongifolia</i></span></td><td valign="top">(ï¿½)-Cinchonidicinol <span style="font-weight: bold; "><b>71</b></span></td><td valign="top"><a title="A. L. Okunade, W. H. Lewis, M. P. Elvin-Lewis, S. J. Casper, D. E. Goldberg,  Fitoterapia 2001 72 717" href="quinoline2003.htm#cit14">14</a></td></tr><tr valign="bottom"><td></td><td valign="top">(ï¿½)-Epicinchonicinol <span style="font-weight: bold; "><b>72</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">Dihydrocinchonicinol/dihydrocinchonidicinol<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>73</b></span> (mixture)</td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Limonia crenulata</i></span></td><td valign="top">Integriquinolone</td><td valign="top"><a title="X.-M. Niu, S.-H. Li, L.-Y. Peng, Z.-W. Lin, G.-X. Rao, H.-D. Sun,  J. Asian Nat. Prod. Res. 2001 3 299( Chem. Abstr., 2002,136, 259980)" href="quinoline2003.htm#cit15">15</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Melicope semecarpifolia</i></span> (= <span style="font-style: italic; "><i>M. confusa</i></span>, <span style="font-style: italic; "><i>Evodia merrillii</i></span>)</td><td valign="top">2-Acetylevolitrine<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>50</b></span></td><td valign="top"><a title="I.-S. Chen, H.-F. Chen, M.-J. Cheng, Y.-L. Chang, C.-M. Teng, I. Tsutomu, J.-J. Chen, I.-L. Tsai,  J. Nat. Prod. 2001 64 1143" href="quinoline2003.htm#cit16">16</a></td></tr><tr valign="bottom"><td></td><td valign="top">2-Acetylpteleine<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>51</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">Dictamnine <span style="font-weight: bold; "><b>53</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(3<span style="font-style: italic; "><i>R</i></span>)-(ï¿½)-8,9-Dimethoxygeibalansine <span style="font-weight: bold; "><b>36</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top"><span style="font-style: italic; "><i>cis</i></span>-(+)-7,8-Dimethoxymyrtopsine <span style="font-weight: bold; "><b>37</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">(2<span style="font-style: italic; "><i>S</i></span>)-(ï¿½)-7,8-Dimethoxyplatydesmine <span style="font-weight: bold; "><b>38</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">Evolitrine <span style="font-weight: bold; "><b>54</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">Semecarpifoline<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>14</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Micromonospora</i></span> sp. IM 2670</td><td valign="top">7-(1-Methyl-2-oxopropyl)streptonigrin<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>78</b></span></td><td valign="top"><a title="H. Wang, S. L. Yeo, J. Xu, X. Xu, H. He, F. Ronca, A. E. Ting, Y. Wang, V. C. Yu, M. M. Sim,  J. Nat. Prod. 2002 65 721" href="quinoline2003.htm#cit17">17</a></td></tr><tr valign="bottom"><td></td><td valign="top">Streptonigrin <span style="font-weight: bold; "><b>77</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Nitraria sibirica</i></span></td><td valign="top">Dihydroschoberine<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>75</b></span></td><td valign="top"><a title="T. S. Tulyaganov, F. K. Allaberdiev,  Chem. Nat. Compd. 2001 37 556( Engl. transl. of Khim. Prir. Soedin., 2001, 476)" href="quinoline2003.htm#cit18">18</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Oryza sativa</i></span> cv. <span style="font-style: italic; "><i>Heugjinmi</i></span></td><td valign="top">Methyl 6-hydroxy-2-oxo-1,2-dihydroquinoline-4-carboxylate<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>69</b></span></td><td valign="top"><a title="H. S. Chung, W. S. Woo,  J. Nat. Prod. 2001 64 1579" href="quinoline2003.htm#cit19">19</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Oryza sativa</i></span> cv. <span style="font-style: italic; "><i>Mihyangbyo</i></span></td><td valign="top">Methyl 6-methoxy-2-oxo-1,2-dihydroquinoline-4-carboxylate<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>70</b></span></td><td valign="top"><a title="H. S. Chung,  Nutraceuticals Food 2002 7 119( Chem. Abstr., 2003,138, 163102)" href="quinoline2003.htm#cit20">20</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Penicillium citrinum</i></span> 90648</td><td valign="top">Quinolactacin A1<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>79</b></span></td><td valign="top"><a title="W.-G. Kim, N.-K. Song, I.-D. Yoo,  J. Antibiot. 2001 54 831" href="quinoline2003.htm#cit21">21</a></td></tr><tr valign="bottom"><td></td><td valign="top">Quinolactacin A2<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>80</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Pseudomonas fluorescens</i></span> G308</td><td valign="top"><span style="font-style: italic; "><i>N</i></span>-Mercapto-4-formylcarbostyril<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>83</b></span></td><td valign="top"><a title="W. Fakhouri, F. Walker, B. Vogler, W. Armbruster, H. Buchenauer,  Phytochemistry 2001 58 1297" href="quinoline2003.htm#cit22">22</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Raulinoa echinata</i></span></td><td valign="top">Flindersiamine <span style="font-weight: bold; "><b>58</b></span></td><td valign="top"><a title="M. W. Biavatti, P. C. Vieira, M. F. das G. F. da Silva, J. B. Fernandes, S. R. Victor, F. C. Pagnocca, S. Albuquerque, I. Caracelli, J. Zukerman-Schpector,  J. Braz. Chem. Soc. 2002 13 66( Chem. Abstr., 2002,136, 263287)" href="quinoline2003.htm#cit23">23</a></td></tr><tr valign="bottom"><td></td><td valign="top">Kokusaginine <span style="font-weight: bold; "><b>56</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">Maculine <span style="font-weight: bold; "><b>59</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top"><span style="font-style: italic; "><i>N</i></span>-Methyl-2-nonylquinolin-4-one <span style="font-weight: bold; "><b>15</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top"><span style="font-style: italic; "><i>N</i></span>-Methyl-2-phenylquinolin-4-one <span style="font-weight: bold; "><b>16</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">2-Nonylquinolin-4(1<span style="font-style: italic; "><i>H</i></span>)-one <span style="font-weight: bold; "><b>17</b></span></td><td></td></tr><tr valign="bottom"><td></td><td valign="top">Skimmianine <span style="font-weight: bold; "><b>57</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Sarcomelicope megistophylla</i></span></td><td valign="top">Cyclomegistine<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>18</b></span></td><td valign="top"><a title="N. Fokialakis, P. Magiatis, A. Terzis, F. Tillequin, A.-L. Skaltsounis,  Tetrahedron Lett. 2001 42 5323" href="quinoline2003.htm#cit24">24</a></td></tr><tr valign="bottom"><td></td><td valign="top">Megistoquinone I<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>60</b></span></td><td valign="top"><a title="N. Fokialakis, P. Magiatis, I. Chinou, S. Mitaku, F. Tillequin,  Chem. Pharm. Bull. 2002 50 413" href="quinoline2003.htm#cit25">25</a></td></tr><tr valign="bottom"><td></td><td valign="top">Megistoquinone II<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>62</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Scolopendra subspinipes mutilans</i></span> (centipede)</td><td valign="top">Scolopendrine<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>104</b></span></td><td valign="top"><a title="N. Noda, Y. Yashiki, T. Nakatani, K. Miyahara, X.-M. Du,  Chem. Pharm. Bull. 2001 49 930" href="quinoline2003.htm#cit26">26</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Severinia buxifolia</i></span></td><td valign="top"><span style="font-style: italic; "><i>N</i></span>-Methylswietinidine-B</td><td valign="top"><a title="C.-M. Chen, F.-W. Lin, P.-C. Kuo, L.-S. Shi, J.-J. Wang, T.-S. Wu,  J. Chin. Chem. Soc. 2001 48 933; T.-S. Wu, C.-M. Chen, F.-W. Lin,  J. Nat. Prod. 2001 64 1040" href="quinoline2003.htm#cit27">27,28</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Streptomyces</i></span> SNA15896</td><td valign="top">(ï¿½)-SW-163C<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>84</b></span></td><td valign="top"><a title="K. Kurosawa, K. Takahashi, E. Tsuda,  J. Antibiot. 2001 54 615; K. Takahashi, H. Koshino, Y. Esumi, E. Tsuda, K. Kurosawa,  J. Antibiot. 2001 54 622" href="quinoline2003.htm#cit29">29,30</a></td></tr><tr valign="bottom"><td></td><td valign="top">(ï¿½)-SW-163E<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>85</b></span></td><td></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Zanthoxylum dimorphophyllum</i></span></td><td valign="top"><img src="https://bitnest.netfirms.com/images/entities/char_03b3.gif">-Fagarine <span style="font-weight: bold; "><b>64</b></span></td><td valign="top"><a title="H. D. T. Mai, H. T. Van-Dufat, S. Michel, F. Tillequin, D. Bastien, T. Sevenet,  Z. Naturforsch., Teil C 2001 56 492" href="quinoline2003.htm#cit31">31</a></td></tr><tr valign="bottom"><td valign="top"><span style="font-style: italic; "><i>Zanthoxylum hyemale</i></span></td><td valign="top">(<span style="font-style: italic; "><i>R</i></span>)-(ï¿½)-Geibalansine<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>39</b></span></td><td valign="top"><a title="N. F. de Moura, A. F. Morel, E. C. Dessoy, N. Zanatta, M. M. Burger, N. Ahlert, G. P. Porto, B. Baldisserotto,  Planta Med. 2002 68 534" href="quinoline2003.htm#cit32">32</a></td></tr><tr valign="bottom"><td></td><td valign="top">Hyemaline<i><small><sup style="color: red;"><a title="New alkaloids." href="quinoline2003.htm#tab1fnb">b</a></sup></small></i><span style="font-weight: bold; "><b>63</b></span></td><td></td></tr></tbody><tfoot><tr valign="bottom"><td colspan="3"><a name="tab1fna"><span style="font-size: 75%; font-style: italic; vertical-align: super; "><i><sup>a</sup></i></span></a><span style="font-size: 75%; ">Only new alkaloids and new records for a given species are listed in the Table. Structures of known alkaloids, if not specifically numbered, may be found in previous reviews in this series.</span>ï¿½ï¿½<a name="tab1fnb"><span style="font-size: 75%; font-style: italic; vertical-align: super; "><i><sup>b</sup></i></span></a><span style="font-size: 75%; ">New alkaloids.</span>ï¿½ï¿½</td></tr></tfoot></table></table><hr><br><a name="sect631"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>1.2 Non-terpenoid quinoline and quinolinone alkaloids from rutaceous plants</b></p></a><p class="firstpara">While 2-arylquinoline alkaloids are not uncommon metabolites of plants belonging to the Rutaceae, it is unusual for them to bear substituents on the carbocyclic ring of the quinoline nucleus. However, no fewer than three 2-aryl-5,6-dimethoxyquinolin-4-one alkaloids, <span style="font-weight: bold; "><b>1ï¿½3</b></span>, were isolated from the leaves of the medicinally useful central American plant <span style="font-style: italic; "><i>Casimiroa edulis</i></span>.<small><sup style="color: ;"><a title="A. E. M. Khaleel,  Monatsh. Chem. 2002 133 183" href="quinoline2003.htm#cit4">4</a></sup></small> The alkaloids were also detected in the seed kernels by TLC. The structures were determined by a combination of spectroscopic methods, and the substitution patterns were inferred in part by comparing chemical shifts with those reported for related flavonoids.</p><p class="otherpara">A GC-MS method for detecting the constituents in the essential oils and extracts from the trunk bark of <span style="font-style: italic; "><i>Galipea officinalis</i></span>, another medicinally valuable plant from South America, has permitted the identification of a further five minor alkaloids, <span style="font-weight: bold; "><b>4ï¿½8</b></span>.<small><sup style="color: ;"><a title="I. Jacquemond-Collet, J.-M. Bessiere, S. Hannedouche, C. Bertrand, I. Fouraste, C. Moulis,  Phytochem. Anal. 2001 12 312" href="quinoline2003.htm#cit7">7</a></sup></small> The structures of the new alkaloids and a further ten known alkaloids were deduced on the basis of their mass spectral fragmentation patterns only. <span style="font-style: italic; "><i>G. officinalis</i></span> is the only species in this genus to contain tetrahydroquinoline alkaloids, and it is noteworthy that four of the five new alkaloids belong to this group. Some of the better-known <span style="font-style: italic; "><i>G. officinalis</i></span> tetrahydroquinolines, including cuspareine <span style="font-weight: bold; "><b>9</b></span>, galipeine <span style="font-weight: bold; "><b>10</b></span>, galipinine <span style="font-weight: bold; "><b>11</b></span> and angustureine <span style="font-weight: bold; "><b>12</b></span>, have been shown to possess antimalarial activity against both chloroquine-sensitive and chloroquine-resistant strains of the malaria parasite <span style="font-style: italic; "><i>Plasmodium falciparum</i></span>, with galipinine being the most active compound (IC<small><sub>50</sub></small> 0.09ï¿½0.9 ï¿½g cm<small><sup>ï¿½3</sup></small> for the resistant strain).<small><sup style="color: ;"><a title="I. Jacquemond-Collet, F. Benoit-Vical,  Mustofa, A. Valentin, E. Stanislas, M. Mallie, I. Fouraste,  Planta Med. 2002 68 68" href="quinoline2003.htm#cit33">33</a></sup></small> The same four alkaloids were cytotoxic towards human fibroblast cells, but in this case cuspareine was the most effective (IC<small><sub>50</sub></small> 5.8ï¿½8.5 ï¿½g cm<small><sup>ï¿½3</sup></small>). 2-Propylquinoline <span style="font-weight: bold; "><b>13</b></span>, from the species <span style="font-style: italic; "><i>G. longiflora</i></span>, has proved to be clinically effective as a trypanocidal agent in mice chronically infected with <span style="font-style: italic; "><i>Trypanosoma cruzi</i></span>, an encouraging result for the treatment of conditions such as Chagas disease.<small><sup style="color: ;"><a title="H. Nakayama, M. E. Ferreira, A. R. de Arias, N. V. de Bilbao, S. Torres, A. Schinini, A. Fournet,  Phytother. Res. 2001 15 630" href="quinoline2003.htm#cit34">34</a></sup></small></p><p class="otherpara">Semecarpifoline <span style="font-weight: bold; "><b>14</b></span> is an atypical metabolite from the root bark of the Taiwanese tree <span style="font-style: italic; "><i>Melicope semecarpifolia</i></span>, which is better known as a source of furoquinoline alkaloids.<small><sup style="color: ;"><a title="I.-S. Chen, H.-F. Chen, M.-J. Cheng, Y.-L. Chang, C.-M. Teng, I. Tsutomu, J.-J. Chen, I.-L. Tsai,  J. Nat. Prod. 2001 64 1143" href="quinoline2003.htm#cit16">16</a></sup></small> The positions of the substituents in this new quinolin-2-one were ascertained by HMBC and nOe experiments. The isolation of <span style="font-weight: bold; "><b>14</b></span> marks the first occurrence of a methoxymethyl substituent in a rutaceous quinoline alkaloid, although the authors seem not to have recognised that this is a precedent-setting feature.</p><p class="otherpara"><small><sup>1</sup></small>H and <small><sup>13</sup></small>C NMR spectra have been reported in full for <span style="font-style: italic; "><i>N</i></span>-methyl-2-nonylquinolin-4-one <span style="font-weight: bold; "><b>15</b></span>, <span style="font-style: italic; "><i>N</i></span>-methyl-2-phenylquinolin-4-one <span style="font-weight: bold; "><b>16</b></span> and 2-nonylquinolin-4(1<span style="font-style: italic; "><i>H</i></span>)-one <span style="font-weight: bold; "><b>17</b></span>, three well-known alkaloids recently isolated from the previously unexplored Brazilian shrub <span style="font-style: italic; "><i>Raulinoa echinata</i></span>.<small><sup style="color: ;"><a title="M. W. Biavatti, P. C. Vieira, M. F. das G. F. da Silva, J. B. Fernandes, S. R. Victor, F. C. Pagnocca, S. Albuquerque, I. Caracelli, J. Zukerman-Schpector,  J. Braz. Chem. Soc. 2002 13 66( Chem. Abstr., 2002,136, 263287)" href="quinoline2003.htm#cit23">23</a></sup></small> Compounds <span style="font-weight: bold; "><b>15</b></span> and <span style="font-weight: bold; "><b>17</b></span> showed moderate antitrypanosomal activity against trypomastigote forms of <span style="font-style: italic; "><i>T. cruzi</i></span> (IC<small><sub>50</sub></small> 134.9 and 100.9 ï¿½g cm<small><sup>ï¿½3</sup></small>, respectively), and the latter was also weakly fungicidal towards <span style="font-style: italic; "><i>Leucoagaricus gongylophorus</i></span>, a symbiotic fungus of leaf-cutting ants.</p><p class="otherpara">The New Caledonian tree <span style="font-style: italic; "><i>Sarcomelicope megistophylla</i></span>, noteworthy for producing unusual quinoline alkaloids, has yielded perhaps its most astounding natural product to date.<small><sup style="color: ;"><a title="N. Fokialakis, P. Magiatis, A. Terzis, F. Tillequin, A.-L. Skaltsounis,  Tetrahedron Lett. 2001 42 5323" href="quinoline2003.htm#cit24">24</a></sup></small> The optically inactive cyclomegistine <span style="font-weight: bold; "><b>18</b></span>, another in the series of putative oxidation products of an oxygenated precursor such as melicopicine <span style="font-weight: bold; "><b>19</b></span> (<span style="font-style: italic; "><i>cf</i></span>. Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2002 19 742" href="quinoline2003.htm#cit35a">35<span style="font-style: italic; "><i>a</i></span></a>), contains a cyclobuta[<span style="font-style: italic; "><i>b</i></span>]quinoline nucleus that is unprecedented both in nature and as a synthetic product. While spectroscopic methods pointed to the gross structure, the four-membered ring and the stereochemistry of its substituents could only be confirmed unambiguously by X-ray diffraction analysis. A plausible biosynthesis from melicopicine involves oxidative cleavage of ring A to give a butadiene intermediate <span style="font-weight: bold; "><b>20</b></span>, photochemical electrocyclic ring closure of which leads to the observed product. Interestingly, when melicopicine was treated with hydrogen peroxide in acetic acid while being irradiated, cyclomegistine was isolated in low yield. The new alkaloid was moderately cytotoxic towards L1210 leukaemia cells (IC<small><sub>50</sub></small> 80 ï¿½M).</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr1"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u1.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">A number of short synthetic approaches to simple naturally occurring 2-substituted quinolines merit brief mention (<a title=" Reagents: i, EtOCH[double bond, length as m-dash]CH2, SmI2(THF)2(0.1 equiv.), CH2Cl2, rt; ii, RuCl2([double bond, length as m-dash]CHPh)(PCy3)2(0.01 equiv.), KOH(1 equiv.), ketone(2 equiv.), dioxane, 80[degree]C; iii,h[small nu](high pressure Hg lamp, Pyrex filter), MeCN, 15-25 min; iv, PhMgCl, Pd(dba)2(5 mol%), dppf(5 mol%), THF,-5[degree]C; v, PhMgBr, Fe(acac)3(10 mol%), THF,-30[degree]C." href="quinoline2003.htm#sch1">Scheme 1</a>). Imino Dielsï¿½Alder reaction between the benzaldimine <span style="font-weight: bold; "><b>21</b></span> and ethyl vinyl ether could be induced by samarium iodide to give the alkaloid 2-phenylquinoline <span style="font-weight: bold; "><b>22</b></span> in modest yield.<small><sup style="color: ;"><a title="J. Collin, N. Jaber, M. I. Lannou,  Tetrahedron Lett. 2001 42 7405" href="quinoline2003.htm#cit36">36</a></sup></small> Various ruthenium catalysts, and in particular the Grubbs catalyst RuCl<small><sub>2</sub></small>(<img src="https://bitnest.netfirms.com/images/entities/char_e001.gif">CHPh)(PCy<small><sub>3</sub></small>)<small><sub>2</sub></small>, induced oxidative cyclisation of 2-aminobenzyl alcohol <span style="font-weight: bold; "><b>23</b></span> with a range of enolisable ketones to give quinoline products, among them the alkaloids <span style="font-weight: bold; "><b>22</b></span>, <span style="font-weight: bold; "><b>24</b></span> and <span style="font-weight: bold; "><b>25</b></span>, by a modified Friedlï¿½nder reaction.<small><sup style="color: ;"><a title="C. S. Cho, B. T. Kim, T.-J. Kim, S. C. Shim,  Chem. Commun. 2001 2576" href="quinoline2003.htm#cit37">37</a></sup></small> Irradiation of the <span style="font-style: italic; "><i>trans</i></span>-2-aminocinnamoyl derivatives <span style="font-weight: bold; "><b>26</b></span> in acetonitrile induced <span style="font-style: italic; "><i>trans</i></span>ï¿½<span style="font-style: italic; "><i>cis</i></span> isomerisation and subsequent cyclisation to give the quinolines <span style="font-weight: bold; "><b>22</b></span> and <span style="font-weight: bold; "><b>24</b></span> in good yield.<small><sup style="color: ;"><a title="T. Horaguchi, N. Hosokawa, K. Tanemura, T. Suzuki,  J. Heterocycl. Chem. 2002 39 61" href="quinoline2003.htm#cit38">38</a></sup></small> Cross-coupling of 2-chloroquinoline <span style="font-weight: bold; "><b>27</b></span> with phenylmagnesium halides could be accomplished in the presence of a palladium catalyst to give 2-phenylquinoline <span style="font-weight: bold; "><b>22</b></span> in 80% yield,<small><sup style="color: ;"><a title="V. Bonnet, F. Mongin, F. Trecourt, G. Queguiner, P. Knochel,  Tetrahedron 2002 58 4429" href="quinoline2003.htm#cit39">39</a></sup></small> or somewhat less efficiently (65%) with iron(<span style="font-variant: 80; "><small>III</small></span>) tris(acetylacetonate).<small><sup style="color: ;"><a title="J. Quintin, X. Franck, R. Hocquemiller, B. Figadere,  Tetrahedron Lett. 2002 43 3547" href="quinoline2003.htm#cit40">40</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch1"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-s1.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 1 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents</i></span>: i, EtOCH<img src="https://bitnest.netfirms.com/images/entities/char_e001.gif">CH<small><sub>2</sub></small>, SmI<small><sub>2</sub></small>(THF)<small><sub>2</sub></small>(0.1 equiv.), CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt; ii, RuCl<small><sub>2</sub></small>(<img src="https://bitnest.netfirms.com/images/entities/char_e001.gif">CHPh)(PCy<small><sub>3</sub></small>)<small><sub>2</sub></small>(0.01 equiv.), KOH (1 equiv.), ketone (2 equiv.), dioxane, 80 ï¿½C; iii, <span style="font-style: italic; "><i>h<img src="https://bitnest.netfirms.com/images/entities/i_char_03bd.gif"></i></span>(high pressure Hg lamp, Pyrex filter), MeCN, 15ï¿½25 min; iv, PhMgCl, Pd(dba)<small><sub>2</sub></small>(5 mol%), dppf (5 mol%), THF, ï¿½5 ï¿½C; v, PhMgBr, Fe(acac)<small><sub>3</sub></small>(10 mol%), THF, ï¿½30 ï¿½C.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect731"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>1.3 Terpenoid quinoline alkaloids and tricyclic derivatives</b></p></a><p class="firstpara">A group of structurally unprecedented polycyclic quinolinone alkaloids formally incorporating a 3-geranylquinoline motif was isolated from the Australian rutaceous plant <span style="font-style: italic; "><i>Eriostemon australasius</i></span> ssp. <span style="font-style: italic; "><i>banksii</i></span> (= <span style="font-style: italic; "><i>E. banksii</i></span>) in 1993<small><sup style="color: ;"><a title="E. V. L. da Cunha, J. A. Armstrong, A. I. Gray, D. C. R. Hockless, P. G. Waterman, A. H. White,  Aust. J. Chem. 1993 46 1507" href="quinoline2003.htm#cit41">41</a></sup></small> (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 1995 12 469" href="quinoline2003.htm#cit35b">35<span style="font-style: italic; "><i>b</i></span></a>). One of these compounds, <span style="font-style: italic; "><i>trans</i></span>-erioaustralasine <span style="font-weight: bold; "><b>28</b></span>, has recently turned up in an apparently taxonomically remote source, <span style="font-style: italic; "><i>Halfordia kendack</i></span>, together with another four novel alkaloids of similar structure.<small><sup style="color: ;"><a title="N. Sultana, P. G. Waterman,  Phytochemistry 2001 58 329" href="quinoline2003.htm#cit10">10</a></sup></small><span style="font-style: italic; "><i>trans</i></span>-Deacetoxyerioaustralasine <span style="font-weight: bold; "><b>29</b></span> gave essentially the same NMR spectra as <span style="font-weight: bold; "><b>28</b></span>, but the unusual <span style="font-style: italic; "><i>N</i></span>-acetoxymethyl substituent was replaced by <span style="font-style: italic; "><i>N</i></span>-methyl. The remaining three minor alkaloids, <span style="font-style: italic; "><i>trans</i></span>-deacetoxyerioaustralasine hydrate <span style="font-weight: bold; "><b>30</b></span>, <span style="font-style: italic; "><i>trans</i></span>-erioaustralasine hydrate <span style="font-weight: bold; "><b>31</b></span> and <span style="font-style: italic; "><i>trans</i></span>-1<img src="https://bitnest.netfirms.com/images/entities/char_2032.gif">-epideacetoxyerioaustralasine hydrate <span style="font-weight: bold; "><b>32</b></span>, are 1,2-diols formally derived by hydrolysis of the epoxide rings of <span style="font-weight: bold; "><b>28</b></span> and <span style="font-weight: bold; "><b>29</b></span>. The relative stereochemistry of <span style="font-weight: bold; "><b>30</b></span> was deduced by analysis of coupling constants and NOESY experiments, while minor differences in the spectra of <span style="font-weight: bold; "><b>30</b></span> and the other two diols led to the assignment of structures <span style="font-weight: bold; "><b>31</b></span> and <span style="font-weight: bold; "><b>32</b></span>.</p><p class="otherpara">The novel tricyclic hemiterpenoid alkaloid haplophytin-A <span style="font-weight: bold; "><b>33</b></span>, isolated from a methanol extract of <span style="font-style: italic; "><i>Haplophyllum acutifolium</i></span>, is a simple methoxy derivative of the common alkaloid flindersine <span style="font-weight: bold; "><b>34</b></span>, which was also found in the extract.<small><sup style="color: ;"><a title="M. S. Ali, M. K. Pervez, M. Saleem, R. B. Tareen,  Phytochemistry 2001 57 1277" href="quinoline2003.htm#cit11">11</a></sup></small> However, the structure reported for haplophytin-B, another apparently new metabolite from the same source, is actually identical to that of the well-known alkaloid evoxine <span style="font-weight: bold; "><b>35</b></span>ï¿½confusingly, also known as haploperine. The name haplophytin-B should thus be abandoned in favour of the long-established name evoxine.<small><sup style="color: ;"><a title="I am grateful to Professor M. S. Ali, University of Karachi, for confirming that the name evoxine should be used in preference to haplophytin-B" href="quinoline2003.htm#cit42">42</a></sup></small> Neither <span style="font-weight: bold; "><b>33</b></span> nor <span style="font-weight: bold; "><b>35</b></span> showed activity when tested against various bacteria and fungi.</p><p class="otherpara">Neither optical rotations nor absolute configurations were reported for the three linearly fused tricyclic quinoline alkaloids 8,9-dimethoxygeibalansine <span style="font-weight: bold; "><b>36</b></span>, 7,8-dimethoxymyrtopsine <span style="font-weight: bold; "><b>37</b></span> and 7,8-dimethoxyplatydesmine <span style="font-weight: bold; "><b>38</b></span> when they were first described in 1992 as metabolites of the New Caledonian plant <span style="font-style: italic; "><i>Dutaillyea baudouinii</i></span><small><sup style="color: ;"><a title="F. Muyard, F. Bevalot, B. Laude, J. Vaquette,  Phytochemistry 1992 31 1087" href="quinoline2003.htm#cit43">43</a></sup></small> (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 1994 11 165" href="quinoline2003.htm#cit35c">35<span style="font-style: italic; "><i>c</i></span></a>), or in a later isolation of <span style="font-weight: bold; "><b>37</b></span> and <span style="font-weight: bold; "><b>38</b></span> from <span style="font-style: italic; "><i>Dictamnus dasycarpus</i></span><small><sup style="color: ;"><a title="T.-S. Wu, M.-L. Wang, H.-J. Shyur, Y-L. Liu, Y.-Y. Chan, C.-M. Teng, S.-C. Kuo,  Chin. Pharm. J. 1994 46 447" href="quinoline2003.htm#cit44">44</a></sup></small> (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 1997 14 11" href="quinoline2003.htm#cit35d">35<span style="font-style: italic; "><i>d</i></span></a>). The recent isolation of the same three alkaloids from a methanol extract of the root bark of <span style="font-style: italic; "><i>Melicope semecarpifolia</i></span> has now permitted some stereochemical inferences to be drawn.<small><sup style="color: ;"><a title="I.-S. Chen, H.-F. Chen, M.-J. Cheng, Y.-L. Chang, C.-M. Teng, I. Tsutomu, J.-J. Chen, I.-L. Tsai,  J. Nat. Prod. 2001 64 1143" href="quinoline2003.htm#cit16">16</a></sup></small> Analogy with the known (3<span style="font-style: italic; "><i>S</i></span>)-(+)-9-methoxygeibalansine, for instance, suggested that the laevorotatory pyrano[2,3-<span style="font-style: italic; "><i>b</i></span>]quinoline <span style="font-weight: bold; "><b>36</b></span> ([<span style="font-style: italic; "><i><img src="https://bitnest.netfirms.com/images/entities/i_char_03b1.gif"></i></span>]<small><sub>D</sub></small> ï¿½18.6, <span style="font-style: italic; "><i>c</i></span> 0.065, CHCl<small><sub>3</sub></small>) should have the (3<span style="font-style: italic; "><i>R</i></span>) configuration as illustrated. A similar comparison drawn between (2<span style="font-style: italic; "><i>R</i></span>)-(+)-8-methoxyplatydesmine and <span style="font-weight: bold; "><b>38</b></span> ([<span style="font-style: italic; "><i><img src="https://bitnest.netfirms.com/images/entities/i_char_03b1.gif"></i></span>]<small><sub>D</sub></small> ï¿½10.3, <span style="font-style: italic; "><i>c</i></span> 0.16, CHCl<small><sub>3</sub></small>) led to assignment of the (2<span style="font-style: italic; "><i>S</i></span>) configuration for the latter. Although the absolute configuration of (+)-7,8-dimethoxymyrtopsine <span style="font-weight: bold; "><b>37</b></span> ([<span style="font-style: italic; "><i><img src="https://bitnest.netfirms.com/images/entities/i_char_03b1.gif"></i></span>]<small><sub>D</sub></small> +16.2, <span style="font-style: italic; "><i>c</i></span> 0.165, CHCl<small><sub>3</sub></small>) was not deduced, the NOESY spectrum indicated that the hydrogen substituents at C-2 and C-3 were <span style="font-style: italic; "><i>cis</i></span> to each other. Interestingly enough, the parent (3<span style="font-style: italic; "><i>R</i></span>)-(ï¿½)-geibalansine <span style="font-weight: bold; "><b>39</b></span> was recently isolated as a new natural product from the stem bark of <span style="font-style: italic; "><i>Zanthoxylum hyemale</i></span>, and its absolute configuration was established by the Horeau method.<small><sup style="color: ;"><a title="N. F. de Moura, A. F. Morel, E. C. Dessoy, N. Zanatta, M. M. Burger, N. Ahlert, G. P. Porto, B. Baldisserotto,  Planta Med. 2002 68 534" href="quinoline2003.htm#cit32">32</a></sup></small> The absolute configuration of the (3<span style="font-style: italic; "><i>S</i></span>)-(+)-enantiomer, a metabolite of <span style="font-style: italic; "><i>Geijera balansae</i></span>, was established as recently as 2000 by total synthesis<small><sup style="color: ;"><a title="D. R. Boyd, N. D. Sharma, S. A. Barr, J. G. Carroll, D. Mackerracher, J. F. Malone,  J. Chem. Soc., Perkin Trans. 1 2000 3397" href="quinoline2003.htm#cit45">45</a></sup></small> (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2002 19 745" href="quinoline2003.htm#cit35e">35<span style="font-style: italic; "><i>e</i></span></a>).</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr2"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u2.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">Several short syntheses of terpenoid quinoline alkaloids and related model systems were published during the review period. The first reported synthesis of the simple hemiterpenoid alkaloid orixiarine <span style="font-weight: bold; "><b>40</b></span> has as its central feature the formation of the 3-substituted quinolin-2-one <span style="font-weight: bold; "><b>41</b></span> by condensation of the malonate derivative <span style="font-weight: bold; "><b>42</b></span> with <span style="font-style: italic; "><i>N</i></span>-methylaniline at 200 ï¿½C, after which sequential treatment with phosphorus oxychloride and sodium methoxide yielded the target alkaloid.<small><sup style="color: ;"><a title="R. N. Kumar, S. T. Selvi, T. Suresh, P. S. Mohan,  Heterocycles 2002 57 357" href="quinoline2003.htm#cit46">46</a></sup></small> A new one-pot synthesis of pyrano[3,2-<span style="font-style: italic; "><i>c</i></span>]quinolin-5-ones by reaction of 4-hydroxyquinolin-2-ones <span style="font-weight: bold; "><b>43</b></span> or <span style="font-weight: bold; "><b>44</b></span> with <img src="https://bitnest.netfirms.com/images/entities/char_03b1.gif">,<img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">-unsaturated aldehydes in the presence of ytterbium(<span style="font-variant: 80; "><small>III</small></span>) trifluoromethanesulfonate in acetonitrile at reflux yielded, among other products, flindersine <span style="font-weight: bold; "><b>34</b></span> (50%) from <span style="font-weight: bold; "><b>43</b></span> and prenal, <span style="font-style: italic; "><i>N</i></span>-methylflindersine <span style="font-weight: bold; "><b>45</b></span> (57%) from <span style="font-weight: bold; "><b>44</b></span> and prenal, and zanthosimuline <span style="font-weight: bold; "><b>46</b></span> (55%) from <span style="font-weight: bold; "><b>44</b></span> and citral.<small><sup style="color: ;"><a title="Y. R. Lee, H. I. Kweon, W. S. Koh, K. R. Min, Y. Kim, S. H. Lee,  Synthesis 2001 1851" href="quinoline2003.htm#cit47">47</a></sup></small> Another potentially useful route to pyrano[3,2-<span style="font-style: italic; "><i>c</i></span>]quinolin-5-one alkaloids, applied so far only to model systems, involved the <span style="font-style: italic; "><i>in situ</i></span> formation of the 3-methylenequinoline-2,4-dione <span style="font-weight: bold; "><b>47</b></span> from <span style="font-weight: bold; "><b>44</b></span> and paraformaldehyde in boiling dioxane, followed by Dielsï¿½Alder trapping with various alkenes to give products of general structure <span style="font-weight: bold; "><b>48</b></span>.<small><sup style="color: ;"><a title="V. Nair, P. M. Treesa, C. N. Jayan, N. P. Rath, M. Vairamani, S. Prabhakar,  Tetrahedron 2001 57 7711" href="quinoline2003.htm#cit48">48</a></sup></small> Also worth noting is the finding that the manganese(<span style="font-variant: 80; "><small>III</small></span>) acetate-mediated radical-reaction of <span style="font-weight: bold; "><b>44</b></span> with alkenes to give furoquinolinones, <span style="font-style: italic; "><i>e.g.</i></span>, <span style="font-weight: bold; "><b>49</b></span>, could be improved when carried out in the ionic liquid 1-butyl-3-methylimidazolium tetrafluoroborate.<small><sup style="color: ;"><a title="G. Bar, A. F. Parsons, C. B. Thomas,  Chem. Commun. 2001 1350" href="quinoline2003.htm#cit49">49</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr3"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u3.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect852"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>1.4 Furoquinoline alkaloids</b></p></a><p class="firstpara">While hemiterpenoid 2,3-dihydrofuro[2,3-<span style="font-style: italic; "><i>b</i></span>]quinoline alkaloids (<span style="font-style: italic; "><i>cf.</i></span> Section 1.3 above) invariably betray their 3-prenylquinoline origins by bearing a three-carbon substituent at C-2, the substituent is lost in their biosynthetically more advanced furo[2,3-<span style="font-style: italic; "><i>b</i></span>]quinoline cousins. It is thus intriguing that two unprecedented 2-acetylfuro[2,3-<span style="font-style: italic; "><i>b</i></span>]quinoline alkaloids have been isolated from the root bark of <span style="font-style: italic; "><i>Melicope semecarpifolia</i></span>.<small><sup style="color: ;"><a title="I.-S. Chen, H.-F. Chen, M.-J. Cheng, Y.-L. Chang, C.-M. Teng, I. Tsutomu, J.-J. Chen, I.-L. Tsai,  J. Nat. Prod. 2001 64 1143" href="quinoline2003.htm#cit16">16</a></sup></small> The structures of the two compounds, 2-acetylevolitrine <span style="font-weight: bold; "><b>50</b></span> and 2-acetylpteleine <span style="font-weight: bold; "><b>51</b></span>, were elucidated spectroscopically, with one- and two-dimensional NMR spectroscopic methods providing unambiguous support for the structures and the location of the substituents. Once again, however, the authors seem not to have recognised the novelty of their discovery. It is worth noting that the antiplatelet aggregation activity of the plant extract was traced to a suite of more conventional furoquinoline alkaloids, among them confusameline <span style="font-weight: bold; "><b>52</b></span>, dictamnine <span style="font-weight: bold; "><b>53</b></span>, evolitrine <span style="font-weight: bold; "><b>54</b></span>, haplopine <span style="font-weight: bold; "><b>55</b></span>, kokusaginine <span style="font-weight: bold; "><b>56</b></span> and skimmianine <span style="font-weight: bold; "><b>57</b></span>.</p><p class="otherpara">The X-ray crystal structure of the known alkaloid flindersiamine <span style="font-weight: bold; "><b>58</b></span>, isolated for the first time from <span style="font-style: italic; "><i>Raulinoa echinata</i></span>, has been reported.<small><sup style="color: ;"><a title="M. W. Biavatti, P. C. Vieira, M. F. das G. F. da Silva, J. B. Fernandes, S. R. Victor, F. C. Pagnocca, S. Albuquerque, I. Caracelli, J. Zukerman-Schpector,  J. Braz. Chem. Soc. 2002 13 66( Chem. Abstr., 2002,136, 263287)" href="quinoline2003.htm#cit23">23</a></sup></small> This alkaloid and its congeners kokusaginine, skimmianine and maculine <span style="font-weight: bold; "><b>59</b></span> showed antifungal activity against <span style="font-style: italic; "><i>Leucoagaricus gongylophorus</i></span>, but were ineffective towards <span style="font-style: italic; "><i>Trypanosoma cruzi</i></span> (<span style="font-style: italic; "><i>cf.</i></span> Section 1.2).</p><p class="otherpara">A further hitherto unprecedented variation in the oxidation pattern found in the astonishing suite of quinoline alkaloids from <span style="font-style: italic; "><i>Sarcomelicope megistophylla</i></span> (<span style="font-style: italic; "><i>cf.</i></span> Section 1.2) involves the oxidation of the aromatic ring up to the quinone level.<small><sup style="color: ;"><a title="N. Fokialakis, P. Magiatis, I. Chinou, S. Mitaku, F. Tillequin,  Chem. Pharm. Bull. 2002 50 413" href="quinoline2003.htm#cit25">25</a></sup></small> Megistoquinone I <span style="font-weight: bold; "><b>60</b></span>, fully characterised by spectroscopic techniques, is probably derived biogenetically by oxidation of a precursor such as acronycidine <span style="font-weight: bold; "><b>61</b></span>, a major alkaloid from the same source. Indeed, treatment of <span style="font-weight: bold; "><b>61</b></span> with nitric acid yielded <span style="font-weight: bold; "><b>60</b></span>, an experiment first reported in 1950 during the structural elucidation of <span style="font-weight: bold; "><b>61</b></span> by degradation experiments.<small><sup style="color: ;"><a title="F. N. Lahey, J. A. Lamberton, J. R. Price,  Aust. J. Sci. Res. 1950 3 155; cited in ref.25" href="quinoline2003.htm#cit50">50</a></sup></small> A second metabolite, megistoquinone II <span style="font-weight: bold; "><b>62</b></span>, is apparently derived from <span style="font-weight: bold; "><b>60</b></span> by hydrolysis of the furan ring followed by methylation of the resulting enol. While a number of quinoline-5,8-quinones have been found in sponges, this is the first report of their occurrence in terrestrial plants. Both new alkaloids showed antibacterial properties, with minimum inhibitory concentrations ranging from 2.35 to 5.25 mg cm<small><sup>ï¿½3</sup></small> for <span style="font-weight: bold; "><b>60</b></span> and 0.73 to 1.23 mg cm<small><sup>ï¿½3</sup></small> for <span style="font-weight: bold; "><b>62</b></span>. Acronycidine itself was inactive in the same battery of tests.</p><p class="otherpara">The first example of a naturally occurring furo[3,2-<span style="font-style: italic; "><i>g</i></span>]quinoline alkaloid has been reported as a constituent of the stem bark of <span style="font-style: italic; "><i>Zanthoxylum hyemale</i></span>, a South American plant with a history of use in folk medicine.<small><sup style="color: ;"><a title="N. F. de Moura, A. F. Morel, E. C. Dessoy, N. Zanatta, M. M. Burger, N. Ahlert, G. P. Porto, B. Baldisserotto,  Planta Med. 2002 68 534" href="quinoline2003.htm#cit32">32</a></sup></small> The structure of this unique compound, hyemaline <span style="font-weight: bold; "><b>63</b></span>, was established by spectroscopic methods, and the positioning of substituents was based on HMBC experiments.</p><p class="otherpara">Haplopine <span style="font-weight: bold; "><b>55</b></span>, skimmianine <span style="font-weight: bold; "><b>57</b></span>, <img src="https://bitnest.netfirms.com/images/entities/char_03b3.gif">-fagarine <span style="font-weight: bold; "><b>64</b></span> and other furoquinoline alkaloids that occur in the genus <span style="font-style: italic; "><i>Haplophyllum</i></span> have been found to show more pronounced estrogenic activity than dihydrofuroquinoline, quinolin-2-one and quinolin-4-one alkaloids from the same genus.<small><sup style="color: ;"><a title="S. S. Nazrullaev, I. A. Bessonova, K. S. Akhmedkhodzhaeva,  Chem. Nat. Compd. 2001 37 551( Engl. transl. of Khim. Prir. Soedin., 2001, 472)" href="quinoline2003.htm#cit51">51</a></sup></small> The related alkaloid dictamnine <span style="font-weight: bold; "><b>53</b></span> has proved to be a feeding deterrent against two insect pests (<span style="font-style: italic; "><i>Sitophilus zeamays</i></span> and <span style="font-style: italic; "><i>Trilobium castaneum</i></span>) responsible for spoilage of stored products.<small><sup style="color: ;"><a title="Z. L. Liu, Y. J. Xu, J. Wu, S. H. Goh, S. H. Ho,  J. Agr. Food Chem. 2002 50 1447" href="quinoline2003.htm#cit52">52</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr4"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u4.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect910"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>1.5 Miscellaneous quinoline alkaloids from higher plants</b></p></a><p class="firstpara">Two new glucoside derivatives of antidesmone <span style="font-weight: bold; "><b>65</b></span>, a recently discovered alkaloid from the African tree <span style="font-style: italic; "><i>Antidesma membranaceum</i></span> (Euphorbiaceae) (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2001 18 546" href="quinoline2003.htm#cit35f">35<span style="font-style: italic; "><i>f</i></span></a>), have been detected in leaf extracts of the same plant.<small><sup style="color: ;"><a title="A. Buske, J. Schmidt, A. Porzel, G. Adam,  Eur. J. Org. Chem. 2001 3537" href="quinoline2003.htm#cit1">1</a></sup></small> The salient structural features of the novel metabolites, (+)-(17<span style="font-style: italic; "><i>RS</i></span>)-17-(<img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">-<span style="font-variant: 80; "><small>D</small></span>-glucopyranosyloxy)antidesmone <span style="font-weight: bold; "><b>66</b></span> and (+)-(17<span style="font-style: italic; "><i>RS</i></span>)-8-deoxo-17-(<img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">-<span style="font-variant: 80; "><small>D</small></span>-glucopyranosyloxy)antidesmone <span style="font-weight: bold; "><b>67</b></span>, were revealed by thorough NMR and mass spectrometric analysis. Although both compounds were mixtures of diastereomers at C-17 in the side chain, comparison with reported <small><sup>1</sup></small>H NMR spectroscopic data for alk-2-yl <img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">-<span style="font-variant: 80; "><small>D</small></span>-glucopyranosides allowed unambiguous differentiation of the (17<span style="font-style: italic; "><i>R</i></span>) and (17<span style="font-style: italic; "><i>S</i></span>) forms, and integration of the methyl signals indicated the (<span style="font-style: italic; "><i>R</i></span>)/(<span style="font-style: italic; "><i>S</i></span>) ratio in <span style="font-weight: bold; "><b>66</b></span> and <span style="font-weight: bold; "><b>67</b></span> to be 3 : 1 and 1.3 : 1, respectively. Analysis of coupling constants showed that the proton at C-5 was in an equatorial or pseudoequatorial position in both alkaloids, while the maxima in the CD spectrum of compound <span style="font-weight: bold; "><b>66</b></span> were the same as in antidesmone itself, from which the (<span style="font-style: italic; "><i>S</i></span>) absolute configuration at C-5 was inferred. The presence of the new alkaloids is thought to imply a biological function for antidesmone as a vehicle for the storage or transport of glucosides. In the meantime, antidesmone has been found to display potent and selective antitrypanosomal activity against <span style="font-style: italic; "><i>Trypanosoma cruzi</i></span>, the pathogenic agent of Chagas disease (IC<small><sub>50</sub></small> 0.02 ï¿½g ml<small><sup>ï¿½1</sup></small>), but little or no activity against <span style="font-style: italic; "><i>T. brucei rhodesiense</i></span>, an extracellular protozoan parasite responsible for African sleeping sickness, or against <span style="font-style: italic; "><i>Leishmania donovani</i></span>, the cause of visceral leishmaniasis.<small><sup style="color: ;"><a title="G. Bringmann, S. Schlauer, H. Rischer, M. Wohlfahrt, R. Haller, S. Bar, R. Brun,  Pharm. Pharmacol. Lett. 2001 2 47" href="quinoline2003.htm#cit53">53</a></sup></small></p><p class="otherpara">Three new carbostyril derivatives have been reported from atypical plant sources and characterised by spectroscopic methods. Bioactivity-guided fractionation of an ethyl acetate extract of the Chinese medicinal plant <span style="font-style: italic; "><i>Aquilegia ecalcarata</i></span> (Ranunculaceae) led to the isolation of 7-hydroxy-4-[5-(hydroxymethyl)-2-furyl]quinolin-2(1<span style="font-style: italic; "><i>H</i></span>)-one <span style="font-weight: bold; "><b>68</b></span>, the furyl substituent of which is unprecedented in a quinoline alkaloid.<small><sup style="color: ;"><a title="S.-B. Chen, G.-Y. Gao, Y.-S. Li, S.-C. Yu, P.-G. Xiao,  Planta Med. 2002 68 554" href="quinoline2003.htm#cit3">3</a></sup></small> The purified alkaloid was moderately cytotoxic towards two human cancer cell lines (IC<small><sub>50</sub></small> 8.8ï¿½10.1 ï¿½M) in <span style="font-style: italic; "><i>in vitro</i></span> tests. The less exotic alkaloid methyl 6-hydroxy-2-oxo-1,2-dihydroquinoline-4-carboxylate <span style="font-weight: bold; "><b>69</b></span> was isolated from the aleurone (protein-containing) layer of the dark purple anthocyanin-pigmented rice cultivar <span style="font-style: italic; "><i>Oryza sativa</i></span> cv. <span style="font-style: italic; "><i>Heugjinmi</i></span> (Gramineae).<small><sup style="color: ;"><a title="H. S. Chung, W. S. Woo,  J. Nat. Prod. 2001 64 1579" href="quinoline2003.htm#cit19">19</a></sup></small> Structural characterisation of the new alkaloid and its readily prepared acetate derivative by spectroscopic methods was straightforward. This is the first report of the compound from a natural source, although it has previously been synthesised.<small><sup style="color: ;"><a title="N. A. Cortese, C. B. Ziegler, Jr., B. J. Hrnjez, R. F. Heck,  J. Org. Chem. 1978 43 2952" href="quinoline2003.htm#cit54">54</a></sup></small> Compound <span style="font-weight: bold; "><b>69</b></span> may well act as an anti-oxidant in the plant, since it was found to exhibit moderate anti-oxidative activity in a radical-scavenging assay (IC<small><sub>50</sub></small> 36.4 ï¿½g ml<small><sup>ï¿½1</sup></small>). A different rice cultivar, <span style="font-style: italic; "><i>Oryza sativa</i></span> cv. <span style="font-style: italic; "><i>Mihyangbyo</i></span>, yielded the corresponding 6-methoxy compound <span style="font-weight: bold; "><b>70</b></span>, which exhibited moderate antineoplastic activity towards the human leukemia cell line U937 (IC<small><sub>50</sub></small> 118.1 ï¿½g ml<small><sup>ï¿½1</sup></small>).<small><sup style="color: ;"><a title="H. S. Chung,  Nutraceuticals Food 2002 7 119( Chem. Abstr., 2003,138, 163102)" href="quinoline2003.htm#cit20">20</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr5"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u5.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">A brief note describing the constituents of the bark of Peruvian <span style="font-style: italic; "><i>Ladenbergia oblongifolia</i></span>, a previously unexplored plant of the Rubiaceae with no apparent history of medicinal use, reported the isolation and full spectroscopic characterisation of the known alkaloids cinchonidicinol <span style="font-weight: bold; "><b>71</b></span> and epicinchonicinol <span style="font-weight: bold; "><b>72</b></span>, as well as a mixture of the epimeric alkaloids dihydrocinchinicinol and dihydrocinchonidicinol <span style="font-weight: bold; "><b>73</b></span>.<small><sup style="color: ;"><a title="A. L. Okunade, W. H. Lewis, M. P. Elvin-Lewis, S. J. Casper, D. E. Goldberg,  Fitoterapia 2001 72 717" href="quinoline2003.htm#cit14">14</a></sup></small> The latter may well be new alkaloids, since no previous reference to them in <span style="font-style: italic; "><i>Chemical Abstracts</i></span> could be traced. None of these compounds showed antimalarial activity towards a chloroquine-sensitive strain of <span style="font-style: italic; "><i>Plasmodium falciparum</i></span>. In this regard, several synthetic analogues of known antimalarial alkaloids such as quinine and cinchonidine having the general structure <span style="font-weight: bold; "><b>74</b></span> showed potent activity against a chloroquine resistant strain of <span style="font-style: italic; "><i>P. falciparum</i></span>, and may be promising alternatives for currently used drugs in antimalarial chemotherapy.<small><sup style="color: ;"><a title="B.-S. Park, D.-Y. Kim, P. J. Rosenthal, S.-C. Huh, B. J. Lee, E.-J. Park, S.-M. Kim, J.-E. Kim, M.-H. Kim, T.-L. Huh, Y.-J. Choi, K.-H. Suh, W.-S. Choi, S.-E. Lee,  Bioorg. Med. Chem. Lett. 2002 12 1351" href="quinoline2003.htm#cit55">55</a></sup></small></p><p class="otherpara">Dihydroschoberine <span style="font-weight: bold; "><b>75</b></span> is a novel decahydroquinoline alkaloid isolated from a chloroform extract of the aerial parts of <span style="font-style: italic; "><i>Nitraria sibirica</i></span> (Nitrareaceae, Zygophyllaceae).<small><sup style="color: ;"><a title="T. S. Tulyaganov, F. K. Allaberdiev,  Chem. Nat. Compd. 2001 37 556( Engl. transl. of Khim. Prir. Soedin., 2001, 476)" href="quinoline2003.htm#cit18">18</a></sup></small> The natural product, an optically inactive oil, proved to be identical to the product obtained by catalytic hydrogenation of schoberine <span style="font-weight: bold; "><b>76</b></span>, a well-known metabolite of the genus <span style="font-style: italic; "><i>Nitraria</i></span>, in acetic acid. The stereochemistry of the ring junction in the new alkaloid was not reported, but is presumably unchanged from that in schoberine itself.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr6"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u6.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect982"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>1.6 Quinoline alkaloids from fungal and microbial sources</b></p></a><p class="firstpara">Bioassay-guided HPLC fractionation of the fermentation broth of the actinomycete strain <span style="font-style: italic; "><i>Micromonospora</i></span> sp. IM 2670 yielded the well-known quinolinequinone antibiotic streptonigrin <span style="font-weight: bold; "><b>77</b></span> and its novel <span style="font-style: italic; "><i>N</i></span>-(1-methyl-2-oxopropyl) derivative <span style="font-weight: bold; "><b>78</b></span>.<small><sup style="color: ;"><a title="H. Wang, S. L. Yeo, J. Xu, X. Xu, H. He, F. Ronca, A. E. Ting, Y. Wang, V. C. Yu, M. M. Sim,  J. Nat. Prod. 2002 65 721" href="quinoline2003.htm#cit17">17</a></sup></small> The structure of <span style="font-weight: bold; "><b>78</b></span> was deduced largely on the basis of NMR spectra and chemical shift comparisons with streptonigrin and a model <span style="font-style: italic; "><i>N</i></span>-(1-methyl-2-oxopropyl)aniline. Both compounds induced apoptosis in human neuroblastoma SH-SY5Y cells containing wild-type p53 (a tumour-suppressing protein functioning as a key component of the cellular emergency response mechanism), although streptonigrin was more active (IC<small><sub>50</sub></small> 0.05 ï¿½M, <span style="font-style: italic; "><i>vs.</i></span> 0.9 ï¿½M).</p><p class="otherpara">The isolation of quinolactacin A from the entomopathogenic fungus <span style="font-style: italic; "><i>Penicillium</i></span> sp. EPF-6 was reported in last year's review<small><sup style="color: ;"><a title="N. Kakinuma, H. Iwai, S. Takahashi, K. Hamano, T. Yanagisawa, K. Nagai, K. Tanaka, K. Suzuki, F. Kirikae, T. Kirikae, A. Nakagawa,  J. Antibiot. 2000 53 1247; S. Takahashi, N. Kakinuma, H. Iwai, T. Yanagisawa, K. Nagai, K. Suzuki, T. Tokunaga, A. Nakagawa,  J. Antibiot. 2000 53 1252" href="quinoline2003.htm#cit56">56,57</a></sup></small> (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2002 19 749" href="quinoline2003.htm#cit35g">35<span style="font-style: italic; "><i>g</i></span></a>). Although a novel 3-(<span style="font-style: italic; "><i>sec</i></span>-butyl)-2,3-dihydro-1<span style="font-style: italic; "><i>H</i></span>-pyrrolo[3,4-<span style="font-style: italic; "><i>b</i></span>]quinoline-1,9(4<span style="font-style: italic; "><i>H</i></span>)-dione structure was proposed for the alkaloid, the stereochemistry at the two stereogenic centres was not elucidated. However, two diastereomeric metabolites having the same gross structure, isolated more recently from <span style="font-style: italic; "><i>Penicillium citrinum</i></span> 90648 and thoroughly characterised by a range of spectroscopic techniques, cast light on this stereochemical ambiguity.<small><sup style="color: ;"><a title="W.-G. Kim, N.-K. Song, I.-D. Yoo,  J. Antibiot. 2001 54 831" href="quinoline2003.htm#cit21">21</a></sup></small> On the basis of significant nOe differences involving the NH, NCH<small><sub>3</sub></small> and 3-H protons on the one hand, and the protons on the conformationally restricted <span style="font-style: italic; "><i>sec</i></span>-butyl group on the other, the authors proposed relative (<span style="font-style: italic; "><i>S</i></span>*,<span style="font-style: italic; "><i>R</i></span>*) and (<span style="font-style: italic; "><i>S</i></span>*,<span style="font-style: italic; "><i>S</i></span>*) stereochemistries for quinolactacins A1 and A2, respectively, as shown in <span style="font-weight: bold; "><b>79</b></span> and <span style="font-weight: bold; "><b>80</b></span>. H-3 and the methyl group of the <span style="font-style: italic; "><i>sec</i></span>-butyl chain appear to be <span style="font-style: italic; "><i>anti</i></span> in the former compound, while H-3 and the methylene group are <span style="font-style: italic; "><i>anti</i></span> in the latter. The chemical shifts of quinolactacin A2 were very similar to those previously reported for quinolactacin A, to which structure <span style="font-weight: bold; "><b>80</b></span> should now also be assigned. Quinolactacin A2 was found to be a more pronounced inhibitor of acetylcholinesterase than quinolactacin A1 (IC<small><sub>50</sub></small> 19.8 <span style="font-style: italic; "><i>vs.</i></span> 280 ï¿½M); its selectivity for acetylcholinesterase rather than butyrylcholinesterase (IC<small><sub>50</sub></small> 650 ï¿½M) may offer opportunities for exploration in the treatment of Alzheimer-type dementia.</p><p class="otherpara">2-Alkyl-4-hydroxyquinolines (or their quinolin-4-one tautomers) have long been known as metabolites of <span style="font-style: italic; "><i>Pseudomonas</i></span> organisms, from which source their alternative name of <img src="https://bitnest.netfirms.com/images/entities/char_2018.gif">pseudans<img src="https://bitnest.netfirms.com/images/entities/char_2019.gif"> is derived. While the recent isolation of the 2-heptyl and 2-nonyl homologues <span style="font-weight: bold; "><b>81</b></span> and <span style="font-weight: bold; "><b>82</b></span> (pseudans VII and IX) from <span style="font-style: italic; "><i>Pseudomonas aeruginosa</i></span> ATCC 15692 was not in itself novel, the point of interest is that these compounds turned out to be novel membrane-associated iron chelators (MAIC) in the cytoplasmic membrane of iron-rich bacterial cells.<small><sup style="color: ;"><a title="P. W. Royt, R. V. Honeychuck, V. Ravich, P. Ponnaluri, L. K. Pannell, J. S. Buyer, V. Chandhoke, W. M. Stalick, L. C. DeSesso, S. Donohue, R. Ghei, J. D. Relyea, R. Ruiz,  Bioorg. Chem. 2001 29 387" href="quinoline2003.htm#cit58">58</a></sup></small> The structure of <span style="font-weight: bold; "><b>82</b></span> was confirmed by spectroscopic comparison with a sample prepared by alkylating the dianion of 2-methylquinolin-4-ol with octyl bromide. Although <span style="font-style: italic; "><i>in vitro</i></span> complexation of synthetic pseudan IX with iron(<span style="font-variant: 80; "><small>III</small></span>) chloride could not be verified spectroscopically, pink micelles similar to those found in the ethanol extract of cell membranes were formed on mixing the precursors. Also, after growth of the cells in the presence of <small><sup>55</sup></small>FeCl<small><sub>3</sub></small>, the radioactivity co-eluted with pseudan IX from an LH-20 Sephadex gel filtration column.</p><p class="otherpara">The simple antibiotic <span style="font-style: italic; "><i>N</i></span>-mercapto-4-formylcarbostyril <span style="font-weight: bold; "><b>83</b></span> is a novel metabolite of <span style="font-style: italic; "><i>Pseudomonas fluorescens</i></span> (strain G308), a microorganism originally found growing on barley leaves.<small><sup style="color: ;"><a title="W. Fakhouri, F. Walker, B. Vogler, W. Armbruster, H. Buchenauer,  Phytochemistry 2001 58 1297" href="quinoline2003.htm#cit22">22</a></sup></small> The structure was deduced from its relatively simple spectra and those of its easily prepared <span style="font-style: italic; "><i>S</i></span>-acetyl derivative. Although no mention was made of the fact, this is the first occurrence of the <span style="font-style: italic; "><i>N</i></span>-mercapto substituentï¿½effectively, part of the rare <span style="font-style: italic; "><i>N</i></span>-mercaptoamide functional groupï¿½in a quinolinone alkaloid. The purified antibiotic exhibited good activity against a range of plant pathogenic fungi, including <span style="font-style: italic; "><i>Fusarium oxysporum</i></span>, <span style="font-style: italic; "><i>F. culmorum</i></span>, <span style="font-style: italic; "><i>Cladosporium cucumerinum</i></span> and <span style="font-style: italic; "><i>Colletotrichum lagenarium</i></span>.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr7"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u7.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">Two new octadepsipeptides bearing pendent 3-hydroxyquinaldic acid chromophores have been isolated from the culture broth of the <span style="font-style: italic; "><i>Streptomyces</i></span> strain SNA15896, collected from a Japanese soil sample.<small><sup style="color: ;"><a title="K. Kurosawa, K. Takahashi, E. Tsuda,  J. Antibiot. 2001 54 615; K. Takahashi, H. Koshino, Y. Esumi, E. Tsuda, K. Kurosawa,  J. Antibiot. 2001 54 622" href="quinoline2003.htm#cit29">29,30</a></sup></small> The symmetrical dimer (ï¿½)-SW-163C <span style="font-weight: bold; "><b>84</b></span> incorporates a central disulfide bridge, while the related compound (ï¿½)-SW-163E <span style="font-weight: bold; "><b>85</b></span> possesses the same periphery as <span style="font-weight: bold; "><b>84</b></span> but differs only in its inclusion of an internal dithioacetal linkage. Compound SW-163E is, in fact, the <span style="font-style: italic; "><i>S</i></span>-ethyl analogue of three antibiotics reported in 1989, and coded as UK-63,052 <span style="font-weight: bold; "><b>86</b></span>, UK-65,662 <span style="font-weight: bold; "><b>87</b></span> and UK-63,598 <span style="font-weight: bold; "><b>88</b></span>.<small><sup style="color: ;"><a title="M. J. Rance, J. C. Ruddock, M. S. Pacey, W. P. Cullen, L. H. Huang, M. T. Jefferson, E. B. Whipple, H. Maeda, J. Tone,  J. Antibiot. 1989 42 206" href="quinoline2003.htm#cit59">59</a></sup></small> The stereochemistry of all these natural products has not been elucidated, although it could no doubt be inferred from the nature of the amino acid constituents. Both SW-163C and SW-163E displayed good antibacterial activity, especially against Gram-positive bacteria. More importantly, potent antitumour activity was demonstrated in <span style="font-style: italic; "><i>in vitro</i></span> tests against various murine and human tumour cell lines, with <span style="font-weight: bold; "><b>85</b></span> being about a hundredfold more active than <span style="font-weight: bold; "><b>84</b></span> (IC<small><sub>50</sub></small> 0.2ï¿½1.6 <span style="font-style: italic; "><i>vs.</i></span> 17ï¿½140 nM, respectively). When <span style="font-style: italic; "><i>in vivo</i></span> activity was assessed in mice implanted with P388 leukaemia, SW-163E was remarkable in prolonging life span at a dose of 0.01 mg kg<small><sup>ï¿½1</sup></small>, but proved to be acutely toxic at higher doses (LD<small><sub>50</sub></small> 0.6 mg kg<small><sup>ï¿½1</sup></small>; <span style="font-style: italic; "><i>cf</i></span>. &gt; 100 mg kg<small><sup>ï¿½1</sup></small> for <span style="font-weight: bold; "><b>84</b></span>).</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr8"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u8.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">Several model studies aimed at the synthesis of quinoline-containing natural products require brief mention. Evolving approaches to the synthesis of lavendamycin <span style="font-weight: bold; "><b>89</b></span> by Holzapfel <span style="font-style: italic; "><i>et al.</i></span> have involved optimising the palladium-catalysed aminocarbonylation of 2-chloroquinolines with amines in the presence of carbon monoxide to give intermediates such as <span style="font-weight: bold; "><b>90</b></span>, Bischlerï¿½Napieralski cyclisation of which produces the antibiotic's pentacyclic core.<small><sup style="color: ;"><a title="C. W. Holzapfel, W. Marais,  J. Chem. Res.(S) 2002 22" href="quinoline2003.htm#cit60">60</a></sup></small> Nicolaou and co-workers have reported a stereocontrolled synthesis of the macrocycle <span style="font-weight: bold; "><b>91</b></span>, envisaged as a key intermediate in the synthesis of the complex thiopeptide antibiotic thiostrepton.<small><sup style="color: ;"><a title="K. C. Nicolaou, B. S. Safina, C. Funke, M. Zak, F. J. Zecri,  Angew. Chem., Int. Ed. 2002 41 1937; K. C. Nicolaou, M. Nevalainen, B. S. Safina, M. Zak, S. Bulat,  Angew. Chem., Int. Ed. 2002 41 1941" href="quinoline2003.htm#cit61">61,62</a></sup></small> The dihydroquinoline building block <span style="font-weight: bold; "><b>92</b></span> employed in this route was prepared in a multi-step procedure from quinaldic acid. Coincidentally, Hashimoto and co-workers almost simultaneously reported a similar multi-step synthesis of the dihydroquinoline <span style="font-weight: bold; "><b>93</b></span> starting from 5,6,7,8-tetrahydroquinoline.<small><sup style="color: ;"><a title="S. Higashibayashi, T. Mori, K. Shinko, K. Hashimoto, M. Nakata,  Heterocycles 2002 57 111" href="quinoline2003.htm#cit63">63</a></sup></small> Compound <span style="font-weight: bold; "><b>93</b></span> is proposed as an intermediate <span style="font-style: italic; "><i>en route</i></span> to siomycin D<small><sub>1</sub></small>, another member of the thiostrepton group of peptide antibiotics.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr9"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u9.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect1084"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>1.7 Quinoline alkaloids from animals</b></p></a><p class="firstpara">Several new lepadins, a group of decahydroquinoline alkaloids isolated from ascidians (tunicates or sea squirts) collected on the Great Barrier Reef, have been described in two independent publications that appeared almost simultaneously. A new species of the animal belonging to the genus <span style="font-style: italic; "><i>Didemnum</i></span> yielded four novel lepadins, the structures of which were elucidated with the aid of a comprehensive suite of spectroscopic techniques.<small><sup style="color: ;"><a title="A. D. Wright, E. Goclik, G. M. Konig, R. Kaminsky,  J. Med. Chem. 2002 45 3067" href="quinoline2003.htm#cit5">5</a></sup></small> In the case of (+)-lepadin D <span style="font-style: italic; "><i>rel</i></span>-<span style="font-weight: bold; "><b>94</b></span>, for example, analysis of coupling constants in combination with nOe experiments indicated <span style="font-style: italic; "><i>cis</i></span>-fusion of the decahydroquinoline nucleus, chair conformations of both rings, a <span style="font-style: italic; "><i>trans</i></span>-diaxial arrangement of the C-2 and C-3 methyl and hydroxy substituents, and a 1,3-diaxial relationship between 5-H and 8a-H. This analysis established the relative stereochemistry of the stereogenic centres on the ring system, but both the configuration of the hydroxy group on the side chain and the molecule's absolute configuration remain unknown despite attempts to form a <span style="font-style: italic; "><i>p</i></span>-bromobenzoyl derivative for crystallographic analysis. Similar considerations led to the elucidation of the relative structures <span style="font-weight: bold; "><b>95</b></span> and <span style="font-weight: bold; "><b>96</b></span> for (ï¿½)-lepadins E and F, respectively, the last-named differing from the others in having an equatorial methyl substituent at C-2. The fourth alkaloid was simply the protonated form of lepadin D, probably with chloride as counter-ion. All the new alkaloids displayed biological activity: lepadins Dï¿½F were weakly antifungal, while the mildly cytotoxic <span style="font-weight: bold; "><b>95</b></span> and <span style="font-weight: bold; "><b>96</b></span> were also moderate inhibitors of tyrosine kinase p56. Most importantly, all four natural products showed significant antitrypanosomal and antiplasmodial activity, the most potent compound being lepadin F. The isolates may thus serve as novel lead compounds for the development of new antimalarial drugs.</p><p class="otherpara">The three new lepadins described in the second publication were isolated from the ascidian <span style="font-style: italic; "><i>Aplidium tabascum</i></span>.<small><sup style="color: ;"><a title="R. A. Davis, A. R. Carroll, R. J. Quinn,  J. Nat. Prod. 2002 65 454" href="quinoline2003.htm#cit2">2</a></sup></small> Apart from its optical rotation (+5.5 rather than ï¿½1.5), lepadin F proved to be identical to the compound described above; slight differences in the reported <small><sup>1</sup></small>H NMR spectra were a consequence of measurement in different solvents (C<small><sub>6</sub></small>D<small><sub>6</sub></small><span style="font-style: italic; "><i>vs.</i></span> CDCl<small><sub>3</sub></small>). It is unlikely that the two isolates are mirror images; it is more probable that minor impurities have distorted the small specific rotations recorded. The structure drawn for lepadin F in this publication was actually <span style="font-style: italic; "><i>ent</i></span>-<span style="font-weight: bold; "><b>96</b></span>, but the relative stereochemistry in the two representations is the same. [In this regard, it is pertinent to note that a recent enantioselective total synthesis of three lepadins, <span style="font-style: italic; "><i>e.g.</i></span>, (ï¿½)-lepadin A <span style="font-weight: bold; "><b>97</b></span>, by Kibayashi's group<small><sup style="color: ;"><a title="T. Ozawa, S. Aoyagi, C. Kibayashi,  J. Org. Chem. 2001 66 3338" href="quinoline2003.htm#cit64">64</a></sup></small> (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2002 19 750" href="quinoline2003.htm#cit35h">35<span style="font-style: italic; "><i>h</i></span></a>) has established a correlation between absolute configuration and optical rotation that may be valid for other members of the lepadin family.] (+)-Lepadin G <span style="font-style: italic; "><i>rel</i></span>-<span style="font-weight: bold; "><b>98</b></span> is a dienoate analogue of lepadin F, while (+)-lepadin H <span style="font-style: italic; "><i>rel</i></span>-<span style="font-weight: bold; "><b>99</b></span> is the octa-2,4-dienoate ester of lepadin D. In this study, molecular modelling was also used for ascertaining the minimum energy conformations of the alkaloids, and substantiated the conformational deductions based on NMR data. Interestingly, the preferred <span style="font-style: italic; "><i>cis</i></span>-fused twin-chair decahydroquinoline ring system for lepadins G and H places the ring nitrogen equatorial, as shown in <span style="font-weight: bold; "><b>100</b></span>, whereas it is known that the nitrogen is axial in lepadin A, as depicted in <span style="font-weight: bold; "><b>101</b></span>.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr10"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u10.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The Okinawan sponge <span style="font-style: italic; "><i>Hyrtios erecta</i></span> was the source of the two simple brominated carbostyrils <span style="font-weight: bold; "><b>102</b></span> and <span style="font-weight: bold; "><b>103</b></span>.<small><sup style="color: ;"><a title="S. Aoki, Y. Ye, K. Higuchi, A. Takashima, Y. Tanaka, I. Kitagawa, M. Kobayashi,  Chem. Pharm. Bull. 2001 49 1372" href="quinoline2003.htm#cit13">13</a></sup></small> Both are novel natural products, although the former was previously reported as a synthetic compound.<small><sup style="color: ;"><a title="D. R. Buckle, B. C. C. Cantello, H. Smith, B. A. Spicer,  J. Med. Chem. 1975 18 726" href="quinoline2003.htm#cit65">65</a></sup></small> The compounds were good but unselective inhibitors of the neural and inducible isozymes of nitric oxide synthase. Another new alkaloid, represented as the 2-hydroxyquinoline <span style="font-weight: bold; "><b>104</b></span> but more probably the tautomeric carbostyril, was isolated from whole body extracts of the centipede <span style="font-style: italic; "><i>Scolopendra subspinipes mutilans</i></span>, which is used in traditional Chinese and Korean medicines.<small><sup style="color: ;"><a title="N. Noda, Y. Yashiki, T. Nakatani, K. Miyahara, X.-M. Du,  Chem. Pharm. Bull. 2001 49 930" href="quinoline2003.htm#cit26">26</a></sup></small> Treatment of <span style="font-weight: bold; "><b>104</b></span>, which has been named scolopendrine, with diazomethane gave <span style="font-weight: bold; "><b>105</b></span>, HMBC correlations on which assisted in the location of the substituents. Scolopendrine's benzyl group at C-7 and sulfate group at C-8 are unprecedented substituents among the quinoline alkaloids.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr11"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u11.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">Continuing uncertainty over the proposed structure <span style="font-weight: bold; "><b>106</b></span> for the sponge metabolite halitulin has prompted Banwell and co-workers to undertake the short convergent synthesis shown in <a title=" Reagents: i, pinacolborane(6 equiv.), PdCl2(dppf)(14 mol%), Et3N(10 equiv.), dioxane, 85[degree]C, 24 h; ii,109(1.4 equiv.), Pd(PPh3)4(10 mol%), Na2CO3(2 M, 10 equiv.), PhMe-MeOH(6 : 5), 65[degree]C, 24 h; iii, H2C[double bond, length as m-dash]CHCO2Me, AcOH, reflux; iv, LiAlH4, THF, 18[degree]C; v, Tf2O, 2,6-di-tert-butyl-4-methylpyridine, CH2Cl2, 0[degree]C; vi, KHMDS+110, THF, 0[degree]C, then add113, 0[degree]C." href="quinoline2003.htm#sch2">Scheme 2</a>.<small><sup style="color: ;"><a title="M. G. Banwell, A. M. Bray, A. J. Edwards, D. J. Wong,  J. Chem. Soc., Perkin Trans. 1 2002 1340" href="quinoline2003.htm#cit66">66</a></sup></small> Palladium(<span style="font-variant: 80; "><small>0</small></span>)-mediated coupling of the 3,4-diiodopyrrole <span style="font-weight: bold; "><b>107</b></span> with pinacolborane followed by Suzukiï¿½Miyaura cross-coupling of the resulting bis(boronic ester) <span style="font-weight: bold; "><b>108</b></span> with the bromoquinoline <span style="font-weight: bold; "><b>109</b></span> produced the desilylated pyrrole <span style="font-weight: bold; "><b>110</b></span> in an overall yield of 29% based on <span style="font-weight: bold; "><b>107</b></span>. The structure of compound <span style="font-weight: bold; "><b>110</b></span> was confirmed by single-crystal X-ray crystallography. The 3-methylazecane <span style="font-weight: bold; "><b>111</b></span>, previously prepared by Banwell's group<small><sup style="color: ;"><a title="M. G. Banwell, A. M. Bray, A. J. Edwards, D. J. Wong,  New J. Chem. 2001 25 1347" href="quinoline2003.htm#cit67">67</a></sup></small> during a synthesis of the putative alkaloid haliclorensin (originally thought to be <span style="font-weight: bold; "><b>112</b></span>, but now known to be a diazacyclotetradecane<small><sup style="color: ;"><a title="M. R. Heinrich, Y. Kashman, P. Spiteller, W. Steglich,  Tetrahedron 2001 57 9973" href="quinoline2003.htm#cit68">68</a></sup></small>), was converted in three steps into the unstable trifluoromethanesulfonate <span style="font-weight: bold; "><b>113</b></span>, which readily alkylated the potassium salt of pyrrole <span style="font-weight: bold; "><b>110</b></span> to give halitulin tetramethyl ether <span style="font-weight: bold; "><b>114</b></span> in 87% yield. Unfortunately, all attempts to cleave the methyl ethers failed. However, detailed comparison of the spectroscopic data reported for halitulin with those obtained on <span style="font-weight: bold; "><b>110</b></span> and <span style="font-weight: bold; "><b>114</b></span> showed disturbing discrepancies in both the cyclic amine and the 3,4-bis(quinolin-5-yl)pyrrole portions of structure <span style="font-weight: bold; "><b>106</b></span>. In the interim, Usuki <span style="font-style: italic; "><i>et al.</i></span> have reported an enantioselective synthesis of (<span style="font-style: italic; "><i>R</i></span>)-(+)-<span style="font-weight: bold; "><b>112</b></span><small><sup style="color: ;"><a title="Y. Usuki, H. Hirakawa, K. Goto, H. Iio,  Tetrahedron: Asymmetry 2001 12 3293" href="quinoline2003.htm#cit69">69</a></sup></small> (renamed isohaliclorensin), the <small><sup>13</sup></small>C NMR data for which were claimed to be comparable with those for the corresponding substructure of halitulin. Final resolution of the disputed structure of halitulin must thus await complete total synthesis or re-collection and further spectroscopic investigation.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch2"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-s2.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 2 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents</i></span>: i, pinacolborane (6 equiv.), PdCl<small><sub>2</sub></small>(dppf)(14 mol%), Et<small><sub>3</sub></small>N (10 equiv.), dioxane, 85 ï¿½C, 24 h; ii, <span style="font-weight: bold; "><b>109</b></span>(1.4 equiv.), Pd(PPh<small><sub>3</sub></small>)<small><sub>4</sub></small>(10 mol%), Na<small><sub>2</sub></small>CO<small><sub>3</sub></small>(2 M, 10 equiv.), PhMeï¿½MeOH (6 : 5), 65 ï¿½C, 24 h; iii, H<small><sub>2</sub></small>C<img src="https://bitnest.netfirms.com/images/entities/char_e001.gif">CHCO<small><sub>2</sub></small>Me, AcOH, reflux; iv, LiAlH<small><sub>4</sub></small>, THF, 18 ï¿½C; v, Tf<small><sub>2</sub></small>O, 2,6-di-<span style="font-style: italic; "><i>tert</i></span>-butyl-4-methylpyridine, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, 0 ï¿½C; vi, KHMDS +<span style="font-weight: bold; "><b>110</b></span>, THF, 0 ï¿½C, then add <span style="font-weight: bold; "><b>113</b></span>, 0 ï¿½C.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The fascinating aspect of the synthesis of decahydroquinoline 195A <span style="font-weight: bold; "><b>115</b></span> (commonly known as pumiliotoxin C) by Mori and co-workers is the use of a nitrogen fixation process to introduce the nitrogen atom as an N-1 synthon (<a title=" Reagents: i,&quot;Ti-N&quot;complex[from Li-Ti(OPri)4-Me3SiCl(10 : 1 : 15)+N2], CsF, THF,-78[degree]C, then rt, 20 h; ii, H2(1 atm), 5%Pd/C, MeOH; iii, ClCO2Bn, K2CO3, CH2Cl2, 0[degree]C to rt; iv, DIBAL-H, PhCH3,-78[degree]C, 15 min, then MeOH, aq. NH4Cl, rt; v, Ph3P[double bond, length as m-dash]CH2, THF, rt." href="quinoline2003.htm#sch3">Scheme 3</a>).<small><sup style="color: ;"><a title="M. Akashi, Y. Sato, M. Mori,  J. Org. Chem. 2001 66 7873" href="quinoline2003.htm#cit70">70</a></sup></small> Nitrogen, bound in a <img src="https://bitnest.netfirms.com/images/entities/char_201c.gif">Tiï¿½N complex<img src="https://bitnest.netfirms.com/images/entities/char_201d.gif"> prepared from titanium(<span style="font-variant: 80; "><small>IV</small></span>) tetrakis(isopropoxide), lithium metal and trimethylsilyl chloride in the presence of molecular nitrogen gas, was efficiently incorporated into the keto-alkyne precursor <span style="font-weight: bold; "><b>116</b></span> to give the azabicyclic product <span style="font-weight: bold; "><b>117</b></span> in 79% yield. Catalytic hydrogenation over palladium on carbon followed by protection of the basic nitrogen site yielded the <span style="font-style: italic; "><i>cis</i></span>-fused decahydroquinoline <span style="font-weight: bold; "><b>118</b></span> as the major diastereomer (50%), probably because of the easier approach of the reagent from the precursor's convex face. The synthesis of the racemic target compound <span style="font-style: italic; "><i>rac</i></span>-<span style="font-weight: bold; "><b>115</b></span>, characterised as the hydrochloride salt, was completed by standard methods as illustrated.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch3"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-s3.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 3 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents</i></span>: i, <img src="https://bitnest.netfirms.com/images/entities/char_201c.gif">Tiï¿½N<img src="https://bitnest.netfirms.com/images/entities/char_201d.gif"> complex [from Liï¿½Ti(OPr<small><sup>i</sup></small>)<small><sub>4</sub></small>ï¿½Me<small><sub>3</sub></small>SiCl (10 : 1 : 15)+ N<small><sub>2</sub></small>], CsF, THF, ï¿½78 ï¿½C, then rt, 20 h; ii, H<small><sub>2</sub></small>(1 atm), 5% Pd/C, MeOH; iii, ClCO<small><sub>2</sub></small>Bn, K<small><sub>2</sub></small>CO<small><sub>3</sub></small>, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, 0 ï¿½C to rt; iv, DIBAL-H, PhCH<small><sub>3</sub></small>, ï¿½78 ï¿½C, 15 min, then MeOH, aq. NH<small><sub>4</sub></small>Cl, rt; v, Ph<small><sub>3</sub></small>P<img src="https://bitnest.netfirms.com/images/entities/char_e001.gif">CH<small><sub>2</sub></small>, THF, rt.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The use of tetra-<span style="font-style: italic; "><i>O</i></span>-pivaloyl-<img src="https://bitnest.netfirms.com/images/entities/char_03b2.gif">-<span style="font-variant: 80; "><small>D</small></span>-galactopyranosylamine <span style="font-weight: bold; "><b>119</b></span> as a chiral auxiliary in enantioselective and stereochemically complementary syntheses of several stereoisomers of pumiliotoxin C has been investigated by Kunz and co-workers.<small><sup style="color: ;"><a title="M. Weymann, M. Schulz-Kukula, S. Knauer, H. Kunz,  Monatsh. Chem. 2002 133 571" href="quinoline2003.htm#cit71">71</a></sup></small> Imines <span style="font-weight: bold; "><b>120</b></span> formed from this precursor underwent highly diastereoselective annulation with the diene <span style="font-weight: bold; "><b>121</b></span> in the presence of zinc(<span style="font-variant: 80; "><small>II</small></span>) chloride to give the dihydropyridones <span style="font-weight: bold; "><b>122</b></span> and <span style="font-weight: bold; "><b>123</b></span> in 68% yield (<a title=" Reagents: i, R(CH2)3CHO(R=H, vinyl), 4[Angstrom]molecular sieves, pentane; ii, ZnCl2[middle dot]Et2O, THF,-20[degree]C; iii, EtOCH(Me)O(CH2)4MgCl, CuBr[middle dot]SMe2, Me3SiCl; iv,n-PrMgCl, CuCl, BF3[middle dot]Et2O, THF,-78[degree]C; v, PPTS, CH2Cl2; vi, TPAP,N-methylmorpholine-N-oxide, 4[Angstrom]molecular sieves, CH2Cl2, rt; vii, NaOH, dibenzo-18-crown-6, C6H6, reflux; viii, K2OsO4[middle dot]2H2O(cat.), NaIO4, dioxane-H2O; ix, Me2CuLi, THF,-78[degree]C, then Me3SiCl; x, Bu4NF, THF,-20[degree]C; xi, aq. HCl, MeOH, rt; xii, ClCO2Ph, aq. NaHCO3; xiii, Me2CuLi, BF3[middle dot]Et2O, THF,-78[degree]C; xiv, Et3N, THF, 2 min; xv, ClCO2Bn, aq. NaHCO3; xvi, HSCH2CH2SH, BF3[middle dot]Et2O, CH2Cl2, 0[degree]C to rt; xvii, H2, Raney Ni, PriOH, rt; xviii, aq. HCl; xix,n-PrMgCl, CuBr[middle dot]SMe2, THF,-78[degree]C, then126, Me3SiCl; xx, NaHMDS, THF,-78[degree]C, then 2-N(SO2CF3)2-5-Cl-pyridine,-78[degree]C to-20[degree]C; xxi, H2, 5%Pd/C, Li2CO3, MeOH, rt." href="quinoline2003.htm#sch4">Scheme 4</a>). Diastereoselective conjugate addition of appropriate cuprates then yielded the 2,6-<span style="font-style: italic; "><i>cis</i></span>-disubstituted piperidinones <span style="font-weight: bold; "><b>124</b></span> and <span style="font-weight: bold; "><b>125</b></span> which, with suitable manipulation of the functionalised side chains, afforded octahydroquinolinones <span style="font-weight: bold; "><b>126</b></span> and <span style="font-weight: bold; "><b>127</b></span> possessing opposite absolute configurations at the C-2 and C-8a sites. Treating isomer <span style="font-weight: bold; "><b>127</b></span> with lithium dimethylcuprate in the presence of trimethylsilyl chloride proceeded with excellent diastereoselectivity to give the expected (5<span style="font-style: italic; "><i>R</i></span>)-methyl product, but resulted in the unanticipated formation of a <span style="font-style: italic; "><i>trans</i></span>-fused decahydroquinoline <span style="font-weight: bold; "><b>128</b></span>, apparently because the chiral auxiliary steered protonation of the intermediate enolate. To substantiate the involvement of the chiral auxiliary in <span style="font-weight: bold; "><b>127</b></span>, exchange with a phenoxycarbonyl protecting group prior to conjugate addition yielded the expected <span style="font-style: italic; "><i>cis</i></span>-fused decahydroquinoline <span style="font-weight: bold; "><b>129</b></span>, a compound previously prepared by Comins and Dehghani in their 1993 synthesis of (ï¿½)-pumiliotoxin C.<small><sup style="color: ;"><a title="D. L. Comins, A. Dehghani,  J. Chem. Soc., Chem. Commun. 1993 1838" href="quinoline2003.htm#cit72">72</a></sup></small> Epimerisation of the <span style="font-style: italic; "><i>N</i></span>-phenoxycarbonyl analogue of <span style="font-weight: bold; "><b>128</b></span> to give <span style="font-weight: bold; "><b>129</b></span> could also be rapidly effected upon treatment with triethylamine. Alternatively, replacing the auxiliary in <span style="font-weight: bold; "><b>128</b></span> with a benzyloxycarbonyl protecting group before defunctionalising the ketone <span style="font-style: italic; "><i>via</i></span> the dithiolane intermediate <span style="font-weight: bold; "><b>130</b></span> eventually completed the total synthesis of <span style="font-style: italic; "><i>trans</i></span>-4a-<span style="font-style: italic; "><i>epi</i></span>-pumiliotoxin C <span style="font-weight: bold; "><b>131</b></span>, which was characterised by spectroscopy and X-ray crystallography as the laevorotatory hydrochloride salt. Finally, similar transformations performed on the octahydroquinolinone <span style="font-weight: bold; "><b>126</b></span> as shown in the Scheme resulted in the synthesis of <span style="font-style: italic; "><i>cis</i></span>-4a-<span style="font-style: italic; "><i>epi</i></span>-perhydrodecahydroquinoline 219A hydrochloride <span style="font-weight: bold; "><b>132</b></span>, which gave NMR spectroscopic data that agreed with those reported in the literature.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch4"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-s4.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 4 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents</i></span>: i, R(CH<small><sub>2</sub></small>)<small><sub>3</sub></small>CHO (R = H, vinyl), 4 <img src="https://bitnest.netfirms.com/images/entities/char_212b.gif"> molecular sieves, pentane; ii, ZnCl<small><sub>2</sub></small><span style="font-weight: bold; "><b>ï¿½</b></span>Et<small><sub>2</sub></small>O, THF, ï¿½20 ï¿½C; iii, EtOCH(Me)O(CH<small><sub>2</sub></small>)<small><sub>4</sub></small>MgCl, CuBr<span style="font-weight: bold; "><b>ï¿½</b></span>SMe<small><sub>2</sub></small>, Me<small><sub>3</sub></small>SiCl; iv, <span style="font-style: italic; "><i>n</i></span>-PrMgCl, CuCl, BF<small><sub>3</sub></small><span style="font-weight: bold; "><b>ï¿½</b></span>Et<small><sub>2</sub></small>O, THF, ï¿½78 ï¿½C; v, PPTS, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>; vi, TPAP, <span style="font-style: italic; "><i>N</i></span>-methylmorpholine-<span style="font-style: italic; "><i>N</i></span>-oxide, 4 <img src="https://bitnest.netfirms.com/images/entities/char_212b.gif"> molecular sieves, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt; vii, NaOH, dibenzo-18-crown-6, C<small><sub>6</sub></small>H<small><sub>6</sub></small>, reflux; viii, K<small><sub>2</sub></small>OsO<small><sub>4</sub></small><span style="font-weight: bold; "><b>ï¿½</b></span>2H<small><sub>2</sub></small>O (cat.), NaIO<small><sub>4</sub></small>, dioxaneï¿½H<small><sub>2</sub></small>O; ix, Me<small><sub>2</sub></small>CuLi, THF, ï¿½78 ï¿½C, then Me<small><sub>3</sub></small>SiCl; x, Bu<small><sub>4</sub></small>NF, THF, ï¿½20 ï¿½C; xi, aq. HCl, MeOH, rt; xii, ClCO<small><sub>2</sub></small>Ph, aq. NaHCO<small><sub>3</sub></small>; xiii, Me<small><sub>2</sub></small>CuLi, BF<small><sub>3</sub></small><span style="font-weight: bold; "><b>ï¿½</b></span>Et<small><sub>2</sub></small>O, THF, ï¿½78 ï¿½C; xiv, Et<small><sub>3</sub></small>N, THF, 2 min; xv, ClCO<small><sub>2</sub></small>Bn, aq. NaHCO<small><sub>3</sub></small>; xvi, HSCH<small><sub>2</sub></small>CH<small><sub>2</sub></small>SH, BF<small><sub>3</sub></small><span style="font-weight: bold; "><b>ï¿½</b></span>Et<small><sub>2</sub></small>O, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, 0 ï¿½C to rt; xvii, H<small><sub>2</sub></small>, Raney Ni, Pr<small><sup>i</sup></small>OH, rt; xviii, aq. HCl; xix, <span style="font-style: italic; "><i>n</i></span>-PrMgCl, CuBr<span style="font-weight: bold; "><b>ï¿½</b></span>SMe<small><sub>2</sub></small>, THF, ï¿½78 ï¿½C, then <span style="font-weight: bold; "><b>126</b></span>, Me<small><sub>3</sub></small>SiCl; xx, NaHMDS, THF, ï¿½78 ï¿½C, then 2-N(SO<small><sub>2</sub></small>CF<small><sub>3</sub></small>)<small><sub>2</sub></small>-5-Cl-pyridine, ï¿½78 ï¿½C to ï¿½20 ï¿½C; xxi, H<small><sub>2</sub></small>, 5% Pd/C, Li<small><sub>2</sub></small>CO<small><sub>3</sub></small>, MeOH, rt.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect1308"><p align="" style="font-weight: bold; margin-top: 0%; margin-bottom: 0%; "><h3><b>2 Quinazoline alkaloids</b></h3></p></a><a name="sect1311"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>2.1 Occurrence, characterisation and biological activity</b></p></a><p class="firstpara">Few new quinazoline alkaloids were reported during the period under review. 3-(2-Hydroxyphenyl)quinazolin-4(3<span style="font-style: italic; "><i>H</i></span>)-one <span style="font-weight: bold; "><b>133</b></span> has been claimed as a new alkaloid from the roots of <span style="font-style: italic; "><i>Isatis indigotica</i></span>,<small><sup style="color: ;"><a title="Y. Liu, G. Qin, S. Ding, X. Wu,  Chin. Trad. Herbal Drugs(=Zhongcaoyao) 2002 33 97( Chem. Abstr., 2002,137, 152323)" href="quinoline2003.htm#cit73">73</a></sup></small> but in fact it was reported from the same source in 1997ï¿½by the same research group!<small><sup style="color: ;"><a title="K. Deng, X. Wu, G. Yang, G. Qin,  Chin. Chem. Lett. 1997 8 237" href="quinoline2003.htm#cit74">74</a></sup></small> The 3a-methoxy-substituted vasicinone analogue <span style="font-weight: bold; "><b>134</b></span> (incorrectly named as 3-methoxyvasicinone) was isolated from leaves of <span style="font-style: italic; "><i>Eranthemum nervosum</i></span>, and its structure was established by electrospray mass spectrometry in combination with IR and NMR spectroscopy.<small><sup style="color: ;"><a title="L. D. Ismail,  Al-Azhar J. Pharm. Sci. 2001 27 293( Chem. Abstr., 2002,136, 2958)" href="quinoline2003.htm#cit75">75</a></sup></small> An unusual feature in the structural assignment of 3-hydroxyrutaecarpine <span style="font-weight: bold; "><b>135</b></span>, a new natural product isolated from leaves and twigs of <span style="font-style: italic; "><i>Leptothyrsa sprucei</i></span> (Rutaceae), was the use of gradient <small><sup>1</sup></small>Hï¿½<small><sup>15</sup></small>N HMBC NMR spectroscopy at natural nitrogen abundance for establishing some of the skeletal connectivities.<small><sup style="color: ;"><a title="X.-C. Li, D. C. Dunbar, H. N. ElSohly, L. A. Walker, A. M. Clark,  Phytochemistry 2001 58 627" href="quinoline2003.htm#cit76">76</a></sup></small> The more complex peptide-derived alkaloid (ï¿½)-serantrypinone <span style="font-weight: bold; "><b>136</b></span>, obtained from mycelial extracts of the fungus <span style="font-style: italic; "><i>Penicillium thymicola</i></span> IBT 5891, is a hydroxylated congener of the known spiroquinazoline alantrypinone <span style="font-weight: bold; "><b>137</b></span>, and effectively arises by replacing an alanine residue with serine.<small><sup style="color: ;"><a title="M. R. Ariza, T. O. Larsen, B. O. Petersen, J.O. Duus, C. Christophersen, A. F. Barrero,  J. Nat. Prod. 2001 64 1590" href="quinoline2003.htm#cit77">77</a></sup></small> The similarity in the CD spectra of the two metabolites suggested that serantrypinone and alantrypinone share the same (3<span style="font-style: italic; "><i>R</i></span>,14<span style="font-style: italic; "><i>R</i></span>,17<span style="font-style: italic; "><i>S</i></span>) absolute configuration.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr12"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u12.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The alkaloids of <span style="font-style: italic; "><i>Adhatoda vasica</i></span>, an important plant in Ayurvedic medicine, are principally derivatives of vasicine <span style="font-weight: bold; "><b>138</b></span> and vasicinone <span style="font-weight: bold; "><b>139</b></span>. Recent tests on the unseparated alkaloid fraction showed anti-inflammatory activity in the HET-CAM assay approximately equal to that of hydrocortisone.<small><sup style="color: ;"><a title="A. Chakraborty, A. H. Brantner,  Phytother. Res. 2001 15 532" href="quinoline2003.htm#cit78">78</a></sup></small> Several synthetic tricyclic vasicinone analogues of general structure <span style="font-weight: bold; "><b>140</b></span> proved to be effective bronchodilators in <span style="font-style: italic; "><i>in vitro</i></span> tests with guinea pig tracheal chain pre-contracted with acetylcholine, the most active compound being the 8,9-dimethoxy derivative.<small><sup style="color: ;"><a title="D. P. Jindal, R. S. Bhatti, S. Ahlawat, R. Gupta,  Eur. J. Med. Chem. 2002 37 419" href="quinoline2003.htm#cit79">79</a></sup></small> Isaindigotone <span style="font-weight: bold; "><b>141</b></span>, a naturally occurring vasicinone analogue isolated from <span style="font-style: italic; "><i>Isatis tinctoria</i></span>, and seven synthetic derivatives displayed a range of biological effects related to anti-inflammatory activity, including inhibition of superoxide, nitric oxide and prostaglandin-E<small><sub>2</sub></small> production.<small><sup style="color: ;"><a title="P. Molina, A. Tarraga, A. Gonzalez-Tejero, I. Rioja, A. Ubeda, M. C. Terencio, M. J. Alcaraz,  J. Nat. Prod. 2001 64 1297" href="quinoline2003.htm#cit80">80</a></sup></small> Isaindigotone itself was a superior scavenger of superoxide generated in the hypoxanthine/xanthine oxidase system (IC<small><sub>50</sub></small> 42.2 nM), no doubt because of its free phenolic group, whereas derivatives <span style="font-weight: bold; "><b>142</b></span> and <span style="font-weight: bold; "><b>143</b></span> were, respectively, the most effective inhibitors of PGE<small><sub>2</sub></small> (IC<small><sub>50</sub></small> 80 nM) and nitrite (1.8 ï¿½M) accumulation in mouse macrophages.</p><p class="otherpara">The efficient extraction and quantitative analysis of tryptanthrin <span style="font-weight: bold; "><b>144</b></span>, the anti-inflammatory principle of <span style="font-style: italic; "><i>Isatis tinctoria</i></span> (woad), have been reproducibly achieved by accelerated solvent extraction (ASE) in a commercial instrument followed by HPLC with electrospray-MS detection.<small><sup style="color: ;"><a title="H. Danz, D. Baumann, M. Hamburger,  Planta Med. 2002 68 152" href="quinoline2003.htm#cit81">81</a></sup></small> Analysis of over 70 woad samples from different sources indicated a highly variable tryptanthrin content of 0.56ï¿½16.74 ï¿½ 10<small><sup>ï¿½3</sup></small> % by mass. In further pharmacological developments, tryptanthrin has been found to ameliorate artificially induced colitis in mice, at the same time suppressing weight loss, tissue damage and subsequent mortality;<small><sup style="color: ;"><a title="M. J. Micallef, K. Iwaki, T. Ishihara, S. Ushio, M. Aga, T. Kunikata, S. Koya-Miyata, T. Kimoto, M. Ikeda, M. Kurimoto,  Int. Immunopharmacol. 2002 2 565" href="quinoline2003.htm#cit82">82</a></sup></small> this relatively non-toxic alkaloid thus has potential for treating inflammatory bowel disease. It also effected cell differentiation and apoptosis of both monocytic (U-937) and promyelocytic (HL-60) leukaemia cells,<small><sup style="color: ;"><a title="T. Kimoto, K. Hino, S. Koya-Miyata, Y. Yamamoto, M. Takeuchi, Y. Nishizaki, M. J. Micallef, S. Ushio, K. Iwaki, M. Ikeda, M. Kurimoto,  Pathol. Int. 2001 51 315( Chem. Abstr., 2002,136, 256816)" href="quinoline2003.htm#cit83">83</a></sup></small> and suppressed the growth of azoxymethane-induced intestinal tumours in F344 rats.<small><sup style="color: ;"><a title="S. Koya-Miyata, T. Kimoto, M. J. Micallef, K. Hino, M. Taniguchi, S. Ushio, K. Iwaki, M. Ikeda, M. Kurimoto,  Anticancer Res. 2001 21 3295( Chem. Abstr., 2002,137, 210516)" href="quinoline2003.htm#cit84">84</a></sup></small> Tryptanthrin has shown activity as an antitrypanosomal agent against <span style="font-style: italic; "><i>Trypanosoma brucei</i></span>; furthermore 11 synthetic analogues were also active, the most potent compounds, <span style="font-weight: bold; "><b>145</b></span> (EC<small><sub>50</sub></small> 0.82 ï¿½M) and <span style="font-weight: bold; "><b>146</b></span> (EC<small><sub>50</sub></small> 0.4 ï¿½M), being substantially more effective than the parent alkaloid (EC<small><sub>50</sub></small> 23.0 ï¿½M).<small><sup style="color: ;"><a title="J. Scovill, E. Blank, M. Konnick, E. Nenortas, T. Shapiro,  Antimicrobial Agents Chemother. 2002 46 882" href="quinoline2003.htm#cit85">85</a></sup></small> Another protozoan parasite, <span style="font-style: italic; "><i>Leishmania donovani</i></span>, was sensitive to no fewer than 27 synthetic analogues of tryptanthrin, 13 of the compounds displaying IC<small><sub>50</sub></small> values of less than 100 ng ml<small><sup>ï¿½1</sup></small> as well as being more toxic to the parasite than to mammalian cell lines; the most active compounds were <span style="font-weight: bold; "><b>147</b></span> and <span style="font-weight: bold; "><b>148</b></span> (IC<small><sub>50</sub></small> 16 ng ml<small><sup>ï¿½1</sup></small>).<small><sup style="color: ;"><a title="A. K. Bhattacharjee, D. J. Skanchy, B. Jennings, T. H. Hudson, J. J. Brendle, K. A. Werbovetz,  Bioorg. Med. Chem. 2002 10 1979" href="quinoline2003.htm#cit86">86</a></sup></small> (For comparison, the clinically prescribed antileishmanial agent amphotericin has an IC<small><sub>50</sub></small> value of 416 ng ml<small><sup>ï¿½1</sup></small>). Structureï¿½activity relationships revealed a reasonable correlation between activity and some calculated and measured molecular properties such as molecular density, LUMO energies and redox potentials (determined by cyclic voltammetry), the implication of the latter two being that electron transfer involving the carbonyl groups might be a crucial factor in the mechanism of action of the compounds.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr13"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u13.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The revival of interest in the antimalarial alkaloid febrifugine <span style="font-weight: bold; "><b>149</b></span> seems set to continue. A brief review by Takeuchi and Harayama includes useful information on the history, structure determination, synthesis, biological activity and structureï¿½activity relationships of the alkaloid and its isomer isofebrifugine <span style="font-weight: bold; "><b>150</b></span>.<small><sup style="color: ;"><a title="Y. Takeuchi, T. Harayama,  Trends Heterocycl. Chem. 2001 7 65" href="quinoline2003.htm#cit87">87</a></sup></small> However, the unacceptable emetic effects of these two compounds have prevented their clinical use as antimalarial agents. In attempts to find analogues with improved properties, Oshima and co-workers investigated the biological activity of <span style="font-weight: bold; "><b>151</b></span> and <span style="font-weight: bold; "><b>152</b></span>, products of condensation of the parent alkaloids with acetone, as well as eleven other synthetic derivatives of <span style="font-weight: bold; "><b>149</b></span> and <span style="font-weight: bold; "><b>150</b></span> and a further fifteen analogues of <span style="font-weight: bold; "><b>151</b></span> and <span style="font-weight: bold; "><b>152</b></span>.<small><sup style="color: ;"><a title="H. Kikuchi, H. Tasaka, S. Hirai, Y. Takaya, Y. Iwabuchi, H. Ooi, S. Hatakeyama, H.-S. Kim, Y. Wataya, Y. Oshima,  J. Med. Chem. 2002 45 2563" href="quinoline2003.htm#cit88">88</a></sup></small> All compounds exhibited good <span style="font-style: italic; "><i>in vitro</i></span> antimalarial activity against <span style="font-style: italic; "><i>P. falciparum</i></span>, though none were as potent as febrifugine itself (EC<small><sub>50</sub></small> 7.0 ï¿½ 10<small><sup>ï¿½10</sup></small> M). Additionally, all compounds were cytotoxic to FM3A mouse mammary cells, but only four of them, <span style="font-style: italic; "><i>viz.</i></span><span style="font-weight: bold; "><b>153ï¿½156</b></span>, were significantly more selective (&gt; 500 : 1) towards the parasite than towards the mammary cells, <span style="font-weight: bold; "><b>156</b></span> being a staggering 3100 times as selective. These findings prompted <span style="font-style: italic; "><i>in vivo</i></span> studies of the antimalarial efficacy of the more accessible racemates of <span style="font-weight: bold; "><b>153ï¿½155</b></span> in mice infected with <span style="font-style: italic; "><i>P. berghei</i></span>. The first two proved to be more potent (ED<small><sub>50</sub></small> 1.3 and 2.9 ï¿½mol kg<small><sup>ï¿½1</sup></small>) than chloroquine or artemisinin (ED<small><sub>50</sub></small> 4.7 and 17.7 ï¿½mol kg<small><sup>ï¿½1</sup></small>), and only slightly less effective than febrifugine (ED<small><sub>50</sub></small> 1 ï¿½mol kg<small><sup>ï¿½1</sup></small>). When injected intraperitoneally, they also prolonged the survival rate of infected mice. Thus this study appears to have revealed exciting new lead compounds for the development of novel antiplasmodial drugs.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr14"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u14.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect1407"><p align="" style="font-weight: bold; margin-top: 2%; margin-bottom: 2%; "><b>2.2 Synthesis and other chemical studies</b></p></a><p class="firstpara">Three simple syntheses of quinazoline alkaloids are illustrated in <a title=" Reagents: i, MeOH, 25[degree]C, 30 min, then 80[degree]C, 6 h; ii, CO(5 atm), Se(5 mol%), NEt3(1 equiv.), DMF, 100[degree]C, 10-20 h; iii, microwave irradiation(450 W), 6 min." href="quinoline2003.htm#sch5">Scheme 5</a>. A straightforward condensation between anthranilic acid <span style="font-weight: bold; "><b>157</b></span> and various imidates of general formula RC(<img src="https://bitnest.netfirms.com/images/entities/char_e001.gif">NH)OMe in boiling methanol produced a range of 2-substituted quinazolin-4(3<span style="font-style: italic; "><i>H</i></span>)-ones, among them the alkaloids 2-methylquinazolin-4(3<span style="font-style: italic; "><i>H</i></span>)-one <span style="font-weight: bold; "><b>158</b></span> (42%) and glycosminine <span style="font-weight: bold; "><b>159</b></span> (65%).<small><sup style="color: ;"><a title="D. J. Connolly, P. J. Guiry,  Synlett 2001 1707" href="quinoline2003.htm#cit89">89</a></sup></small> A short synthesis of deoxyvasicinone <span style="font-weight: bold; "><b>160</b></span> showcasing the reductive cyclisation of <span style="font-style: italic; "><i>N</i></span>-(2-nitrobenzoyl)pyrrolidin-2-one <span style="font-weight: bold; "><b>161</b></span> with carbon monoxide in DMF in the presence of triethylamine and a catalytic amount of selenium was also applied to the synthesis of substituted and six- to eight-membered ring C analogues <span style="font-weight: bold; "><b>162</b></span> in yields that were generally above 75%.<small><sup style="color: ;"><a title="Y. Nishiyama, M. Hirose, W. Kitagaito, N. Sonoda,  Tetrahedron Lett. 2002 43 1855" href="quinoline2003.htm#cit90">90</a></sup></small> The shortest synthesis of all, entailing reaction of isatoic anhydride <span style="font-weight: bold; "><b>163</b></span> with lactams <span style="font-weight: bold; "><b>164</b></span> (<span style="font-style: italic; "><i>n</i></span> = 1ï¿½3) under solvent-free conditions in a microwave oven, gave deoxyvasicinone in 92% yield within 6 minutes, and was also used for preparing the six- and seven-membered ring C congeners <span style="font-weight: bold; "><b>162</b></span> (R = H; <span style="font-style: italic; "><i>n</i></span> = 2, 3) in 90% and 89% yields, respectively.<small><sup style="color: ;"><a title="J. S. Yadav, B. V. S. Reddy,  Tetrahedron Lett. 2002 43 1905" href="quinoline2003.htm#cit91">91</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch5"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-s5.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 5 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents</i></span>: i, MeOH, 25 ï¿½C, 30 min, then 80 ï¿½C, 6 h; ii, CO (5 atm), Se (5 mol%), NEt<small><sub>3</sub></small>(1 equiv.), DMF, 100 ï¿½C, 10ï¿½20 h; iii, microwave irradiation (450 W), 6 min.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">Treatment of anthranilamide <span style="font-weight: bold; "><b>165</b></span> with the succinic anhydrides <span style="font-weight: bold; "><b>166</b></span> and esterification of the intermediate succinanilic acids produced esters <span style="font-weight: bold; "><b>167</b></span>, chemoselective reduction of which with lithium aluminium hydride followed by aqueous work-up smoothly yielded the quinazolinones <span style="font-weight: bold; "><b>168</b></span> and <span style="font-weight: bold; "><b>169</b></span> (<a title=" Reagents: i, Et2O-C6H6-dioxane(2 : 2 : 1), rt, 2 h; ii, CH2N2, Et2O, 0[degree]C to rt; iii, LiAlH4, THF, 0[degree]C to rt, then aq. NH4Cl, evaporationin vacuo; iv, PPh3, EtO2CN[double bond, length as m-dash]NCO2Et, THF, rt; v, PCC, 4[Angstrom]molecular sieves, CH2Cl2, rt; vi, 2-aminobenzaldehyde, KOH, EtOH, reflux; vii, CrO3, H5IO6, DMF, rt." href="quinoline2003.htm#sch6">Scheme 6</a>).<small><sup style="color: ;"><a title="S. B. Mhaske, N. P. Argade,  J. Org. Chem. 2001 66 9038" href="quinoline2003.htm#cit92">92</a></sup></small> The latter is a natural product, pegamine, and this is the first report of its synthesis (in 89% overall yield from <span style="font-weight: bold; "><b>165</b></span>). Both <span style="font-weight: bold; "><b>168</b></span> and <span style="font-weight: bold; "><b>169</b></span> underwent further ring closure under Mitsunobu conditions to give (ï¿½)-vasicinone <span style="font-weight: bold; "><b>139</b></span> and deoxyvasicinone <span style="font-weight: bold; "><b>160</b></span>. The (<span style="font-style: italic; "><i>S</i></span>) absolute configuration of (ï¿½)-vasicinone was established by NMR spectroscopic analysis of its Mosher esters, a technique that also indicated its enantiomeric excess to be 97ï¿½98%. In an extension of this work, pegamine <span style="font-weight: bold; "><b>169</b></span> was oxidised with pyridinium chlorochromate to give the masked aldehyde isovasicinone <span style="font-weight: bold; "><b>170</b></span> (64%), Friedlï¿½nder condensation of which with 2-aminobenzaldehyde followed by benzylic oxidation of the resulting quinoline completed a synthesis of luotonin F <span style="font-weight: bold; "><b>171</b></span>, an anti-tumour alkaloid originally obtained from <span style="font-style: italic; "><i>Peganum nigellastrum</i></span>.<small><sup style="color: ;"><a title="S. B. Mhaske, N. P. Argade,  Synthesis 2002 323" href="quinoline2003.htm#cit93">93</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch6"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-s6.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 6 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents</i></span>: i, Et<small><sub>2</sub></small>Oï¿½C<small><sub>6</sub></small>H<small><sub>6</sub></small>ï¿½dioxane (2 : 2 : 1), rt, 2 h; ii, CH<small><sub>2</sub></small>N<small><sub>2</sub></small>, Et<small><sub>2</sub></small>O, 0 ï¿½C to rt; iii, LiAlH<small><sub>4</sub></small>, THF, 0 ï¿½C to rt, then aq. NH<small><sub>4</sub></small>Cl, evaporation <span style="font-style: italic; "><i>in vacuo</i></span>; iv, PPh<small><sub>3</sub></small>, EtO<small><sub>2</sub></small>CN<img src="https://bitnest.netfirms.com/images/entities/char_e001.gif">NCO<small><sub>2</sub></small>Et, THF, rt; v, PCC, 4 <img src="https://bitnest.netfirms.com/images/entities/char_212b.gif"> molecular sieves, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt; vi, 2-aminobenzaldehyde, KOH, EtOH, reflux; vii, CrO<small><sub>3</sub></small>, H<small><sub>5</sub></small>IO<small><sub>6</sub></small>, DMF, rt.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The current popularity of luotonin A <span style="font-weight: bold; "><b>172</b></span> as a synthetic target is a consequence of its cytotoxicity towards murine leukemia P-388 cells. A further three syntheses of this alkaloid were published during the review period. The key steps are shown in <a title=" Reagents: i, isatoic anhydride163, microwave irradiation(450 W), 7 min; ii, 2-aminobenzaldehyde,p-TsOH(cat.), PhMe, reflux(Dean-Stark apparatus); iii, PdCl2(5 mol%), PPh3(20 mol%), DMF-H2O(4 : 1), reflux; iv, HCl(6 M), reflux; v, NaH, THF, 60[degree]C, then 2-nitrobenzoyl chloride, 0[degree]C to 50[degree]C; vi, Fe, AcOH-EtOH(1 : 1), reflux; vii,o-anisic acid, bis(2-oxo-3-oxazolidinyl)phosphinic chloride, Et3N, CH2Cl2; viii, Pd2(dba)3, dppf, CuCN, Et4N+CN-, dioxane, reflux; ix, TMSCl, ZnCl2, Et3N, PhMe, 150[degree]C(sealed tube)." href="quinoline2003.htm#sch7">Scheme 7</a>. Adaptation of the microwave synthesis described above entailed heating isatoic anhydride with the known pyrroloquinoline <span style="font-weight: bold; "><b>173</b></span> under solvent-free conditions in a microwave oven to give luotonin A in 85% yield within seven minutes.<small><sup style="color: ;"><a title="J. S. Yadav, B. V. S. Reddy,  Tetrahedron Lett. 2002 43 1905" href="quinoline2003.htm#cit91">91</a></sup></small> Alternatively, the same pyrroloquinoline <span style="font-weight: bold; "><b>173</b></span>, prepared in a novel manner by Friedlï¿½nder synthesis from 1-allylpyrrolidine-2,3-dione <span style="font-weight: bold; "><b>174</b></span> and 2-aminobenzaldehyde followed by removal of the <span style="font-style: italic; "><i>N</i></span>-allyl protecting group, was acylated with 2-nitrobenzoyl chloride, after which reductive cyclisation completed the synthesis of <span style="font-weight: bold; "><b>172</b></span>.<small><sup style="color: ;"><a title="S. Dallavalle, L. Merlini,  Tetrahedron Lett. 2002 43 1835" href="quinoline2003.htm#cit94">94</a></sup></small> In the third route, <span style="font-style: italic; "><i>in situ</i></span> conversion of the amide <span style="font-weight: bold; "><b>175</b></span> into the <span style="font-style: italic; "><i>O</i></span>-silylimidate <span style="font-weight: bold; "><b>176</b></span> in a sealed tube at 150 ï¿½C preceded spontaneous intramolecular hetero Dielsï¿½Alder reaction to give luotonin A in 46% yield.<small><sup style="color: ;"><a title="M. Toyota, C. Komori, M. Ihara,  Heterocycles 2002 56 101" href="quinoline2003.htm#cit95">95</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch7"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-s7.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 7 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents</i></span>: i, isatoic anhydride <span style="font-weight: bold; "><b>163</b></span>, microwave irradiation (450 W), 7 min; ii, 2-aminobenzaldehyde, <span style="font-style: italic; "><i>p</i></span>-TsOH (cat.), PhMe, reflux (Deanï¿½Stark apparatus); iii, PdCl<small><sub>2</sub></small>(5 mol%), PPh<small><sub>3</sub></small>(20 mol%), DMFï¿½H<small><sub>2</sub></small>O (4 : 1), reflux; iv, HCl (6 M), reflux; v, NaH, THF, 60 ï¿½C, then 2-nitrobenzoyl chloride, 0 ï¿½C to 50 ï¿½C; vi, Fe, AcOHï¿½EtOH (1 : 1), reflux; vii, <span style="font-style: italic; "><i>o</i></span>-anisic acid, bis(2-oxo-3-oxazolidinyl)phosphinic chloride, Et<small><sub>3</sub></small>N, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>; viii, Pd<small><sub>2</sub></small>(dba)<small><sub>3</sub></small>, dppf, CuCN, Et<small><sub>4</sub></small>N<small><sup>+</sup></small> CN<small><sup>ï¿½</sup></small>, dioxane, reflux; ix, TMSCl, ZnCl<small><sub>2</sub></small>, Et<small><sub>3</sub></small>N, PhMe, 150 ï¿½C (sealed tube).</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">Much of the recent synthetic activity aimed at the synthesis of febrifugine analogues has centred on the stereoselective construction of the piperidinol moiety, as, for instance, in the asymmetric synthesis of model 2-substituted piperidin-3-ols such as <span style="font-weight: bold; "><b>177</b></span> by Enders <span style="font-style: italic; "><i>et al</i></span>.<small><sup style="color: ;"><a title="D. Enders, B. Nolte, J. Runsink,  Tetrahedron: Asymmetry 2002 13 587" href="quinoline2003.htm#cit96">96</a></sup></small> The ongoing researches of Kobayashi have concentrated on the ring opening of racemic<small><sup style="color: ;"><a title="M. Sugiura, H. Hagio, R. Hirabayashi, S. Kobayashi,  Synlett 2001 1225" href="quinoline2003.htm#cit97">97</a></sup></small> and enantiomerically pure<small><sup style="color: ;"><a title="M. Sugiura, H. Hagio, R. Hirabayashi, S. Kobayashi,  J. Am. Chem. Soc. 2001 123 12510" href="quinoline2003.htm#cit98">98</a></sup></small> semicyclic <span style="font-style: italic; "><i>N</i></span>,<span style="font-style: italic; "><i>O</i></span>-acetals with nucleophiles in the presence of Lewis acid catalysts. The systematic model studies performed by these workers culminated in the diastereoselective transformation of (<span style="font-style: italic; "><i>S</i></span>)-<span style="font-weight: bold; "><b>178</b></span> into <span style="font-weight: bold; "><b>179</b></span>, which proceeded in 81% yield and a diastereomeric ratio of 86 : 14 (<a title=" Reagents: i, H2C[double bond, length as m-dash]CHCH2SiMe3(2 equiv.), TMSOTf(0.2 equiv.), MeCN,-20[degree]C; ii, MCPBA, CH2Cl2, rt; iii, quinazolin-4-ol, KOH(0.2 equiv.), MeOH, reflux; iv, Dess-Martin reagent, CH2Cl2, rt; v, Et3SiH, TMSOTf, MeCN, 0[degree]C; vi, HCl(6 M), reflux, 2 h; vii,(3S)-178,183(2 equiv.), TMSOTf(2.5 equiv.), MeCN, rt." href="quinoline2003.htm#sch8">Scheme 8</a>). This compound was converted <span style="font-style: italic; "><i>via</i></span> the 1 : 1 diastereomeric mixture of epoxides <span style="font-weight: bold; "><b>180</b></span> into the 3-substituted quinazolin-4-one <span style="font-weight: bold; "><b>181</b></span>, oxidation and intramolecular reductive amination of which yielded the protected isofebrifugine analogue <span style="font-weight: bold; "><b>182</b></span>. The same workers had previously converted racemic <span style="font-weight: bold; "><b>182</b></span> into (ï¿½)-isofebrifugine<small><sup style="color: ;"><a title="M. Sugiura, S. Kobayashi,  Org. Lett. 2001 3 477" href="quinoline2003.htm#cit99">99</a></sup></small> (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2002 19 756" href="quinoline2003.htm#cit35i">35<span style="font-style: italic; "><i>i</i></span></a>); similar hydrolysis of the enantiomer (+)-<span style="font-weight: bold; "><b>182</b></span> with boiling hydrochloric acid completed the synthesis of (+)-isofebrifugine <span style="font-weight: bold; "><b>150</b></span>. The less efficient alternative reaction of (3<span style="font-style: italic; "><i>S</i></span>)-<span style="font-weight: bold; "><b>178</b></span> with the silyl enol ether <span style="font-weight: bold; "><b>183</b></span> was mediated by trimethylsilyl triflate to yield <span style="font-weight: bold; "><b>184</b></span> (51%, <span style="font-style: italic; "><i>syn</i></span> : <span style="font-style: italic; "><i>anti</i></span> ratio 93 : 7), which was also converted into the isofebrifugine precursor <span style="font-weight: bold; "><b>182</b></span> as illustrated.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch8"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-s8.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 8 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents</i></span>: i, H<small><sub>2</sub></small>C<img src="https://bitnest.netfirms.com/images/entities/char_e001.gif">CHCH<small><sub>2</sub></small>SiMe<small><sub>3</sub></small>(2 equiv.), TMSOTf (0.2 equiv.), MeCN, ï¿½20 ï¿½C; ii, MCPBA, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt; iii, quinazolin-4-ol, KOH (0.2 equiv.), MeOH, reflux; iv, Dessï¿½Martin reagent, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt; v, Et<small><sub>3</sub></small>SiH, TMSOTf, MeCN, 0 ï¿½C; vi, HCl (6 M), reflux, 2 h; vii, (3<span style="font-style: italic; "><i>S</i></span>)-<span style="font-weight: bold; "><b>178</b></span>, <span style="font-weight: bold; "><b>183</b></span>(2 equiv.), TMSOTf (2.5 equiv.), MeCN, rt.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The short synthesis of rutaecarpine <span style="font-weight: bold; "><b>185</b></span> and related alkaloids shown in <a title=" Reagents: i, pyridine, CH2Cl2, rt, 2-3 h; ii, CH2Cl2, rt, 24-31 h; iii, TFAA, HCl(g), 120-130[degree]C; iv, PhCHO, Ac2O, reflux; v, O3, CH2Cl2,-78[degree]C, then Me2S; vi, PhNHNH2, EtOH; vii, PPA, 180[degree]C." href="quinoline2003.htm#sch9">Scheme 9</a> commenced with reaction of anthranilate esters <span style="font-weight: bold; "><b>186</b></span> with 4,5-dichloro-1,2,3-dithiazolium chloride (Appel's salt) <span style="font-weight: bold; "><b>187</b></span> to produce the imines <span style="font-weight: bold; "><b>188</b></span>, which reacted with substituted tryptamines to yield the 2-cyanoquinazolin-4-ones <span style="font-weight: bold; "><b>189</b></span>.<small><sup style="color: ;"><a title="P. K. Mohanta, K. Kim,  Tetrahedron Lett. 2002 43 3993" href="quinoline2003.htm#cit100">100</a></sup></small> Simply heating these intermediates with trifluoroacetic anhydride and hydrogen chloride gas completed syntheses of rutaecarpine <span style="font-weight: bold; "><b>185</b></span>, hortiacine <span style="font-weight: bold; "><b>190</b></span>, euxylophoricine A <span style="font-weight: bold; "><b>191</b></span> and euxylophoricine D <span style="font-weight: bold; "><b>192</b></span> in 90ï¿½95% yields. Also shown in the Scheme is another short synthesis of rutaecarpine, the key step of which was a Fischer indole synthesis using the readily prepared quinazolinedione <span style="font-weight: bold; "><b>193</b></span>.<small><sup style="color: ;"><a title="S. H. Lee, S. I. Kim, J. G. Park, E. S. Lee, Y. Jahng,  Heterocycles 2001 55 1555" href="quinoline2003.htm#cit101">101</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch9"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-s9.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 9 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents</i></span>: i, pyridine, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt, 2ï¿½3 h; ii, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt, 24ï¿½31 h; iii, TFAA, HCl(g), 120ï¿½130 ï¿½C; iv, PhCHO, Ac<small><sub>2</sub></small>O, reflux; v, O<small><sub>3</sub></small>, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, ï¿½78 ï¿½C, then Me<small><sub>2</sub></small>S; vi, PhNHNH<small><sub>2</sub></small>, EtOH; vii, PPA, 180 ï¿½C.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The reaction of benzoxazine <span style="font-weight: bold; "><b>194</b></span> with methyl anthranilate followed by thermal recyclisation, although rapidly giving the quinazolin-4-one <span style="font-weight: bold; "><b>195</b></span> in a poor overall yield of 4.7%, was featured in a short new synthesis of circumdatin F <span style="font-weight: bold; "><b>196</b></span> (<a title=" Reagents: i, methyl anthranilate, AcOH, reflux; ii, DMF, reflux; iii, Br2, NaOAc, HOAc, 60[degree]C; iv, NaN3, H2O-PriOH(1 : 5), reflux; v, H2(220 psi), 5%Pd/C, EtOH, rt; vi, MeCN, reflux." href="quinoline2003.htm#sch10">Scheme 10</a>).<small><sup style="color: ;"><a title="A. Witt, J. Bergmann,  J. Heterocycl. Chem. 2002 39 351" href="quinoline2003.htm#cit102">102</a></sup></small> Electrophilic bromination of <span style="font-weight: bold; "><b>195</b></span> yielded <span style="font-weight: bold; "><b>197</b></span> as a mixture of two diastereomers, probably arising from restricted rotation around the Nï¿½aryl bond. Conversion of <span style="font-weight: bold; "><b>197</b></span> into the amine <span style="font-weight: bold; "><b>198</b></span> followed by thermally-induced lactam formation completed the synthesis of the target alkaloid <span style="font-weight: bold; "><b>196</b></span>. Similarly, acid-induced conversion of the bromoacetamide <span style="font-weight: bold; "><b>199</b></span> into the corresponding quinazolinone followed by treatment with ammonia yielded sclerotigenin <span style="font-weight: bold; "><b>200</b></span> (16% overall yield), while heating <span style="font-weight: bold; "><b>199</b></span> and the methyl homologue <span style="font-weight: bold; "><b>201</b></span> in DMF at reflux produced the oxygen analogues of sclerotigenin and circumdatin, <span style="font-weight: bold; "><b>202</b></span> and <span style="font-weight: bold; "><b>203</b></span>, respectively, in 20% yield.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch10"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-s10.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 10 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents</i></span>: i, methyl anthranilate, AcOH, reflux; ii, DMF, reflux; iii, Br<small><sub>2</sub></small>, NaOAc, HOAc, 60 ï¿½C; iv, NaN<small><sub>3</sub></small>, H<small><sub>2</sub></small>Oï¿½Pr<small><sup>i</sup></small>OH (1 : 5), reflux; v, H<small><sub>2</sub></small>(220 psi), 5% Pd/C, EtOH, rt; vi, MeCN, reflux.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">Avendaï¿½o and co-workers have investigated the acylation of a range of diketopiperazines <span style="font-weight: bold; "><b>204</b></span>, prepared by standard methods from the respective <span style="font-style: italic; "><i>N</i></span>-Boc dipeptides, with 2-azidobenzoyl chloride <span style="font-style: italic; "><i>via</i></span> the silyl imidates <span style="font-weight: bold; "><b>205</b></span> (<a title=" Reagents: i, TMSCl(2 equiv.), Et3N(2 equiv.), CH2Cl2, rt; ii, 2-N3C6H4COCl(1.1 equiv.), CH2Cl2, rt; iii, Bu3P, PhMe, rt; iv, LiHMDS(10 equiv.), THF,-78[degree]C, 10 min; v,N-Boc-3-indolylmethyl bromide(2 equiv.), THF,-78[degree]C; vi, BBr3, CH2Cl2,-78[degree]C." href="quinoline2003.htm#sch11">Scheme 11</a>).<small><sup style="color: ;"><a title="F. Hernandez, A. Lumetzberger, C. Avendano, M. Sollhuber,  Synlett 2001 1387" href="quinoline2003.htm#cit103">103</a></sup></small> With the glycine derivative of <span style="font-weight: bold; "><b>204</b></span> (<span style="font-style: italic; "><i>i.e.</i></span>, R = H), selective monoacylation on <span style="font-style: italic; "><i>N</i></span>(4) to give <span style="font-weight: bold; "><b>206</b></span> was ascribed to a boat-like conformation of the silylated intermediate, with the indolyl substituent folding in such a way that <span style="font-style: italic; "><i>N</i></span>(1) was blocked. Selectivity was also good with the (<span style="font-style: italic; "><i>S</i></span>)-alanine derivative of <span style="font-weight: bold; "><b>204</b></span> [R = (<span style="font-style: italic; "><i>S</i></span>)-Me], but less impressive with the (<span style="font-style: italic; "><i>R</i></span>)-alanine and (<span style="font-style: italic; "><i>S</i></span>)-valine analogues [R = (<span style="font-style: italic; "><i>R</i></span>)-Me and (<span style="font-style: italic; "><i>S</i></span>)-Pr<small><sup>i</sup></small>], which gave almost equal amounts of the <span style="font-style: italic; "><i>N</i></span>(1)-acylated products. All of the acylated products <span style="font-weight: bold; "><b>206</b></span> could be cyclised by an intramolecular Staudinger reaction upon treatment with tributylphosphine to complete syntheses of (ï¿½)-glyantrypine <span style="font-weight: bold; "><b>207</b></span>, (ï¿½)-fumiquinazoline F <span style="font-weight: bold; "><b>208</b></span>, fumiquinazoline G <span style="font-weight: bold; "><b>209</b></span> and fiscalin B <span style="font-weight: bold; "><b>210</b></span>, respectively. In an alternative synthesis of fiscalin B, treatment of the quinazolinedione <span style="font-weight: bold; "><b>211</b></span> with lithium hexamethyldisilazide and <span style="font-style: italic; "><i>N</i></span>-Boc-3-indolylmethyl bromide gave a mixture of the 1,4-<span style="font-style: italic; "><i>syn</i></span>- and <span style="font-style: italic; "><i>anti</i></span>-disubstituted products <span style="font-weight: bold; "><b>212</b></span> (46%) and <span style="font-weight: bold; "><b>213</b></span> (31%). Deprotection of the minor isomer was accomplished with boron tribromide to give fiscalin B in 88% yield.<small><sup style="color: ;"><a title="F. Hernandez, F. L. Buenadicha, C. Avendano, M. Sollhuber,  Tetrahedron: Asymmetry 2001 12 3387" href="quinoline2003.htm#cit104">104</a></sup></small> The <span style="font-style: italic; "><i>syn</i></span> preference in this example was somewhat surprising, since alkylation of the methyl analogue of <span style="font-weight: bold; "><b>211</b></span> gave mainly 1,4-<span style="font-style: italic; "><i>anti</i></span>-disubstituted products,<small><sup style="color: ;"><a title="F. Hernandez, F. L. Buenadicha, C. Avendano, M. Sollhuber,  Tetrahedron: Asymmetry 2001 12 3387; F. L. Buenadicha, C. Avendano, M. Sollhuber,  Tetrahedron: Asymmetry 2001 12 3019" href="quinoline2003.htm#cit104">104,105</a></sup></small> a feature that was also borne out by SCF-MO calculations.<small><sup style="color: ;"><a title="S. Martin-Santamaria, R. Corzo-Suarez, C. Avendano, M. Espada, F. Gago, S. Garcia-Granda, H. S. Rzepa,  J. Org. Chem. 2002 67 2013" href="quinoline2003.htm#cit106">106</a></sup></small> This research group has also reported a variety of model studies on the formation of the pyrazino[2,1-<span style="font-style: italic; "><i>b</i></span>]quinazoline-3,6-dione ring system <span style="font-style: italic; "><i>via</i></span><span style="font-style: italic; "><i>N</i></span>-acyliminium ion intermediates.<small><sup style="color: ;"><a title="M. L. Heredia, E. de la Cuesta, C. Avendano,  Tetrahedron: Asymmetry 2001 12 2883; J. D. Sanchez, M. T. Ramos, C. Avendano,  J. Org. Chem. 2001 66 5731" href="quinoline2003.htm#cit107">107,108</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch11"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-s11.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 11 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents</i></span>: i, TMSCl (2 equiv.), Et<small><sub>3</sub></small>N (2 equiv.), CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt; ii, 2-N<small><sub>3</sub></small>C<small><sub>6</sub></small>H<small><sub>4</sub></small>COCl (1.1 equiv.), CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt; iii, Bu<small><sub>3</sub></small>P, PhMe, rt; iv, LiHMDS (10 equiv.), THF, ï¿½78 ï¿½C, 10 min; v, <span style="font-style: italic; "><i>N</i></span>-Boc-3-indolylmethyl bromide (2 equiv.), THF, ï¿½78 ï¿½C; vi, BBr<small><sub>3</sub></small>, CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, ï¿½78 ï¿½C.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The first reported syntheses of three related pyrazino[2,1-<span style="font-style: italic; "><i>b</i></span>]quinazoline-3,6-dione alkaloids, verrucine A <span style="font-weight: bold; "><b>214</b></span>, verrucine B <span style="font-weight: bold; "><b>215</b></span> and anacine <span style="font-weight: bold; "><b>216</b></span>, have been accomplished by exploiting peptide assembly on Sasrin resin (<a title=" Reagents: i, 20%piperidine in DMF, 15 min, then repeat; ii, EDC(13.4 equiv.), anthranilic acid(12.1 equiv.), DMF or NMP, rt, 19 h; iii, Fmoc-l-Phe-Cl(5.1 equiv.), pyridine(29 equiv.), CH2Cl2, rt, 13 h, then workup, then repeat in DMF; iv, PPh3(12 equiv.), I2(11.1 equiv.), EtNPri2(25 equiv.), CH2Cl2, rt, 15 h; v, 20%piperidine in CH2Cl2, rt, 30 min; vi, MeCN-(CH2Cl)2(1 : 1), reflux overnight; vii, TFA-Et3SiH-CH2Cl2(2 : 2 : 1), rt, 15 min." href="quinoline2003.htm#sch12">Scheme 12</a>).<small><sup style="color: ;"><a title="H. Wang, M. M. Sim,  J. Nat. Prod. 2001 64 1497" href="quinoline2003.htm#cit109">109</a></sup></small> For example, the resin-bound <span style="font-variant: 80; "><small>L</small></span>-glutamine derivative <span style="font-weight: bold; "><b>217</b></span> was sequentially condensed with anthranilic acid and Fmoc-protected <span style="font-variant: 80; "><small>L</small></span>-phenylalanine chloride to give the resin-bound tripeptide <span style="font-weight: bold; "><b>218</b></span>. Intramolecular dehydration followed by treatment with piperidine, a general procedure developed by Wang and Ganesan<small><sup style="color: ;"><a title="H. Wang, A. Ganesan,  J. Org. Chem. 1998 63 2432" href="quinoline2003.htm#cit110">110</a></sup></small> and optimised by He and Snider<small><sup style="color: ;"><a title="F. He, B. B. Snider,  J. Org. Chem. 1999 64 1397" href="quinoline2003.htm#cit111">111</a></sup></small> (<span style="font-style: italic; "><i>cf</i></span>. Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2000 17 617" href="quinoline2003.htm#cit35j">35<span style="font-style: italic; "><i>j</i></span></a>), afforded amidine <span style="font-weight: bold; "><b>219</b></span>. Cyclisation with concomitant detachment from the resin was effected by overnight heating in a mixture of acetonitrile and 1,2-dichloroethane to give <span style="font-style: italic; "><i>N</i></span>-tritylverrucine A <span style="font-weight: bold; "><b>220</b></span> in 17% overall yield from <span style="font-weight: bold; "><b>217</b></span>; only 0.8% of the corresponding 1,4-<span style="font-style: italic; "><i>anti</i></span>-disubstituted isomer was isolated. The removal of the trityl group was achieved reductively with triethylsilane in trifluoroacetic acid to give (+)-verrucine A <span style="font-weight: bold; "><b>214</b></span>, the specific rotation of which was much greater than for the natural product isolated from its fungal source. Similar reaction sequences employing <span style="font-variant: 80; "><small>D</small></span>-phenylalanine and <span style="font-variant: 80; "><small>L</small></span>-leucine afforded (+)-verrucine B <span style="font-weight: bold; "><b>215</b></span> and (+)-anacine <span style="font-weight: bold; "><b>216</b></span>, respectively, in overall yields of 14.5% and 9.3% based on <span style="font-weight: bold; "><b>217</b></span>. The absolute configuration of the former, not assigned when it was originally isolated, has thus been established unambiguously. The originally proposed benzodiazepine structure <span style="font-weight: bold; "><b>221</b></span> for anacine, revised to <span style="font-weight: bold; "><b>216</b></span> after the isolation of the verrucines, has also been unequivocally refuted. It is worth noting that verrucine B and anacine underwent aerial oxidation in solution, the former yielding the hydroxy product <span style="font-weight: bold; "><b>222</b></span>. This type of reaction may explain the origin of the hydroxy group in related pyrazinoquinazoline alkaloids.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch12"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-s12.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 12 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents</i></span>: i, 20% piperidine in DMF, 15 min, then repeat; ii, EDC (13.4 equiv.), anthranilic acid (12.1 equiv.), DMF or NMP, rt, 19 h; iii, Fmoc-<span style="font-variant: 80; "><small>L</small></span>-Phe-Cl (5.1 equiv.), pyridine (29 equiv.), CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt, 13 h, then workup, then repeat in DMF; iv, PPh<small><sub>3</sub></small>(12 equiv.), I<small><sub>2</sub></small>(11.1 equiv.), EtNPr<small><sup>i</sup></small><small><sub>2</sub></small>(25 equiv.), CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt, 15 h; v, 20% piperidine in CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>, rt, 30 min; vi, MeCNï¿½(CH<small><sub>2</sub></small>Cl)<small><sub>2</sub></small>(1 : 1), reflux overnight; vii, TFAï¿½Et<small><sub>3</sub></small>SiHï¿½CH<small><sub>2</sub></small>Cl<small><sub>2</sub></small>(2 : 2 : 1), rt, 15 min.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">The advanced intermediate <span style="font-weight: bold; "><b>223</b></span>, previously used by Snider and Zeng in a synthesis of the <span style="font-style: italic; "><i>Aspergillus</i></span> metabolite fumiquinazoline A<small><sup style="color: ;"><a title="B. B. Snider, H. Zeng,  Org. Lett. 2000 2 4103" href="quinoline2003.htm#cit112">112</a></sup></small> (<span style="font-style: italic; "><i>cf.</i></span> Ref. <a title="J. P. Michael,  Nat. Prod. Rep. 2002 19 757" href="quinoline2003.htm#cit35k">35<span style="font-style: italic; "><i>k</i></span></a>), has been transformed into another two complex fumiquinazolines by the same workers (<a title=" Reagents: i,(R)-FmocNHCH(CH2SePh)CO2H, EDAC, MeCN; ii, PPh3, Br2, EtNPri2; iii, piperidine(10 equiv.), EtOAc, rt, 10 min; iv, MeCN-HOAc(25 : 1), reflux, 2 h; v, MeCN-HOAc(100 : 1), reflux, 2 h; vi, HCl(0.2 M), MeOH, 25[degree]C; vii, H2(1 atm), Pd/C, 30 min; viii, H2(4 atm), Pd/C, 30 h." href="quinoline2003.htm#sch13">Scheme 13</a>).<small><sup style="color: ;"><a title="B. B. Snider, H. Zeng,  Org. Lett. 2002 4 1087" href="quinoline2003.htm#cit113">113</a></sup></small> Condensation of <span style="font-weight: bold; "><b>223</b></span> with a selenocysteine derivative, (<span style="font-style: italic; "><i>R</i></span>)-FmocNHCH(CH<small><sub>2</sub></small>SePh)CO<small><sub>2</sub></small>H, yielded the quinazoline precursor <span style="font-weight: bold; "><b>224</b></span>, subjection of which to the Ganesan cyclisation procedure (<span style="font-style: italic; "><i>cf</i></span>. <a title=" Reagents: i, 20%piperidine in DMF, 15 min, then repeat; ii, EDC(13.4 equiv.), anthranilic acid(12.1 equiv.), DMF or NMP, rt, 19 h; iii, Fmoc-l-Phe-Cl(5.1 equiv.), pyridine(29 equiv.), CH2Cl2, rt, 13 h, then workup, then repeat in DMF; iv, PPh3(12 equiv.), I2(11.1 equiv.), EtNPri2(25 equiv.), CH2Cl2, rt, 15 h; v, 20%piperidine in CH2Cl2, rt, 30 min; vi, MeCN-(CH2Cl)2(1 : 1), reflux overnight; vii, TFA-Et3SiH-CH2Cl2(2 : 2 : 1), rt, 15 min." href="quinoline2003.htm#sch12">Scheme 12</a>) sequentially afforded the benzoxazine and amidine intermediates <span style="font-weight: bold; "><b>225</b></span> and <span style="font-weight: bold; "><b>226</b></span>. Simply heating crude <span style="font-weight: bold; "><b>226</b></span> in acetonitrileï¿½acetic acid (25 : 1) at reflux set off a cascade of reactions that culminated in the formation of a mixture of <span style="font-weight: bold; "><b>227</b></span> and its oxygen-bridged isomer <span style="font-weight: bold; "><b>228</b></span> in yields of 56% and 14%, respectively, based on <span style="font-weight: bold; "><b>225</b></span>. Compound <span style="font-weight: bold; "><b>227</b></span> could be partially converted into <span style="font-weight: bold; "><b>228</b></span> by further heating, and recovered <span style="font-weight: bold; "><b>227</b></span> could be recycled. Finally, standard transformations on both products completed the first reported total syntheses of (ï¿½)-fumiquinazolines E <span style="font-weight: bold; "><b>229</b></span> and C <span style="font-weight: bold; "><b>230</b></span>, respectively. A similar set of reactions on the appropriate analogue of <span style="font-weight: bold; "><b>224</b></span>, designed to produce (ï¿½)-fumiquinazoline H <span style="font-weight: bold; "><b>231</b></span>, was less easily accomplished, and required replacement of the Cbz protecting group by Fmoc in the benzoxazine equivalent of <span style="font-weight: bold; "><b>225</b></span> before satisfactory cyclisation could be effected.</p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="sch13"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-s13.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"><b>Scheme 13 </b><span style="font-style: normal; text-align: left; "><span style="font-style: italic; "><i>Reagents</i></span>: i, (<span style="font-style: italic; "><i>R</i></span>)-FmocNHCH(CH<small><sub>2</sub></small>SePh)CO<small><sub>2</sub></small>H, EDAC, MeCN; ii, PPh<small><sub>3</sub></small>, Br<small><sub>2</sub></small>, EtNPr<small><sup>i</sup></small><small><sub>2</sub></small>; iii, piperidine (10 equiv.), EtOAc, rt, 10 min; iv, MeCNï¿½HOAc (25 : 1), reflux, 2 h; v, MeCNï¿½HOAc (100 : 1), reflux, 2 h; vi, HCl (0.2 M), MeOH, 25 ï¿½C; vii, H<small><sub>2</sub></small>(1 atm), Pd/C, 30 min; viii, H<small><sub>2</sub></small>(4 atm), Pd/C, 30 h.</span></td><td align="center" width="25%"></td></tr></table><br clear="all"><a name="sect1751"><p align="" style="font-weight: bold; margin-top: 0%; margin-bottom: 0%; "><h3><b>3 Acridone alkaloids</b></h3></p></a><p class="firstpara">Known acridone alkaloids isolated from new sources during the period covered by this review include 1-hydroxy-3-methoxy-<span style="font-style: italic; "><i>N</i></span>-methylacridone <span style="font-weight: bold; "><b>232</b></span> from <span style="font-style: italic; "><i>Feronia limonia</i></span> (= <span style="font-style: italic; "><i>F. elephantum</i></span>),<small><sup style="color: ;"><a title="M. M. Rahman, A. I. Gray,  Phytochemistry 2002 59 73" href="quinoline2003.htm#cit114">114</a></sup></small> 5-hydroxynoracronycine <span style="font-weight: bold; "><b>233</b></span> from <span style="font-style: italic; "><i>Swinglea citrumelo</i></span>,<small><sup style="color: ;"><a title="A. M. El-Shamy, A. H. Shehata, H. M. M. Eid,  Egypt. J. Biomed. Sci. 2001 8 145( Chem. Abstr., 2002,137, 60272)" href="quinoline2003.htm#cit115">115</a></sup></small> and citrusinine-II <span style="font-weight: bold; "><b>234</b></span>, glycocitrine-IV <span style="font-weight: bold; "><b>235</b></span> and 5-hydroxynoracronycine from <span style="font-style: italic; "><i>S. glutinosa</i></span>.<small><sup style="color: ;"><a title="B. Weniger, B.-H. Um, A. Valentin, A. Estrada, A. Lobstein, R. Anton, M. Maille, M. Sauvain,  J. Nat. Prod. 2001 64 1221" href="quinoline2003.htm#cit116">116</a></sup></small> The last-named species was also the source of a novel alkaloid, 1,3,5-trihydroxy-2,8-diprenyl-<span style="font-style: italic; "><i>N</i></span>-methylacridone <span style="font-weight: bold; "><b>236</b></span>, which is one of the very few acridone alkaloids to bear a substituent at C-8, and the only one to have a prenyl substituent at this position.</p><p class="otherpara">The biological activities of acridone alkaloids continue to attract interest. Citrusinine-II <span style="font-weight: bold; "><b>234</b></span>, citrusinine-I <span style="font-weight: bold; "><b>237</b></span>, severifoline <span style="font-weight: bold; "><b>238</b></span> and buxifoliadine-H <span style="font-weight: bold; "><b>239</b></span>, isolated from the root bark of <span style="font-style: italic; "><i>Severinia buxifolia</i></span>, were cytotoxic towards nasopharyngeal carcinoma KB cells (ED<small><sub>50</sub></small> 0.09ï¿½0.82 ï¿½g ml<small><sup>ï¿½1</sup></small>); <span style="font-weight: bold; "><b>237</b></span> and <span style="font-weight: bold; "><b>239</b></span> were also marginally active against hepatoma 3B cells (ED<small><sub>50</sub></small> 6.6 and 5.2 ï¿½g ml<small><sup>ï¿½1</sup></small>), whereas <span style="font-weight: bold; "><b>237</b></span>, buxifoliadine-B <span style="font-weight: bold; "><b>240</b></span> and buxifoliadine-D <span style="font-weight: bold; "><b>241</b></span> were cytotoxic towards colon carcinoma colo-205 cells (ED<small><sub>50</sub></small> 0.58ï¿½6.3 ï¿½g ml<small><sup>ï¿½1</sup></small>).<small><sup style="color: ;"><a title="T.-S. Wu, C.-M. Chen, F.-W. Lin,  J. Nat. Prod. 2001 64 1040" href="quinoline2003.htm#cit28">28</a></sup></small> The four alkaloids from <span style="font-style: italic; "><i>S. glutinosa</i></span> mentioned in the previous paragraph, and glycocitrine-IV in particular, were cytotoxic towards human fibroblast (HeLa) cells, and also showed antiplasmodial activity against both chloroquine-sensitive and -resistant strains of <span style="font-style: italic; "><i>Plasmodium falciparum</i></span>.<small><sup style="color: ;"><a title="B. Weniger, B.-H. Um, A. Valentin, A. Estrada, A. Lobstein, R. Anton, M. Maille, M. Sauvain,  J. Nat. Prod. 2001 64 1221" href="quinoline2003.htm#cit116">116</a></sup></small> Three acridones from the African medicinal plant <span style="font-style: italic; "><i>Fagara macrophylla</i></span>, <span style="font-style: italic; "><i>viz.</i></span> 1-hydroxy-3-methoxy-<span style="font-style: italic; "><i>N</i></span>-methylacridone <span style="font-weight: bold; "><b>232</b></span>, arborinine <span style="font-weight: bold; "><b>242</b></span> and xanthoxoline <span style="font-weight: bold; "><b>243</b></span>, showed potent antifeedant activity against final stage larvae of the lepidopteran pest <span style="font-style: italic; "><i>Spodoptera frugiperda</i></span>, but only xanthoxoline was effective against <span style="font-style: italic; "><i>S. littoralis</i></span>.<small><sup style="color: ;"><a title="C. Tringali, C. Spatafora, V. Cali, M. S. J. Simmonds,  Fitoterapia 2001 72 538" href="quinoline2003.htm#cit117">117</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr15"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u15.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><p class="otherpara">Acronycine <span style="font-weight: bold; "><b>244</b></span> is a promising lead compound for the development of novel antitumour agents. Recent progress in the synthesis and evaluation of novel acronycine analogues has been summarised in two timely reviews, both of which highlight the unique pharmacological profile of the derivative S23906-1 <span style="font-weight: bold; "><b>245</b></span> when tested on aggressive human lung, ovarian and colon cancer xenografts in nude mice.<small><sup style="color: ;"><a title="F. Tillequin,  Ann. Pharm. Fr. 2002 60 246; N. Guilbaud, S. Leonce, F. Tillequin, M. Koch, J. A. Hickman, A. Pierre,  Anti-Cancer Drugs 2002 13 445" href="quinoline2003.htm#cit118">118,119</a></sup></small> Details of the experimental testing of this potent new anticancer agent and its probable mode of action were described in two full publications.<small><sup style="color: ;"><a title="N. Guilbaud, L. Kraus-Berthier, F. Meyer-Losic, V. Malivet, C. Chacun, M. Jan, F. Tillequin, S. Michel, M. Koch, B. Pfeiffer, G. Atassi, J. A. Hickman, A. Pierre,  Clin. Cancer Res. 2001 7 2573; J. Kluza, A. Lansiaux, N. Wattez, M.-P. Hildebrand, S. Leonce, A. Pierre, J. A. Hickman, C. Bailly,  Biochem. Pharmacol. 2002 63 1443" href="quinoline2003.htm#cit120">120,121</a></sup></small></p><p class="otherpara">1-Oxo-2-hydroxy-1,2-dihydroacronycine <span style="font-weight: bold; "><b>246</b></span>, easily prepared by permanganate oxidation of acronycine, has proved to be a useful precursor for preparing biologically active nitrogen-containing derivatives both by replacement of the methoxy group and by further manipulation of the pyran ring; it has also been transformed into the cytotoxic furanone derivative <span style="font-weight: bold; "><b>247</b></span> by treatment with sodium hydroxide in methanol.<small><sup style="color: ;"><a title="P. Magiatis, S. Mitaku, A.-L. Skaltsounis, F. Tillequin,  Chem. Pharm. Bull. 2001 49 1304" href="quinoline2003.htm#cit122">122</a></sup></small> Isoacronycine <span style="font-weight: bold; "><b>248</b></span>, synthesised from 1,3-dihydroxy-<span style="font-style: italic; "><i>N</i></span>-methylacridone and prenal, has itself been transformed into various derivatives by functionalisation of the double bond in the pyran ring, but only <span style="font-weight: bold; "><b>249</b></span> and <span style="font-weight: bold; "><b>250</b></span> were appreciably cytotoxic towards L-1210 leukaemia cells.<small><sup style="color: ;"><a title="P. Magiatis, S. Mitaku, A. Pierre, G. Atassi,  Heterocycles 2002 57 341" href="quinoline2003.htm#cit123">123</a></sup></small> Further synthetic analogues of acronycine to exhibit promising cytotoxicity included benzophenanthroline derivatives such as <span style="font-weight: bold; "><b>251</b></span> and <span style="font-weight: bold; "><b>252</b></span>,<small><sup style="color: ;"><a title="J.-P. Bongui, A. Elomri, E. Seguin, F. Tillequin, B. Pfeiffer, P. Renard, A. Pierre, G. Atassi,  Chem. Pharm. Bull. 2001 49 1077" href="quinoline2003.htm#cit124">124</a></sup></small> while some more exotic pyrazole-fused systems of general structure <span style="font-weight: bold; "><b>253</b></span> were substantially more active towards L-1210 cells than the parent alkaloid, and even inhibited the proliferation of several human solid tumour cells.<small><sup style="color: ;"><a title="I. K. Kostakis, P. Magiatis, N. Pouli, P. Marakos, A.-L. Skaltsounis, H. Pratsinis, S. Leonce, A. Pierre,  J. Med. Chem. 2002 45 2599" href="quinoline2003.htm#cit125">125</a></sup></small></p><br clear="all"><table align="center" width="100%"><tr><td align="center" colspan="3"><a name="ugr16"><img align="center" src="https://bitnest.netfirms.com/ej/NP/2003/b208140g/b208140g-u16.gif"></a></td></tr><tr><td width="25%"></td><td align="left" width="50%"></td><td align="center" width="25%"></td></tr></table><br clear="all"><rsc:art-back><a name="sect1821"><p align="" style="font-weight: bold; margin-top: 0%; margin-bottom: 0%; "><h3><b>Acknowledgements</b></h3></p></a><p class="firstpara">This material is based upon work supported by the National Research Foundation under grant number 2053652. Financial support from the University of the Witwatersrand is also gratefully acknowledged.</p><a name="sect1820"><p align="" style="font-weight: bold; margin-top: 0%; margin-bottom: 0%; "><h3><b>References</b></h3></p></a><table align="center" width="100%" border="0"><tr><td valign="top" align="right"><a name="cit1">1</a></td><td valign="top"></td><td valign="top">A. Buske<span style="">, </span>J. Schmidt<span style="">, </span>A. Porzel and G. Adam, <span style="font-style: italic; "><i>Eur. J. Org. Chem.</i></span>, 2001, 3537<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637431" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit2">2</a></td><td valign="top"></td><td valign="top">R. A. Davis<span style="">, </span>A. R. Carroll and R. J. Quinn, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2002, <span style="font-weight: bold; "><b>65</b></span>, 454<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637432" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit3">3</a></td><td valign="top"></td><td valign="top">S.-B. Chen<span style="">, </span>G.-Y. Gao<span style="">, </span>Y.-S. Li<span style="">, </span>S.-C. Yu and P.-G. Xiao, <span style="font-style: italic; "><i>Planta Med.</i></span>, 2002, <span style="font-weight: bold; "><b>68</b></span>, 554<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637433" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit4">4</a></td><td valign="top"></td><td valign="top">A. E. M. Khaleel, <span style="font-style: italic; "><i>Monatsh. Chem.</i></span>, 2002, <span style="font-weight: bold; "><b>133</b></span>, 183<rsc:citlink msid="b208140g" citgroupID="cit4" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit5">5</a></td><td valign="top"></td><td valign="top">A. D. Wright<span style="">, </span>E. Goclik<span style="">, </span>G. M. Kï¿½nig and R. Kaminsky, <span style="font-style: italic; "><i>J. Med. Chem.</i></span>, 2002, <span style="font-weight: bold; "><b>45</b></span>, 3067<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=635748" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit6">6</a></td><td valign="top"></td><td valign="top">M. Y. Rios<span style="">, </span>E. Rosas-Alonso and A. B. Aguilar-Guadarrama, <span style="font-style: italic; "><i>Biochem. Syst. Ecol.</i></span>, 2002, <span style="font-weight: bold; "><b>30</b></span>, 367<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=562829" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit7">7</a></td><td valign="top"></td><td valign="top">I. Jacquemond-Collet<span style="">, </span>J.-M. Bessiï¿½re<span style="">, </span>S. Hannedouche<span style="">, </span>C. Bertrand<span style="">, </span>I. Fourastï¿½ and C. Moulis, <span style="font-style: italic; "><i>Phytochem. Anal.</i></span>, 2001, <span style="font-weight: bold; "><b>12</b></span>, 312<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637434" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit8">8</a></td><td valign="top"></td><td valign="top">B. P. Smith<span style="">, </span>M. J. Tyler<span style="">, </span>T. Kaneko<span style="">, </span>H. M. Garraffo<span style="">, </span>T. F. Spande and J. W. Daly, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2002, <span style="font-weight: bold; "><b>65</b></span>, 439<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637435" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit9">9</a></td><td valign="top"></td><td valign="top">T. Pacher<span style="">, </span>M. Bacher<span style="">, </span>O. Hofer and H. Greger, <span style="font-style: italic; "><i>Phytochemistry</i></span>, 2001, <span style="font-weight: bold; "><b>58</b></span>, 129<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=305331" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit10">10</a></td><td valign="top"></td><td valign="top">N. Sultana and P. G. Waterman, <span style="font-style: italic; "><i>Phytochemistry</i></span>, 2001, <span style="font-weight: bold; "><b>58</b></span>, 329<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637436" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit11">11</a></td><td valign="top"></td><td valign="top">M. S. Ali<span style="">, </span>M. K. Pervez<span style="">, </span>M. Saleem and R. B. Tareen, <span style="font-style: italic; "><i>Phytochemistry</i></span>, 2001, <span style="font-weight: bold; "><b>57</b></span>, 1277<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637437" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit12">12</a></td><td valign="top"></td><td valign="top">L. Puricelli<span style="">, </span>G. Innocenti<span style="">, </span>L. Delle Monache<span style="">, </span>R. Caniato<span style="">, </span>R. Filippini and E. M. Cappelletti, <span style="font-style: italic; "><i>Nat. Prod. Lett.</i></span>, 2002, <span style="font-weight: bold; "><b>16</b></span>, 95<rsc:citlink msid="b208140g" citgroupID="cit12" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit13">13</a></td><td valign="top"></td><td valign="top">S. Aoki<span style="">, </span>Y. Ye<span style="">, </span>K. Higuchi<span style="">, </span>A. Takashima<span style="">, </span>Y. Tanaka<span style="">, </span>I. Kitagawa and M. Kobayashi, <span style="font-style: italic; "><i>Chem. Pharm. Bull.</i></span>, 2001, <span style="font-weight: bold; "><b>49</b></span>, 1372<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=297831" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit14">14</a></td><td valign="top"></td><td valign="top">A. L. Okunade<span style="">, </span>W. H. Lewis<span style="">, </span>M. P. Elvin-Lewis<span style="">, </span>S. J. Casper and D. E. Goldberg, <span style="font-style: italic; "><i>Fitoterapia</i></span>, 2001, <span style="font-weight: bold; "><b>72</b></span>, 717<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637438" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit15">15</a></td><td valign="top"></td><td valign="top">X.-M. Niu<span style="">, </span>S.-H. Li<span style="">, </span>L.-Y. Peng<span style="">, </span>Z.-W. Lin<span style="">, </span>G.-X. Rao and H.-D. Sun, <span style="font-style: italic; "><i>J. Asian Nat. Prod. Res.</i></span>, 2001, <span style="font-weight: bold; "><b>3</b></span>, 299<rsc:citlink msid="b208140g" citgroupID="cit15" position="1"></rsc:citlink>; (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2002, <span style="font-weight: bold; "><b>136</b></span>, 259980)<rsc:citlink msid="b208140g" citgroupID="cit15" position="2"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit16">16</a></td><td valign="top"></td><td valign="top">I.-S. Chen<span style="">, </span>H.-F. Chen<span style="">, </span>M.-J. Cheng<span style="">, </span>Y.-L. Chang<span style="">, </span>C.-M. Teng<span style="">, </span>I. Tsutomu<span style="">, </span>J.-J. Chen and I.-L. Tsai, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2001, <span style="font-weight: bold; "><b>64</b></span>, 1143<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637439" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit17">17</a></td><td valign="top"></td><td valign="top">H. Wang<span style="">, </span>S. L. Yeo<span style="">, </span>J. Xu<span style="">, </span>X. Xu<span style="">, </span>H. He<span style="">, </span>F. Ronca<span style="">, </span>A. E. Ting<span style="">, </span>Y. Wang<span style="">, </span>V. C. Yu and M. M. Sim, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2002, <span style="font-weight: bold; "><b>65</b></span>, 721<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637440" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit18">18</a></td><td valign="top"></td><td valign="top">T. S. Tulyaganov and F. K. Allaberdiev, <span style="font-style: italic; "><i>Chem. Nat. Compd.</i></span>, 2001, <span style="font-weight: bold; "><b>37</b></span>, 556<rsc:citlink msid="b208140g" citgroupID="cit18" position="1"></rsc:citlink>; (<span style="font-style: italic; "><i>Engl. transl. of Khim. Prir. Soedin.</i></span>, 2001, 476)<rsc:citlink msid="b208140g" citgroupID="cit18" position="2"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit19">19</a></td><td valign="top"></td><td valign="top">H. S. Chung and W. S. Woo, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2001, <span style="font-weight: bold; "><b>64</b></span>, 1579<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637441" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit20">20</a></td><td valign="top"></td><td valign="top">H. S. Chung, <span style="font-style: italic; "><i>Nutraceuticals Food</i></span>, 2002, <span style="font-weight: bold; "><b>7</b></span>, 119<rsc:citlink msid="b208140g" citgroupID="cit20" position="1"></rsc:citlink>; (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2003, <span style="font-weight: bold; "><b>138</b></span>, 163102)<rsc:citlink msid="b208140g" citgroupID="cit20" position="2"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit21">21</a></td><td valign="top"></td><td valign="top">W.-G. Kim<span style="">, </span>N.-K. Song and I.-D. Yoo, <span style="font-style: italic; "><i>J. Antibiot.</i></span>, 2001, <span style="font-weight: bold; "><b>54</b></span>, 831<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637442" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit22">22</a></td><td valign="top"></td><td valign="top">W. Fakhouri<span style="">, </span>F. Walker<span style="">, </span>B. Vogler<span style="">, </span>W. Armbruster and H. Buchenauer, <span style="font-style: italic; "><i>Phytochemistry</i></span>, 2001, <span style="font-weight: bold; "><b>58</b></span>, 1297<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637443" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit23">23</a></td><td valign="top"></td><td valign="top">M. W. Biavatti<span style="">, </span>P. C. Vieira<span style="">, </span>M. F. das G. F. da Silva<span style="">, </span>J. B. Fernandes<span style="">, </span>S. R. Victor<span style="">, </span>F. C. Pagnocca<span style="">, </span>S. Albuquerque<span style="">, </span>I. Caracelli and J. Zukerman-Schpector, <span style="font-style: italic; "><i>J. Braz. Chem. Soc.</i></span>, 2002, <span style="font-weight: bold; "><b>13</b></span>, 66<rsc:citlink msid="b208140g" citgroupID="cit23" position="1"></rsc:citlink>; (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2002, <span style="font-weight: bold; "><b>136</b></span>, 263287)<rsc:citlink msid="b208140g" citgroupID="cit23" position="2"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit24">24</a></td><td valign="top"></td><td valign="top">N. Fokialakis<span style="">, </span>P. Magiatis<span style="">, </span>A. Terzis<span style="">, </span>F. Tillequin and A.-L. Skaltsounis, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 2001, <span style="font-weight: bold; "><b>42</b></span>, 5323<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637444" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit25">25</a></td><td valign="top"></td><td valign="top">N. Fokialakis<span style="">, </span>P. Magiatis<span style="">, </span>I. Chinou<span style="">, </span>S. Mitaku and F. Tillequin, <span style="font-style: italic; "><i>Chem. Pharm. Bull.</i></span>, 2002, <span style="font-weight: bold; "><b>50</b></span>, 413<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637445" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit26">26</a></td><td valign="top"></td><td valign="top">N. Noda<span style="">, </span>Y. Yashiki<span style="">, </span>T. Nakatani<span style="">, </span>K. Miyahara and X.-M. Du, <span style="font-style: italic; "><i>Chem. Pharm. Bull.</i></span>, 2001, <span style="font-weight: bold; "><b>49</b></span>, 930<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637446" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit27">27</a></td><td valign="top"></td><td valign="top">C.-M. Chen<span style="">, </span>F.-W. Lin<span style="">, </span>P.-C. Kuo<span style="">, </span>L.-S. Shi<span style="">, </span>J.-J. Wang and T.-S. Wu, <span style="font-style: italic; "><i>J. Chin. Chem. Soc.</i></span>, 2001, <span style="font-weight: bold; "><b>48</b></span>, 933<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637447" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit28">28</a></td><td valign="top"></td><td valign="top">T.-S. Wu<span style="">, </span>C.-M. Chen and F.-W. Lin, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2001, <span style="font-weight: bold; "><b>64</b></span>, 1040<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637448" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit29">29</a></td><td valign="top"></td><td valign="top">K. Kurosawa<span style="">, </span>K. Takahashi and E. Tsuda, <span style="font-style: italic; "><i>J. Antibiot.</i></span>, 2001, <span style="font-weight: bold; "><b>54</b></span>, 615<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637449" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit30">30</a></td><td valign="top"></td><td valign="top">K. Takahashi<span style="">, </span>H. Koshino<span style="">, </span>Y. Esumi<span style="">, </span>E. Tsuda and K. Kurosawa, <span style="font-style: italic; "><i>J. Antibiot.</i></span>, 2001, <span style="font-weight: bold; "><b>54</b></span>, 622<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637450" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit31">31</a></td><td valign="top"></td><td valign="top">H. D. T. Mai<span style="">, </span>H. T. Van-Dufat<span style="">, </span>S. Michel<span style="">, </span>F. Tillequin<span style="">, </span>D. Bastien and T. Sï¿½venet, <span style="font-style: italic; "><i>Z. Naturforsch., Teil C</i></span>, 2001, <span style="font-weight: bold; "><b>56</b></span>, 492<rsc:citlink msid="b208140g" citgroupID="cit31" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit32">32</a></td><td valign="top"></td><td valign="top">N. F. de Moura<span style="">, </span>A. F. Morel<span style="">, </span>E. C. Dessoy<span style="">, </span>N. Zanatta<span style="">, </span>M. M. Bï¿½rger<span style="">, </span>N. Ahlert<span style="">, </span>G. P. Porto and B. Baldisserotto, <span style="font-style: italic; "><i>Planta Med.</i></span>, 2002, <span style="font-weight: bold; "><b>68</b></span>, 534<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637451" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit33">33</a></td><td valign="top"></td><td valign="top">I. Jacquemond-Collet<span style="">, </span>F. Benoit-Vical<span style="">, </span>Mustofa<span style="">, </span>A. Valentin<span style="">, </span>E. Stanislas<span style="">, </span>M. Malliï¿½ and I. Fourastï¿½, <span style="font-style: italic; "><i>Planta Med.</i></span>, 2002, <span style="font-weight: bold; "><b>68</b></span>, 68<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637452" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit34">34</a></td><td valign="top"></td><td valign="top">H. Nakayama<span style="">, </span>M. E. Ferreira<span style="">, </span>A. R. de Arias<span style="">, </span>N. V. de Bilbao<span style="">, </span>S. Torres<span style="">, </span>A. Schinini and A. Fournet, <span style="font-style: italic; "><i>Phytother. Res.</i></span>, 2001, <span style="font-weight: bold; "><b>15</b></span>, 630<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637453" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit35">35</a></td><td valign="top"></td><td valign="top"><a name="cit35a">(<i>a</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2002, <span style="font-weight: bold; "><b>19</b></span>, 742<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=294920&amp;rscID=b104971m" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>; <a name="cit35b">(<i>b</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 1995, <span style="font-weight: bold; "><b>12</b></span>, 469<rsc:citlink msid="b208140g" citgroupID="cit35b" position="1"></rsc:citlink>; <a name="cit35c">(<i>c</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 1994, <span style="font-weight: bold; "><b>11</b></span>, 165<rsc:citlink msid="b208140g" citgroupID="cit35c" position="1"></rsc:citlink>; <a name="cit35d">(<i>d</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 1997, <span style="font-weight: bold; "><b>14</b></span>, 11<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=414517" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>; <a name="cit35e">(<i>e</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2002, <span style="font-weight: bold; "><b>19</b></span>, 745<rsc:citlink msid="b208140g" citgroupID="cit35e" position="1"></rsc:citlink>; <a name="cit35f">(<i>f</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2001, <span style="font-weight: bold; "><b>18</b></span>, 546<rsc:citlink msid="b208140g" citgroupID="cit35f" position="1"></rsc:citlink>; <a name="cit35g">(<i>g</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2002, <span style="font-weight: bold; "><b>19</b></span>, 749<rsc:citlink msid="b208140g" citgroupID="cit35g" position="1"></rsc:citlink>; <a name="cit35h">(<i>h</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2002, <span style="font-weight: bold; "><b>19</b></span>, 750<rsc:citlink msid="b208140g" citgroupID="cit35h" position="1"></rsc:citlink>; <a name="cit35i">(<i>i</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2002, <span style="font-weight: bold; "><b>19</b></span>, 756<rsc:citlink msid="b208140g" citgroupID="cit35i" position="1"></rsc:citlink>; <a name="cit35j">(<i>j</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2000, <span style="font-weight: bold; "><b>17</b></span>, 617<rsc:citlink msid="b208140g" citgroupID="cit35j" position="1"></rsc:citlink>; <a name="cit35k">(<i>k</i>) </a>J. P. Michael, <span style="font-style: italic; "><i>Nat. Prod. Rep.</i></span>, 2002, <span style="font-weight: bold; "><b>19</b></span>, 757<rsc:citlink msid="b208140g" citgroupID="cit35k" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit36">36</a></td><td valign="top"></td><td valign="top">J. Collin<span style="">, </span>N. Jaber and M. I. Lannou, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 2001, <span style="font-weight: bold; "><b>42</b></span>, 7405<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=307560" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit37">37</a></td><td valign="top"></td><td valign="top">C. S. Cho<span style="">, </span>B. T. Kim<span style="">, </span>T.-J. Kim and S. C. Shim, <span style="font-style: italic; "><i>Chem. Commun.</i></span>, 2001, 2576<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=70863&amp;rscID=b109245f" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit38">38</a></td><td valign="top"></td><td valign="top">T. Horaguchi<span style="">, </span>N. Hosokawa<span style="">, </span>K. Tanemura and T. Suzuki, <span style="font-style: italic; "><i>J. Heterocycl. Chem.</i></span>, 2002, <span style="font-weight: bold; "><b>39</b></span>, 61<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637463" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit39">39</a></td><td valign="top"></td><td valign="top">V. Bonnet<span style="">, </span>F. Mongin<span style="">, </span>F. Trï¿½court<span style="">, </span>G. Quï¿½guiner and P. Knochel, <span style="font-style: italic; "><i>Tetrahedron</i></span>, 2002, <span style="font-weight: bold; "><b>58</b></span>, 4429<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637464" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit40">40</a></td><td valign="top"></td><td valign="top">J. Quintin<span style="">, </span>X. Franck<span style="">, </span>R. Hocquemiller and B. Figadï¿½re, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 2002, <span style="font-weight: bold; "><b>43</b></span>, 3547<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637465" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit41">41</a></td><td valign="top"></td><td valign="top">E. V. L. da Cunha<span style="">, </span>J. A. Armstrong<span style="">, </span>A. I. Gray<span style="">, </span>D. C. R. Hockless<span style="">, </span>P. G. Waterman and A. H. White, <span style="font-style: italic; "><i>Aust. J. Chem.</i></span>, 1993, <span style="font-weight: bold; "><b>46</b></span>, 1507<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637466" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit42">42</a></td><td valign="top"></td><td valign="top">I am grateful to Professor M. S. Ali, University of Karachi, for confirming that the name evoxine should be used in preference to haplophytin-B.</td></tr><tr><td valign="top" align="right"><a name="cit43">43</a></td><td valign="top"></td><td valign="top">F. Muyard<span style="">, </span>F. Bevalot<span style="">, </span>B. Laude and J. Vaquette, <span style="font-style: italic; "><i>Phytochemistry</i></span>, 1992, <span style="font-weight: bold; "><b>31</b></span>, 1087<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637467" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit44">44</a></td><td valign="top"></td><td valign="top">T.-S. Wu<span style="">, </span>M.-L. Wang<span style="">, </span>H.-J. Shyur<span style="">, </span>Y-L. Liu<span style="">, </span>Y.-Y. Chan<span style="">, </span>C.-M. Teng and S.-C. Kuo, <span style="font-style: italic; "><i>Chin. Pharm. J.</i></span>, 1994, <span style="font-weight: bold; "><b>46</b></span>, 447<rsc:citlink msid="b208140g" citgroupID="cit44" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit45">45</a></td><td valign="top"></td><td valign="top">D. R. Boyd<span style="">, </span>N. D. Sharma<span style="">, </span>S. A. Barr<span style="">, </span>J. G. Carroll<span style="">, </span>D. Mackerracher and J. F. Malone, <span style="font-style: italic; "><i>J. Chem. Soc., Perkin Trans. 1</i></span>, 2000, 3397<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=40937&amp;rscID=b005285j" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit46">46</a></td><td valign="top"></td><td valign="top">R. N. Kumar<span style="">, </span>S. T. Selvi<span style="">, </span>T. Suresh and P. S. Mohan, <span style="font-style: italic; "><i>Heterocycles</i></span>, 2002, <span style="font-weight: bold; "><b>57</b></span>, 357<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637468" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit47">47</a></td><td valign="top"></td><td valign="top">Y. R. Lee<span style="">, </span>H. I. Kweon<span style="">, </span>W. S. Koh<span style="">, </span>K. R. Min<span style="">, </span>Y. Kim and S. H. Lee, <span style="font-style: italic; "><i>Synthesis</i></span>, 2001, 1851<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637469" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit48">48</a></td><td valign="top"></td><td valign="top">V. Nair<span style="">, </span>P. M. Treesa<span style="">, </span>C. N. Jayan<span style="">, </span>N. P. Rath<span style="">, </span>M. Vairamani and S. Prabhakar, <span style="font-style: italic; "><i>Tetrahedron</i></span>, 2001, <span style="font-weight: bold; "><b>57</b></span>, 7711<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637470" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit49">49</a></td><td valign="top"></td><td valign="top">G. Bar<span style="">, </span>A. F. Parsons and C. B. Thomas, <span style="font-style: italic; "><i>Chem. Commun.</i></span>, 2001, 1350<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=7404&amp;rscID=b103544b" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit50">50</a></td><td valign="top"></td><td valign="top">F. N. Lahey<span style="">, </span>J. A. Lamberton and J. R. Price, <span style="font-style: italic; "><i>Aust. J. Sci. Res.</i></span>, 1950, <span style="font-weight: bold; "><b>3</b></span>, 155<rsc:citlink msid="b208140g" citgroupID="cit50" position="1"></rsc:citlink> ; cited in ref. <a title="N. Fokialakis, P. Magiatis, I. Chinou, S. Mitaku, F. Tillequin,  Chem. Pharm. Bull. 2002 50 413" href="quinoline2003.htm#cit25">25</a>.</td></tr><tr><td valign="top" align="right"><a name="cit51">51</a></td><td valign="top"></td><td valign="top">S. S. Nazrullaev<span style="">, </span>I. A. Bessonova and K. S. Akhmedkhodzhaeva, <span style="font-style: italic; "><i>Chem. Nat. Compd.</i></span>, 2001, <span style="font-weight: bold; "><b>37</b></span>, 551<rsc:citlink msid="b208140g" citgroupID="cit51" position="1"></rsc:citlink>; (<span style="font-style: italic; "><i>Engl. transl. of Khim. Prir. Soedin.</i></span>, 2001, 472)<rsc:citlink msid="b208140g" citgroupID="cit51" position="2"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit52">52</a></td><td valign="top"></td><td valign="top">Z. L. Liu<span style="">, </span>Y. J. Xu<span style="">, </span>J. Wu<span style="">, </span>S. H. Goh and S. H. Ho, <span style="font-style: italic; "><i>J. Agr. Food Chem.</i></span>, 2002, <span style="font-weight: bold; "><b>50</b></span>, 1447<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637471" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit53">53</a></td><td valign="top"></td><td valign="top">G. Bringmann<span style="">, </span>S. Schlauer<span style="">, </span>H. Rischer<span style="">, </span>M. Wohlfahrt<span style="">, </span>R. Haller<span style="">, </span>S. Bï¿½r and R. Brun, <span style="font-style: italic; "><i>Pharm. Pharmacol. Lett.</i></span>, 2001, <span style="font-weight: bold; "><b>2</b></span>, 47<rsc:citlink msid="b208140g" citgroupID="cit53" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit54">54</a></td><td valign="top"></td><td valign="top">N. A. Cortese<span style="">, </span>C. B. Ziegler, Jr.<span style="">, </span>B. J. Hrnjez and R. F. Heck, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 1978, <span style="font-weight: bold; "><b>43</b></span>, 2952<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=54529" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit55">55</a></td><td valign="top"></td><td valign="top">B.-S. Park<span style="">, </span>D.-Y. Kim<span style="">, </span>P. J. Rosenthal<span style="">, </span>S.-C. Huh<span style="">, </span>B. J. Lee<span style="">, </span>E.-J. Park<span style="">, </span>S.-M. Kim<span style="">, </span>J.-E. Kim<span style="">, </span>M.-H. Kim<span style="">, </span>T.-L. Huh<span style="">, </span>Y.-J. Choi<span style="">, </span>K.-H. Suh<span style="">, </span>W.-S. Choi and S.-E. Lee, <span style="font-style: italic; "><i>Bioorg. Med. Chem. Lett.</i></span>, 2002, <span style="font-weight: bold; "><b>12</b></span>, 1351<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637472" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit56">56</a></td><td valign="top"></td><td valign="top">N. Kakinuma<span style="">, </span>H. Iwai<span style="">, </span>S. Takahashi<span style="">, </span>K. Hamano<span style="">, </span>T. Yanagisawa<span style="">, </span>K. Nagai<span style="">, </span>K. Tanaka<span style="">, </span>K. Suzuki<span style="">, </span>F. Kirikae<span style="">, </span>T. Kirikae and A. Nakagawa, <span style="font-style: italic; "><i>J. Antibiot.</i></span>, 2000, <span style="font-weight: bold; "><b>53</b></span>, 1247<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637473" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit57">57</a></td><td valign="top"></td><td valign="top">S. Takahashi<span style="">, </span>N. Kakinuma<span style="">, </span>H. Iwai<span style="">, </span>T. Yanagisawa<span style="">, </span>K. Nagai<span style="">, </span>K. Suzuki<span style="">, </span>T. Tokunaga and A. Nakagawa, <span style="font-style: italic; "><i>J. Antibiot.</i></span>, 2000, <span style="font-weight: bold; "><b>53</b></span>, 1252<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637474" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit58">58</a></td><td valign="top"></td><td valign="top">P.
W. Royt<span style="">, </span>R. V. Honeychuck<span style="">, </span>V. Ravich<span style="">, </span>P. Ponnaluri<span style="">, </span>L. K. Pannell<span style="">, </span>J. S. Buyer<span style="">, </span>V. Chandhoke<span style="">, </span>W. M. Stalick<span style="">, </span>L. C. DeSesso<span style="">, </span>S. Donohue<span style="">, </span>R. Ghei<span style="">, </span>J. D. Relyea and R. Ruiz, <span style="font-style: italic; "><i>Bioorg. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>29</b></span>, 387<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637475" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit59">59</a></td><td valign="top"></td><td valign="top">M. J. Rance<span style="">, </span>J. C. Ruddock<span style="">, </span>M. S. Pacey<span style="">, </span>W. P. Cullen<span style="">, </span>L. H. Huang<span style="">, </span>M. T. Jefferson<span style="">, </span>E. B. Whipple<span style="">, </span>H. Maeda and J. Tone, <span style="font-style: italic; "><i>J. Antibiot.</i></span>, 1989, <span style="font-weight: bold; "><b>42</b></span>, 206<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637476" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit60">60</a></td><td valign="top"></td><td valign="top">C. W. Holzapfel and W. Marais, <span style="font-style: italic; "><i>J. Chem. Res. (S)</i></span>, 2002, 22<rsc:citlink msid="b208140g" citgroupID="cit60" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit61">61</a></td><td valign="top"></td><td valign="top">K. C. Nicolaou<span style="">, </span>B. S. Safina<span style="">, </span>C. Funke<span style="">, </span>M. Zak and F. J. Zï¿½cri, <span style="font-style: italic; "><i>Angew. Chem., Int. Ed.</i></span>, 2002, <span style="font-weight: bold; "><b>41</b></span>, 1937<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637477" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit62">62</a></td><td valign="top"></td><td valign="top">K. C. Nicolaou<span style="">, </span>M. Nevalainen<span style="">, </span>B. S. Safina<span style="">, </span>M. Zak and S. Bulat, <span style="font-style: italic; "><i>Angew. Chem., Int. Ed.</i></span>, 2002, <span style="font-weight: bold; "><b>41</b></span>, 1941<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=253466" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit63">63</a></td><td valign="top"></td><td valign="top">S. Higashibayashi<span style="">, </span>T. Mori<span style="">, </span>K. Shinko<span style="">, </span>K. Hashimoto and M. Nakata, <span style="font-style: italic; "><i>Heterocycles</i></span>, 2002, <span style="font-weight: bold; "><b>57</b></span>, 111<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637478" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit64">64</a></td><td valign="top"></td><td valign="top">T. Ozawa<span style="">, </span>S. Aoyagi and C. Kibayashi, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>66</b></span>, 3338<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=219575" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit65">65</a></td><td valign="top"></td><td valign="top">D. R. Buckle<span style="">, </span>B. C. C. Cantello<span style="">, </span>H. Smith and B. A. Spicer, <span style="font-style: italic; "><i>J. Med. Chem.</i></span>, 1975, <span style="font-weight: bold; "><b>18</b></span>, 726<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=494539" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit66">66</a></td><td valign="top"></td><td valign="top">M. G. Banwell<span style="">, </span>A. M. Bray<span style="">, </span>A. J. Edwards and D. J. Wong, <span style="font-style: italic; "><i>J. Chem. Soc., Perkin Trans. 1</i></span>, 2002, 1340<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=224204&amp;rscID=b111401h" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit67">67</a></td><td valign="top"></td><td valign="top">M. G. Banwell<span style="">, </span>A. M. Bray<span style="">, </span>A. J. Edwards and D. J. Wong, <span style="font-style: italic; "><i>New J. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>25</b></span>, 1347<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=224205&amp;rscID=b105045c" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit68">68</a></td><td valign="top"></td><td valign="top">M. R. Heinrich<span style="">, </span>Y. Kashman<span style="">, </span>P. Spiteller and W. Steglich, <span style="font-style: italic; "><i>Tetrahedron</i></span>, 2001, <span style="font-weight: bold; "><b>57</b></span>, 9973<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=224208" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit69">69</a></td><td valign="top"></td><td valign="top">Y. Usuki<span style="">, </span>H. Hirakawa<span style="">, </span>K. Goto and H. Iio, <span style="font-style: italic; "><i>Tetrahedron: Asymmetry</i></span>, 2001, <span style="font-weight: bold; "><b>12</b></span>, 3293<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637479" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit70">70</a></td><td valign="top"></td><td valign="top">M. Akashi<span style="">, </span>Y. Sato and M. Mori, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>66</b></span>, 7873<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637480" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit71">71</a></td><td valign="top"></td><td valign="top">M. Weymann<span style="">, </span>M. Schulz-Kukula<span style="">, </span>S. Knauer and H. Kunz, <span style="font-style: italic; "><i>Monatsh. Chem.</i></span>, 2002, <span style="font-weight: bold; "><b>133</b></span>, 571<rsc:citlink msid="b208140g" citgroupID="cit71" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit72">72</a></td><td valign="top"></td><td valign="top">D. L. Comins and A. Dehghani, <span style="font-style: italic; "><i>J. Chem. Soc., Chem. Commun.</i></span>, 1993, 1838<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637481&amp;rscID=C39930001838" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit73">73</a></td><td valign="top"></td><td valign="top">Y. Liu<span style="">, </span>G. Qin<span style="">, </span>S. Ding and X. Wu, <span style="font-style: italic; "><i>Chin. Trad. Herbal Drugs (= Zhongcaoyao)</i></span>, 2002, <span style="font-weight: bold; "><b>33</b></span>, 97<rsc:citlink msid="b208140g" citgroupID="cit73" position="1"></rsc:citlink>; (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2002, <span style="font-weight: bold; "><b>137</b></span>, 152323)<rsc:citlink msid="b208140g" citgroupID="cit73" position="2"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit74">74</a></td><td valign="top"></td><td valign="top">K. Deng<span style="">, </span>X. Wu<span style="">, </span>G. Yang and G. Qin, <span style="font-style: italic; "><i>Chin. Chem. Lett.</i></span>, 1997, <span style="font-weight: bold; "><b>8</b></span>, 237<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=425660" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit75">75</a></td><td valign="top"></td><td valign="top">L. D. Ismail, <span style="font-style: italic; "><i>Al-Azhar J. Pharm. Sci.</i></span>, 2001, <span style="font-weight: bold; "><b>27</b></span>, 293<rsc:citlink msid="b208140g" citgroupID="cit75" position="1"></rsc:citlink>; (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2002, <span style="font-weight: bold; "><b>136</b></span>, 2958)<rsc:citlink msid="b208140g" citgroupID="cit75" position="2"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit76">76</a></td><td valign="top"></td><td valign="top">X.-C. Li<span style="">, </span>D. C. Dunbar<span style="">, </span>H. N. ElSohly<span style="">, </span>L. A. Walker and A. M. Clark, <span style="font-style: italic; "><i>Phytochemistry</i></span>, 2001, <span style="font-weight: bold; "><b>58</b></span>, 627<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=305363" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit77">77</a></td><td valign="top"></td><td valign="top">M. R. Ariza<span style="">, </span>T. O. Larsen<span style="">, </span>B. O. Petersen<span style="">, </span>J. ï¿½. Duus<span style="">, </span>C. Christophersen and A. F. Barrero, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2001, <span style="font-weight: bold; "><b>64</b></span>, 1590<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637482" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit78">78</a></td><td valign="top"></td><td valign="top">A. Chakraborty and A. H. Brantner, <span style="font-style: italic; "><i>Phytother. Res.</i></span>, 2001, <span style="font-weight: bold; "><b>15</b></span>, 532<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637483" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit79">79</a></td><td valign="top"></td><td valign="top">D. P. Jindal<span style="">, </span>R. S. Bhatti<span style="">, </span>S. Ahlawat and R. Gupta, <span style="font-style: italic; "><i>Eur. J. Med. Chem.</i></span>, 2002, <span style="font-weight: bold; "><b>37</b></span>, 419<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637484" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit80">80</a></td><td valign="top"></td><td valign="top">P. Molina<span style="">, </span>A. Tï¿½rraga<span style="">, </span>A. Gonzalez-Tejero<span style="">, </span>I. Rioja<span style="">, </span>A. Ubeda<span style="">, </span>M. C. Terencio and M. J. Alcaraz, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2001, <span style="font-weight: bold; "><b>64</b></span>, 1297<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637485" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit81">81</a></td><td valign="top"></td><td valign="top">H. Danz<span style="">, </span>D. Baumann and M. Hamburger, <span style="font-style: italic; "><i>Planta Med.</i></span>, 2002, <span style="font-weight: bold; "><b>68</b></span>, 152<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637486" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit82">82</a></td><td valign="top"></td><td valign="top">M. J. Micallef<span style="">, </span>K. Iwaki<span style="">, </span>T. Ishihara<span style="">, </span>S. Ushio<span style="">, </span>M. Aga<span style="">, </span>T. Kunikata<span style="">, </span>S. Koya-Miyata<span style="">, </span>T. Kimoto<span style="">, </span>M. Ikeda and M. Kurimoto, <span style="font-style: italic; "><i>Int. Immunopharmacol.</i></span>, 2002, <span style="font-weight: bold; "><b>2</b></span>, 565<rsc:citlink msid="b208140g" citgroupID="cit82" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit83">83</a></td><td valign="top"></td><td valign="top">T. Kimoto<span style="">, </span>K. Hino<span style="">, </span>S. Koya-Miyata<span style="">, </span>Y. Yamamoto<span style="">, </span>M. Takeuchi<span style="">, </span>Y. Nishizaki<span style="">, </span>M. J. Micallef<span style="">, </span>S. Ushio<span style="">, </span>K. Iwaki<span style="">, </span>M. Ikeda and M. Kurimoto, <span style="font-style: italic; "><i>Pathol. Int.</i></span>, 2001, <span style="font-weight: bold; "><b>51</b></span>, 315<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637487" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>; (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2002, <span style="font-weight: bold; "><b>136</b></span>, 256816)<rsc:citlink msid="b208140g" citgroupID="cit83" position="2"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit84">84</a></td><td valign="top"></td><td valign="top">S. Koya-Miyata<span style="">, </span>T. Kimoto<span style="">, </span>M. J. Micallef<span style="">, </span>K. Hino<span style="">, </span>M. Taniguchi<span style="">, </span>S. Ushio<span style="">, </span>K. Iwaki<span style="">, </span>M. Ikeda and M. Kurimoto, <span style="font-style: italic; "><i>Anticancer Res.</i></span>, 2001, <span style="font-weight: bold; "><b>21</b></span>, 3295<rsc:citlink msid="b208140g" citgroupID="cit84" position="1"></rsc:citlink>; (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2002, <span style="font-weight: bold; "><b>137</b></span>, 210516)<rsc:citlink msid="b208140g" citgroupID="cit84" position="2"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit85">85</a></td><td valign="top"></td><td valign="top">J. Scovill<span style="">, </span>E. Blank<span style="">, </span>M. Konnick<span style="">, </span>E. Nenortas and T. Shapiro, <span style="font-style: italic; "><i>Antimicrobial Agents Chemother.</i></span>, 2002, <span style="font-weight: bold; "><b>46</b></span>, 882<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637488" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit86">86</a></td><td valign="top"></td><td valign="top">A. K. Bhattacharjee<span style="">, </span>D. J. Skanchy<span style="">, </span>B. Jennings<span style="">, </span>T. H. Hudson<span style="">, </span>J. J. Brendle and K. A. Werbovetz, <span style="font-style: italic; "><i>Bioorg. Med. Chem.</i></span>, 2002, <span style="font-weight: bold; "><b>10</b></span>, 1979<rsc:citlink msid="b208140g" citgroupID="cit86" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit87">87</a></td><td valign="top"></td><td valign="top">Y. Takeuchi and T. Harayama, <span style="font-style: italic; "><i>Trends Heterocycl. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>7</b></span>, 65<rsc:citlink msid="b208140g" citgroupID="cit87" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit88">88</a></td><td valign="top"></td><td valign="top">H. Kikuchi<span style="">, </span>H. Tasaka<span style="">, </span>S. Hirai<span style="">, </span>Y. Takaya<span style="">, </span>Y. Iwabuchi<span style="">, </span>H. Ooi<span style="">, </span>S. Hatakeyama<span style="">, </span>H.-S. Kim<span style="">, </span>Y. Wataya and Y. Oshima, <span style="font-style: italic; "><i>J. Med. Chem.</i></span>, 2002, <span style="font-weight: bold; "><b>45</b></span>, 2563<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637489" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit89">89</a></td><td valign="top"></td><td valign="top">D. J. Connolly and P. J. Guiry, <span style="font-style: italic; "><i>Synlett</i></span>, 2001, 1707<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637490" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit90">90</a></td><td valign="top"></td><td valign="top">Y. Nishiyama<span style="">, </span>M. Hirose<span style="">, </span>W. Kitagaito and N. Sonoda, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 2002, <span style="font-weight: bold; "><b>43</b></span>, 1855<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637491" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit91">91</a></td><td valign="top"></td><td valign="top">J. S. Yadav and B. V. S. Reddy, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 2002, <span style="font-weight: bold; "><b>43</b></span>, 1905<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637492" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit92">92</a></td><td valign="top"></td><td valign="top">S. B. Mhaske and N. P. Argade, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>66</b></span>, 9038<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637493" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit93">93</a></td><td valign="top"></td><td valign="top">S. B. Mhaske and N. P. Argade, <span style="font-style: italic; "><i>Synthesis</i></span>, 2002, 323<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637494" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit94">94</a></td><td valign="top"></td><td valign="top">S. Dallavalle and L. Merlini, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 2002, <span style="font-weight: bold; "><b>43</b></span>, 1835<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637495" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit95">95</a></td><td valign="top"></td><td valign="top">M. Toyota<span style="">, </span>C. Komori and M. Ihara, <span style="font-style: italic; "><i>Heterocycles</i></span>, 2002, <span style="font-weight: bold; "><b>56</b></span>, 101<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637496" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit96">96</a></td><td valign="top"></td><td valign="top">D. Enders<span style="">, </span>B. Nolte and J. Runsink, <span style="font-style: italic; "><i>Tetrahedron: Asymmetry</i></span>, 2002, <span style="font-weight: bold; "><b>13</b></span>, 587<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637497" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit97">97</a></td><td valign="top"></td><td valign="top">M. Sugiura<span style="">, </span>H. Hagio<span style="">, </span>R. Hirabayashi and S. Kobayashi, <span style="font-style: italic; "><i>Synlett</i></span>, 2001, 1225<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637498" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit98">98</a></td><td valign="top"></td><td valign="top">M. Sugiura<span style="">, </span>H. Hagio<span style="">, </span>R. Hirabayashi and S. Kobayashi, <span style="font-style: italic; "><i>J. Am. Chem. Soc.</i></span>, 2001, <span style="font-weight: bold; "><b>123</b></span>, 12510<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637499" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit99">99</a></td><td valign="top"></td><td valign="top">M. Sugiura and S. Kobayashi, <span style="font-style: italic; "><i>Org. Lett.</i></span>, 2001, <span style="font-weight: bold; "><b>3</b></span>, 477<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=280738" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit100">100</a></td><td valign="top"></td><td valign="top">P. K. Mohanta and K. Kim, <span style="font-style: italic; "><i>Tetrahedron Lett.</i></span>, 2002, <span style="font-weight: bold; "><b>43</b></span>, 3993<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637500" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit101">101</a></td><td valign="top"></td><td valign="top">S. H. Lee<span style="">, </span>S. I. Kim<span style="">, </span>J. G. Park<span style="">, </span>E. S. Lee and Y. Jahng, <span style="font-style: italic; "><i>Heterocycles</i></span>, 2001, <span style="font-weight: bold; "><b>55</b></span>, 1555<rsc:citlink msid="b208140g" citgroupID="cit101" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit102">102</a></td><td valign="top"></td><td valign="top">A. Witt and J. Bergmann, <span style="font-style: italic; "><i>J. Heterocycl. Chem.</i></span>, 2002, <span style="font-weight: bold; "><b>39</b></span>, 351<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637501" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit103">103</a></td><td valign="top"></td><td valign="top">F. Hernï¿½ndez<span style="">, </span>A. Lumetzberger<span style="">, </span>C. Avendaï¿½o and M. Sï¿½llhuber, <span style="font-style: italic; "><i>Synlett</i></span>, 2001, 1387<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637502" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit104">104</a></td><td valign="top"></td><td valign="top">F. Hernï¿½ndez<span style="">, </span>F. L. Buenadicha<span style="">, </span>C. Avendaï¿½o and M. Sï¿½llhuber, <span style="font-style: italic; "><i>Tetrahedron: Asymmetry</i></span>, 2001, <span style="font-weight: bold; "><b>12</b></span>, 3387<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637503" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit105">105</a></td><td valign="top"></td><td valign="top">F. L. Buenadicha<span style="">, </span>C. Avendaï¿½o and M. Sï¿½llhuber, <span style="font-style: italic; "><i>Tetrahedron: Asymmetry</i></span>, 2001, <span style="font-weight: bold; "><b>12</b></span>, 3019<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637504" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit106">106</a></td><td valign="top"></td><td valign="top">S. Martï¿½n-Santamaria<span style="">, </span>R. Corzo-Suï¿½rez<span style="">, </span>C. Avendaï¿½o<span style="">, </span>M. Espada<span style="">, </span>F. Gago<span style="">, </span>S. Garcï¿½a-Granda and H. S. Rzepa, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 2002, <span style="font-weight: bold; "><b>67</b></span>, 2013<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637505" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit107">107</a></td><td valign="top"></td><td valign="top">M. L. Heredia<span style="">, </span>E. de la Cuesta and C. Avendaï¿½o, <span style="font-style: italic; "><i>Tetrahedron: Asymmetry</i></span>, 2001, <span style="font-weight: bold; "><b>12</b></span>, 2883<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637506" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit108">108</a></td><td valign="top"></td><td valign="top">J. D. Sï¿½nchez<span style="">, </span>M. T. Ramos and C. Avendaï¿½o, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 2001, <span style="font-weight: bold; "><b>66</b></span>, 5731<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637507" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit109">109</a></td><td valign="top"></td><td valign="top">H. Wang and M. M. Sim, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2001, <span style="font-weight: bold; "><b>64</b></span>, 1497<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637508" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit110">110</a></td><td valign="top"></td><td valign="top">H. Wang and A. Ganesan, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 1998, <span style="font-weight: bold; "><b>63</b></span>, 2432<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=189450" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit111">111</a></td><td valign="top"></td><td valign="top">F. He and B. B. Snider, <span style="font-style: italic; "><i>J. Org. Chem.</i></span>, 1999, <span style="font-weight: bold; "><b>64</b></span>, 1397<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=191179" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit112">112</a></td><td valign="top"></td><td valign="top">B. B. Snider and H. Zeng, <span style="font-style: italic; "><i>Org. Lett.</i></span>, 2000, <span style="font-weight: bold; "><b>2</b></span>, 4103<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=194531" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit113">113</a></td><td valign="top"></td><td valign="top">B. B. Snider and H. Zeng, <span style="font-style: italic; "><i>Org. Lett.</i></span>, 2002, <span style="font-weight: bold; "><b>4</b></span>, 1087<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637509" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit114">114</a></td><td valign="top"></td><td valign="top">M. M. Rahman and A. I. Gray, <span style="font-style: italic; "><i>Phytochemistry</i></span>, 2002, <span style="font-weight: bold; "><b>59</b></span>, 73<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637510" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit115">115</a></td><td valign="top"></td><td valign="top">A. M. El-Shamy<span style="">, </span>A. H. Shehata and H. M. M. Eid, <span style="font-style: italic; "><i>Egypt. J. Biomed. Sci.</i></span>, 2001, <span style="font-weight: bold; "><b>8</b></span>, 145<rsc:citlink msid="b208140g" citgroupID="cit115" position="1"></rsc:citlink>; (<span style="font-style: italic; "><i>Chem. Abstr.</i></span>, 2002, <span style="font-weight: bold; "><b>137</b></span>, 60272)<rsc:citlink msid="b208140g" citgroupID="cit115" position="2"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit116">116</a></td><td valign="top"></td><td valign="top">B. Weniger<span style="">, </span>B.-H. Um<span style="">, </span>A. Valentin<span style="">, </span>A. Estrada<span style="">, </span>A. Lobstein<span style="">, </span>R. Anton<span style="">, </span>M. Maillï¿½ and M. Sauvain, <span style="font-style: italic; "><i>J. Nat. Prod.</i></span>, 2001, <span style="font-weight: bold; "><b>64</b></span>, 1221<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637511" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit117">117</a></td><td valign="top"></td><td valign="top">C. Tringali<span style="">, </span>C. Spatafora<span style="">, </span>V. Calï¿½ and M. S. J. Simmonds, <span style="font-style: italic; "><i>Fitoterapia</i></span>, 2001, <span style="font-weight: bold; "><b>72</b></span>, 538<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637512" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit118">118</a></td><td valign="top"></td><td valign="top">F. Tillequin, <span style="font-style: italic; "><i>Ann. Pharm. Fr.</i></span>, 2002, <span style="font-weight: bold; "><b>60</b></span>, 246<rsc:citlink msid="b208140g" citgroupID="cit118" position="1"></rsc:citlink>.</td></tr><tr><td valign="top" align="right"><a name="cit119">119</a></td><td valign="top"></td><td valign="top">N. Guilbaud<span style="">, </span>S. Lï¿½once<span style="">, </span>F. Tillequin<span style="">, </span>M. Koch<span style="">, </span>J. A. Hickman and A. Pierrï¿½, <span style="font-style: italic; "><i>Anti-Cancer Drugs</i></span>, 2002, <span style="font-weight: bold; "><b>13</b></span>, 445<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637513" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit120">120</a></td><td valign="top"></td><td valign="top">N. Guilbaud<span style="">, </span>L. Kraus-Berthier<span style="">, </span>F. Meyer-Losic<span style="">, </span>V. Malivet<span style="">, </span>C. Chacun<span style="">, </span>M. Jan<span style="">, </span>F. Tillequin<span style="">, </span>S. Michel<span style="">, </span>M. Koch<span style="">, </span>B. Pfeiffer<span style="">, </span>G. Atassi<span style="">, </span>J. A. Hickman and A. Pierrï¿½, <span style="font-style: italic; "><i>Clin. Cancer Res.</i></span>, 2001, <span style="font-weight: bold; "><b>7</b></span>, 2573<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=550821" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit121">121</a></td><td valign="top"></td><td valign="top">J. Kluza<span style="">, </span>A. Lansiaux<span style="">, </span>N. Wattez<span style="">, </span>M.-P. Hildebrand<span style="">, </span>S. Lï¿½once<span style="">, </span>A. Pierrï¿½<span style="">, </span>J. A. Hickman and C. Bailly, <span style="font-style: italic; "><i>Biochem. Pharmacol.</i></span>, 2002, <span style="font-weight: bold; "><b>63</b></span>, 1443<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637514" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit122">122</a></td><td valign="top"></td><td valign="top">P. Magiatis<span style="">, </span>S. Mitaku<span style="">, </span>A.-L. Skaltsounis and F. Tillequin, <span style="font-style: italic; "><i>Chem. Pharm. Bull.</i></span>, 2001, <span style="font-weight: bold; "><b>49</b></span>, 1304<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637515" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit123">123</a></td><td valign="top"></td><td valign="top">P. Magiatis<span style="">, </span>S. Mitaku<span style="">, </span>A. Pierrï¿½ and G. Atassi, <span style="font-style: italic; "><i>Heterocycles</i></span>, 2002, <span style="font-weight: bold; "><b>57</b></span>, 341<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637516" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit124">124</a></td><td valign="top"></td><td valign="top">J.-P. Bongui<span style="">, </span>A. Elomri<span style="">, </span>E. Seguin<span style="">, </span>F. Tillequin<span style="">, </span>B. Pfeiffer<span style="">, </span>P. Renard<span style="">, </span>A. Pierrï¿½ and G. Atassi, <span style="font-style: italic; "><i>Chem. Pharm. Bull.</i></span>, 2001, <span style="font-weight: bold; "><b>49</b></span>, 1077<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637517" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr><tr><td valign="top" align="right"><a name="cit125">125</a></td><td valign="top"></td><td valign="top">I. K. Kostakis<span style="">, </span>P. Magiatis<span style="">, </span>N. Pouli<span style="">, </span>P. Marakos<span style="">, </span>A.-L. Skaltsounis<span style="">, </span>H. Pratsinis<span style="">, </span>S. Lï¿½once and A. Pierrï¿½, <span style="font-style: italic; "><i>J. Med. Chem.</i></span>, 2002, <span style="font-weight: bold; "><b>45</b></span>, 2599<font> </font><a href="http://jas.rsc.org/CFAL3/resolvecitation.cfm?artID=637518" target="_BLANK"><span title="Select to see links for this"><font>[Links]</font></span></a>.</td></tr></table><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span><span style="font-weight: bold; "><b></b></span></rsc:art-back><table width="100%"><tr><td><hr></td></tr><tr><td><b>This journal is ï¿½ The Royal Society of Chemistry 2003</b></td></tr></table></body></html>
<!-- content end -->
	
	


	

<!-- Debugging
2<BR>
2<BR>

-->
	

<!--	
5
Server Software     Microsoft-IIS/4.0<br>
Server name         pubs.rsc.org<br>
Gateway Interface   CGI/1.1<br>
Server Protocol     HTTP/1.0<br>
Server Port         80<br>
Request Method      GET<br>
Path Info           /CFmuscat/direpubs.cfm<br>
Path Translated     e:\e_commerce_content\muscat\direpubs.cfm<br>
Script name         /CFmuscat/direpubs.cfm<br>
Query               REDURL=/ej/NP/2003/b208140g/index.htm&VOLNO=%26nbsp%3B%3Cb%3E20%3C%2Fb%3E&Yr=2003&Fp=476&Ep=493&JournalCode=NP&Iss=5&CFID=450082&CFTOKEN=82896682<br>
Host name           128.111.125.82<br>
Host ip             128.111.125.82<br>
Auth Type           <br>
Remote User         <br>
Auth User           <br>
Remote Ident        <br>
Content Type        <br>
Content Length      0<br>
Http referer        <br>
Http user agent     Mozilla/4.0 (compatible; MSIE 6.0; Windows NT 5.0)<br>
JAS server Used	    jas2<br>
Primary Server          jas2
Secondary Server        jas1 
-->
																				